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General Introduction 
 
   Our surroundings are full of organic compounds such as pharmaceuticals, functional materials, 
pesticides, perfumes, and paints.   Thus, the academic and social contribution of synthetic organic 
chemistry supporting the basis of our living is extremely high.   However, it is still far from the 
ultimate craftsmanship of "carbon skeleton construction by freely molecular transformation 
reaction".   Various molecular transformation reactions have been reported so far, but many of 
them require preparation of highly reactive bonds beforehand and require multiple stages, so that 
byproducts accompanied by it are inevitable to generate.   In other words, when designing 
complex molecules including development of pharmaceuticals and functional materials, it is 
important how to synthesize the target compound in a short process while controlling the reaction 
with high selectivity and efficiency.   Therefore, reducing the number of reaction steps as much as 
possible, and developing the high regio- and stereoselective carbon skeleton formation is extremely 
attractive from the viewpoint of resource saving, energy saving, and atomic economics. 
   Research on organic synthetic chemistry is roughly divided into "reaction" and "synthesis".   
Research on "reaction" is the main purpose of developing "novel synthesis means" that has never 
existed before.   On the other hand, research on "synthesis" is aimed at "establishment of synthesis 
method of desired compound", which leads to understanding and exploration of the chemical 
properties of the compound itself and related compounds.   Therefore, research on "reaction" and 
"synthesis" becomes "two sides of the same coin" and development of organic synthetic chemistry 
will eventually be applied to "creation of new compounds" and "development of mass synthesis 
method".   In this trend of organic synthetic chemistry, we focus on "development of reaction" 
and are conducting research.   In developing reactions to establish new synthetic means, we 
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approach organometallic chemistry as a base.   This organometallic chemistry has achieved the 
development of synthetic means that breaks common sense by maximizing the features of transition 
metal complexes.   Catalytic reactions using transition-metals, such as cross-coupling reactions, 
are extremely useful in organic synthesis, from the synthesis of physiologically active substances to 
the synthesis of biaryls that can be used for liquid crystal materials, so the application range is 
extremely broad.1   The author focused on "activation of multiple bonds" which is a feature of 
transition metal complexes.   That is, molecules having multiple bonds such as olefins, alkynes, 
and carbonyl compounds are coordinated to the transition metal complex and activated, whereby 
oxidative cyclization proceeds to form metallacycle.2   Transition-metal-catalyzed reactions via 
metallacycles generated by oxidative cyclization are one of the most efficient methods to connect 
multiple components in one step, because it shows various reactivity and can be converted into 
various compounds.3   For example, metallacycles has been used as important intermediates in the 
olefin metathesis, cyclization, oligomerization, and polymerization, and various catalytic reactions 
have been reported numerous.   On the other hand, the development of reactions using 
oxametallacycles in which the carbon next to the metal has been replaced by oxygen has developed 
much less.   Formation of oxametallacycle containing the early transition metal was reported, but 
it was difficult to use it as an efficient reaction intermediate because of stronger oxygen affinity (ex. 
Ti−O: 157.6 kcal/mol, V−O: 153.3 kcal/mol).   That is, many of them required stoichiometric 
amounts of transition metal complexes.   In recent years, attempts have been made to develop 
catalytic reactions through oxametallacycle formation by late transition metals.   In particular, 
nickel and palladium have relatively low affinity with oxygen, and oxidation addition and reductive 
elimination are relatively easy to proceed, so that reactions using oxanickelacycle and 
oxapalladacycle as active species are actively researched. 2,4 
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   As a pioneering example, in 1997, Montgomery and co-workers have reported that the reductive 
coupling reaction of alkynes with aldehydes proceeded to give the corresponding enyl alcohols via 
oxanickelacycles (Scheme 1, top).5   In 1998, Kimura, Tamaru, and co-workers have reported that 
the reductive coupling of conjugated diene and aldehyde via oxanickelacycle proceeds to provide 




Scheme 1. Ni-Catalyzed C−C Bond Formation Reactions via Oxanickelacycles 
 
   In 2004, the elegant work by Kurosawa, Ogoshi, and co-workers for the first time isolated and 
identified the oxanickelacycle, demonstrated the reaction mechanism, and is spurring the 
development of a new catalytic reaction (Scheme 2).7 
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   Our research group is actively studying C−C bond formation8 reactions to construct the carbon 
skeleton at once utilizing oxametallacycles as key active species.   For example, Kimura, Tamaru, 
and co-workers have previously demonstrated that Ni-catalyzed four-component coupling reaction 
of 1,3-butadiene, alkyne, aldehyde, and Me2Zn proceeds to furnish (3E, 6Z)-octadien-1-ol with high 
stereoselectivity and in excellent yield (Scheme 3, top).8a   Furthermore, our group have 
developed that Ni-catalyzed five-component coupling reaction of 1,3-butadiene, alkyne, aldehyde, 
amine, and Me2Zn to afford dienyl amine in excellent yield (Scheme 3, middle).8b, 8c   Recently, 
our group have reported that Ni-catalyzed stereoselective coupling reaction of vinylepoxide, alkyne, 








Scheme 3. Ni-Catalyzed C−C Bond Formation Reactions via Oxanickelacycles 
 
   Our research group is also studying C−C bond cleavage reactions via oxametallacycles as key 
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smooth transformation of vinyl cyclic carbonates into the corresponding ω-dienyl aldehydes by 
decarboxylative fragmentation through a key oxapalladacycle intermediates (Scheme 4, top).9a   
4-Pentene-1,3-diols also underwent the dehydrative β-carbon elimination of oxapalladacycles 
promoted by Pd(0) catalyst and organoboran reagent (Scheme 4, bottom).9b      Despite the 
conflicting reactions of bond cleavage and bond formation, it is very interesting that the reaction 
proceeds through a common oxametallacycle key active species.   From such a point of view, the 
author has started to develop a highly efficient tandem organic synthesis reaction using the 
characteristics of the transition metal catalyst for the purpose of exploring new possibilities of 
oxametallacycle exhibiting unique reactivity. 
 
Scheme 4. Pd-Catalyzed C−C Bond Cleavage Reaction via Oxapalladacycles 
 
 
   This thesis consists of four chapters. 
   Chapter 1 describes that Ni-catalyzed selective formation of unsaturated carboxylic acids and 
phenylacetic acids via cleavage of the C=C double bond.10   In the presence of Ni(0) catalyst and 
PPh3, the regio- and stereoselective three-component coupling reaction of diketene, alkyne, and 
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instead of Me2Al(OMe) as organoalminium reagent, [2+2+1+1] type cycloaddition reaction of 
diketene and two equivalents of alkynes provided phenylacetic acids (Scheme 5, path B).   The 
structures of the products suggested that these reactions might proceed via C=C bond cleavage of 
diketene. 
 
Scheme 5. Nickel-Catalyzed Multicoupling Reaction of Diketene, Alkyne, and Organometallic 
Reagents 
 
   Chapter 2 deals with Ni-catalyzed CO2 rearrangement of enol metal carbonates for the efficient 
synthesis of β-ketocarboxylic acids (Scheme 6).11   In the presence of Ni(0) catalyst, the 
three-component coupling reaction of 4-methylene-1,3-dioxolan-2-one, alkyne, and Me2Al(OMe) 
proceeded to give δ,ε-unsaturated β-ketocarboxylic acids with high regio- and stereoselectivities.   
The main difference compared with the decarboxylation conversion of the previously reported 
vinyl-substituted cyclic carbonates is that all atoms of the carbonate substrate are retained in the 
final product, that is, this is not a decarboxylative transformation.   The presence of Me2Al(OMe) 
is crucial toward the selective formation of β-ketocarboxylic acids, and other organometallic 
reagents such as Me3B and Me2Zn proved to be less efficient. An eight-membered nickelacycle and 
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Scheme 6. Nickel-Catalyzed CO2 Rearrangement of Enol Metal Carbonates for the Efficient 
Synthesis of δ,ε-Unsaturated β-Ketocarboxylic Acids 
 
   Chapter 3 describes that Ni-catalyzed three-component coupling of 
4-methylene-2-oxazolidinone, alkyne, and trimethylaluminium (Scheme 7).12   In the presence of 
Ni(0) catalyst, the regio- and stereoselective three-component coupling reaction of 
4-methylene-2-oxazolidinone, alkynes, and Me3Al accompanied by extrusion of carbon dioxide to 
furnish 2-amino-1,4-hexadiene in good yields.   The products are useful as the synthetic enamine 
key intermediates for the preparation of nitrogen containing compounds.  The study is in progress 
to apply our protocol to the synthesis of physiologically active molecules, such as unsaturated 
amines and amino acids. 
 
 
Scheme 7. Ni-Catalyzed Three-Component Coupling Reaction of 4-Methylene-2-oxazolidinone, 
Alkyne, and Me3Al 
 
   Chapter 4 deals with Reconstruction of Carbon Bond Frameworks via Oxapalladacycle 
Promoted by Synergistic Effect of Palladium Catalyst and Triethylborane (Scheme 8).13   In the 
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acids with aldehydes proceeds to provide the corresponding 3,5-hexadien-1-ols with good 
stereoselectivities.   3-Hydroxy-4-pentenoic acid behaved as a conjugated diene equivalent in this 
reaction system.  Notably, the reaction proceeded through an unique process of the C−C bond 
cleavage and successive C−C bond formation under single operation. 
 
 
Scheme 8. Pd-Catalyzed C−C Bond Formation Utilizing 3-Hydroxy-4-pentenoic Acids as an 
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Chapter 1 
 
Nickel-Catalyzed Selective Formation of Unsaturated Carboxylic Acids 














Summary: In the presence of Nickel catalyst and PPh3, the regio- and stereoselective 
multicomponent coupling reaction of diketene, alkyne, and Me2Al(OMe) proceeded to give 
3,5-hexadienoic acids (path A).   On the other hand, by use of Et2Al(OEt) instead of Me2Al(OMe) 
under the similar reaction conditions, [2+2+1+1] cycloaddition reaction of diketene and two 
equivalents of alkynes provided phenylacetic acids (path B).   These reactions might proceeds via 

















(path A) (path B)!
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Introduction 
    
   Metallacycles formed from unsaturated hydrocarbon and transition metal complex, are attractive 
and convenient key intermediates for C−C bond cleavage and C−C bond formation reactions.1   
Above all, the reaction via nickelacycle is an efficient synthetic method for the construction of 
useful and complicated molecules in modern organic chemistry.2   We reported the 
Nickel(0)-catalysed multicomponent coupling reaction of vinylcyclopropane, alkyne, and Me2Zn to 
accomplish the C−C bond formations with high regio- and stereoselectivity (Scheme 1).3   These 
coupling reactions proceeded via oxanickelacyle intermediates by oxidative cyclization of 
unsaturated hydrocarbons and a Nickel(0) catalyst. 
 
 
Scheme 1. Nickel-Catalyzed Coupling Reaction of Vinylcyclopropane, Alkyne, and Me2Zn 
 
   In the course of our study on the multicomponent coupling reaction, we have focused on a 
diketene as a starting material for the efficient formation of oxanickelacycle species.   Diketene is 
a unique and important key intermediate formed by dimerization of ketene,4 and is often used as an 
acetoacetylation reagent for versatile nucleophiles, such as alcohols, amines, thiols and carbanions, 
in organic synthesis (Scheme 2, path A).5   On the other hand, in the presence of transition metal 
catalysts, diketene smoothly reacts with organometallic compounds, such as Grignard reagents and 
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bond (Scheme 2, path B).6   The 3-butenoic acid skeleton serves as a synthon for the preparation 
of physiologically active molecules and the fine chemicals.7 
 
 
Scheme 2. Reactivity of Diketene with Nucleophiles 
 
   We have previously demonstrated the Nickel-catalyzed three-component coupling reaction of 
diketene, alkyne, and Me2Zn provided 3-methylene-4-hexenoic acids with excellent regio- and 
stereoselectivity (Scheme 3, path A).8   By use of Et2Al(OEt) instead of Me2Zn, [2+2+2] 
cycloaddition reaction of diketene and two equivalents of alkynes proceeded to give phenylacetic 
acids (Scheme 3, path B). 
    
 
Scheme 3. Nickel-Catalyzed Multicoupling Reaction of Diketene, Alkyne, and Organometallic 
Reagents 
 
   Herein, we disclose the multi-component coupling reaction of diketene, alkyne, and 
Me2Al(OMe) under a Ni/PPh3 catalytic system via oxanickelacycles proceeded to give 
3,5-hexadienoic acids (Scheme 4, path A).   Furthermore, by use of Et2Al(OEt) instead of 





























(path A) (path B)
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and two equivalents of alkynes provided phenylacetic acids (Scheme 4, path B).   The structure of 
the product suggested that these reactions proceeded via C=C bond cleavage of diketene.   
Although nickel-catalyzed cycloaddition reactions with alkynes have been developed, efficient 
syntheses of phenylacetic acids by a cycloaddition reaction between an alkyne and diketene have 
not been reported to date. 
 
 
Scheme 4. Nickel-Catalyzed Multicoupling Reaction of Diketene, Alkyne, and Organometallic 


















(path A) (path B)!
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Results and Discussion 
 
   The optimization of the reaction conditions are summarized in Table 1.   In the presence of 
Ni catalyst, diketene underent a coupling reaction with 3-hexyne and Me2Zn to afford 
3-methylene-4-hexenoic acid 3a in 58% yield (Entry 1, Table 1).   By use of PPh3 as a ligand, 3a 
was obtained in 45% yield, along with the isomeric product, 3,5-hexadienoic acid 4a, in 6% yield as 
a byproduct (Entry 2, Table 1). Interestingly, when Me3Al was used as an organometallic reagent 
instead of Me2Zn, the desired reaction proceeded to give 4a as a main product (Entry 3, Table 1).   
Me2Al(OMe) was the most efficient organoaluminium reagent for this reaction (Entry 4, Table 1).   
The features of the coupling reaction of diketene and alkyne, promoted by a nickel/PPh3 catalytic 
system, changed dramatically when organoaluminum reagents bearing an ethyl group were used in 
place of Me2Al(OMe).   By use of Et3Al and Et2Al(OEt), a formal [2+2+1+1] cycloaddition 
reaction proceeds to afford the phenylacetic acid derivatives 5a in 46% and 73% yields, 
respectively (Entries 5 and 6, Table 1).   Encouraged by these results, we examined the effects of 
various ligands in the presence of Ni(cod)2.   However, n-Bu3P, PCy3, XPhos, DPPE, DPPF, 
Xantphos, and IPr were not effective for these reactions (Entries 7-18, Table 1).   
 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  20 
Table 1. Optimization of the Reaction Conditions for Nickel-Catalyzed Multicoupling Reaction of 
Diketene, Alkyne, and Organometallic Reagents via C=C Bond Cleavagea 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (10 mol%), ligand (10-20 mol%), diketene (3.0 
mmol), alkyne (1.0 mmol), and organoaluminium reagent (1.2 mmol) at room temperature under nitrogen 



























Entry Ligand (mol%) Organoaluminum
Isolated Yield [%]
3a 4a 5a
1 none Me2Zn 58 0 0
2 PPh3 Me2Zn 45 6 0(20)
3 PPh3 Me3Al 20 60 0(20)
4 PPh3 Me2Al(OMe) 22 77 0(20)
5 PPh3 Et3Al 0 0 46(20)
6 PPh3 Et2Al(OEt) 0 0 73(20)
7 n-Bu3P Me2Al(OMe) trace trace 0(20)
8 PCy3 Me2Al(OMe) trace trace 0(20)
9 XPhos Me2Al(OMe) 0 trace 0(20)
10 DPPE Me2Al(OMe) 0 0 0(10)
11 DPPF Me2Al(OMe) 0 0 0(10)
12 Xantphos Me2Al(OMe) 0 9 0(10)
13 IPr Me2Al(OMe) 0 11 0(10)
14 n-Bu3P Et2Al(OEt) 0 0 0(20)
15 PCy3 Et2Al(OEt) 0 0 20(20)
16 DPPF Et2Al(OEt) 0 0 23(10)
17 Xantphos Et2Al(OEt) 0 0 3(10)
18 IPr Et2Al(OEt) 0 0 0(10)
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   Next, we considered the desired product 4a and the by-product 3a possibly being isomerized 
with each other, and examined the reaction time.   The results are summarized in Table 2.   
Although the reaction time was examined, there was almost no change in the formation ratio of 
products 4a and 3a (Entries 1-3, Table 2). 
 
Table 2. Investigation of the Reaction Timea 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (10 mol%), PPh3 (20 mol%), diketene (3.0 mmol), 
3-hexyne (1.0 mmol), and Me2Al(OMe) (1.2 mmol) at room temperature under nitrogen atmosphere for 3-72 
h. 
 
   Furthermore, separately isolated 3a was unreacted under the optimized conditions and no 
isomerization was observed but 3a was recovered (Scheme 5).   Based on these experimental 
results, we believe that products 4a and 3a were provided via completely different reaction 
























4a 3a 4a : 3a
1 3 61 18 3.4 : 1
2 24 74 22 3.4 : 1
3 72 77 22 3.5 : 1
+
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Scheme 5. Isomerization Experiment under the Optimized Conditions 
 
   Then, a similar coupling reaction using a wide variety of alkynes under optimized conditions 
was investigated.   At first, we examined the three-component coupling reaction with a variety of 
alkynes, diketene and Me2Al(OMe), and the results are summarized in Table 3.   Symmetrical 
substituted alkynes, such as 2-butyne, 3-hexyne, 4-octyne, 5-decyne, and diphenyl acetylene reacted 
with diketene and Me2Al(OMe) smoothly to provide unsaturated carboxylic acids 4a-e in moderate 
to good yields (Entries 1-5, Table 3).   However, when dimethyl acetylenedicarboxylate was used, 
the desired reaction did not proceed (Entry 6, Table 3).   In the case of terminal alkynes, such as 
3,3-dimethyl-1-butyne and phenylacetylene, the reaction provided the corresponding unsaturated 


















Not Observed !! 72%(1.0 mmol)
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Table 3. Ni-Catalyzed Three-Component Coupling Reaction of Diketene, Alkyne, and 
Me2Al(OMe) via C=C Bond Cleavagea 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (10 mol%), PPh3 (20 mol%), diketene (3.0 mmol), 
alkyne (1.0 mmol), and Me2Al(OMe) (1.2 mmol) at room temperature under nitrogen atmosphere for 72 h. 
 
   Next, we investigated the multicoupling reaction with a variety of alkynes and diketene using 
Ni/PPh3/Et2Al(OEt) system, and the results are summarized in Table 4.   In the case of 
symmetrical substituted alkynes, such as 2-butyne, 3-hexyne, 4-octyne, 5-decyne, and diphenyl 
acetylene reacted with diketene and Et2Al(OEt) smoothly to provide phenylacetic acids 5a-e in 
moderate to good yields (Entries 1-5, Table 4).   On the other hand, dimethyl 
acetylenedicarboxylate was not effective for this reaction (Entry 6, Table 4).   When 
























1 Me Me 4b : 61 3b : 26 87
2 Et Et 4a : 77 3a : 22 99
3 n-Pr n-Pr 4c : 77 3c : 14 91
4 n-Bu n-Bu 4d : 66 3d : 10 76
5 Ph Ph 4e : 50 3e : 17 67
6 CO2Me CO2Me 0 0 0
7 t-Bu H 4f : 47 0 47
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good yields (Entry 7, Table 4).   In the case of 4-methyl-2-pentyne, the desired product 5g was 
obtained in low yield as a mixture of regioisomers (Entry 8, Table 4).   Terminal alkynes, such as 
trimethylsilylacetylene and 3,3-dimethyl-1-butyne, the multicoupling reaction provided the 
corresponding phenylacetic acids 5h-i in low to moderate yields as a single product  (Entries 9-10, 
Table 4).  
 
Table 4. Ni-Catalyzed Multicoupling Reaction of Diketene and Alkyne Using Ni/PPh3/Et2Al(OEt) 
System via C=C Bond Cleavagea 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (10 mol%), PPh3 (20 mol%), diketene (3.0 mmol), 





















1 Me Me 5b : 60
2 Et Et 5a : 73
3 n-Pr n-Pr 5c : 80
4 n-Bu n-Bu 5d : 71
5 Ph Ph 5e : 50
6 CO2Me CO2Me 0
7 TMS Me 5f : 45




9 TMS H 5h : 60
10 t-Bu H 5i : 34
[single]
[single]
Isolated Yield of 5 [%]
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   The structures of the products were determined based on coupling constants from 1H NMR 
spectral data and NOE experiment.   The selected data for the NOE observed by the irradiation are 
illustrated in Figure 1. 
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   The reactions of a stoichiometric amount of Ni(cod)2, PPh3, alkyne, and diketene without 
Et2Al(OEt) were conducted (Scheme 6).    
 
 
Scheme 6. C=C Bond Cleavage Reaction of Diketene Prompted by Stoichiometric Amount of 
Ni(cod)2 and PPh3 
 
   The reaction mixture of Ni(cod)2 (0.5 mmol), PPh3 (1.0 mmol), 3-hexyne (1.0 mmol), and 
diketene (0.5 mmol) stirred for 72 hours followed by hydrolysis with acidic water provided the 
phenylacetic acid 5a in 54% (Scheme 6, Eq. (a)).  Hydrolysis of the reaction mixture at 1 hour 
afforded  (3E)-4-ethyl-5-methylene-3-heptenoic acid 6a as a sole product in 80% yield with high 






























Under N2, r.t., 1 h
1a 2a 6a : 80%

















Under N2, r.t., 1 h
1a 2a
8a : 39%
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Furthermore, as for the stoichiometric reaction of a mixture of Ni(cod)2 (0.5 mmol), PPh3 (1 mmol), 
3-hexyne (0.5 mmol), and diketene (0.5 mmol), addition of PhMgBr to the reaction mixture 
provided (3Z)-4-ethyl-5-methylene-3-phenyl-3-heptenoic acid 7a in 26% along with 
(3Z)-4-ethyl-5-methylene-3-[(3Z)-4-phenyl-3-hexenyl]-3-heptenoic acid 8a in 39% (Scheme 6, Eq. 
(c)).   These results suggest that scission of the C-C double bond is triggered by synergistic effects 
of both Ni(0) metal and PPh3 ligand, and Et2Al(OEt) seems to serve as a promoter to regenerate 
active Ni(0) species for the catalytic reaction system through an important key intermediate.9 
 
   A plausible reaction mechanism for the coupling reactions of diketene and alkyne promoted by 
a nickel catalyst, PPh3, and organoaluminium reagents are illustrated in Scheme 7 and 8.   In the 
presence of Ni(cod)2 and PPh3 ligand, promotes diketene to undergo the oxidative cyclization with 
alkyne to form the nickelacyclopentene intermediate I.   The active metallacycle I having PPh3 
ligand invokes C-C bond cleavage reaction via nickel carbene cyclopropane rearrangement to form 
the nickelacyclopentene IV.10   [1,2]-Shift of the Ni atom proceeds to avoid the distortion of the 
spiro-β-lactone ring giving rise to the oxanickelacycle V.   In the case of Me2Al(OMe), the methyl 
group transfer from Me2Al(OMe) to nickel provides unsaturated carboxylic acids 4 by reductive 
elimination and liberation of the active Ni(0) catalyst (Scheme 7). On the other hands, in the case of 
Et2Al(OEt), cycloaddition reaction of oxanickelacycle V and alkyne to form vinylnickel 
intermediate VI (Scheme 8).11   Intramolecular carbonickelation follows by aromatization 
provides phenylacetic acids 5 by transmetalation with Et2Al(OEt) accompanying the regeneration of 
catalytically active Ni(0) species.12 
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Scheme 7. Plausible Reaction Mechanism for the Formation of 3,5-Hexadienoic Acid 4 
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Conclusion 
 
   In conclusion, in the presence of nickel catalyst and PPh3, the regio- and stereoselective 
multicomponent coupling reaction of diketene, alkyne, and Me2Al(OMe) demonstrated to give 
3,5-hexadienoic acids 4 via C=C bond cleavage reaction.   Interestingly, by use of Et2Al(OEt) 
instead of Me2Al(OMe) under the similar reaction conditions, phenylacetic acids derivatives 5 are 
constructed via the formal [2+2+1+1] cycloaddition reactions with diketene and 2 equivalents of 
alkyne accompanying the cleavage reaction of methylene C=C bond of diketene.   This is the first 
example of the selective formation of unsaturated carboxylic acids and phenylacetic acids from 
diketene involving oxanickelacycles.  This protocol might be a powerful and useful tool in the 
expedient synthesis of the physiologically active molecules, such as isoprenoid acids and 
non-steroidal anti-inflammatory drugs (NSAIDs). 
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Experimental Section 
 
   Reactions employed oven-dried glassware unless otherwise noted.  Thin layer chromatography 
(TLC) employed glass 0.25 mm silica gel plates with UV indicator (Merck, Silica gel 60F
254
).  
Flash chromatography columns were packed with 230-400 mesh silica gel as a slurry in hexane.  
Gradient flash chromatography was conducted eluting with a continuous gradient from hexane to 
the indicated solvent.  Proton and carbon NMR data were obtained with a JEOL-GX400 with 
tetramethylsilane as an internal standard.  Chemical shift values were given in ppm downfield 
from the internal standard.  Infrared spectra were recorded with a JASCO A-100 FT-IR 
spectrophotometer.  High resolution mass spectra (HRMS) were measured with a JEOL 
JMS-DX303.  
 
Solvents and Reagents  
   Anhydrous toluene were purchased (Aldrich) and used without further purification.   Ni(cod)2, 
PPh3, n-Bu3P, PCy3, XPhos, DPPE, DPPF Xantphos 
[4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene], Ipr, Me2Zn (1.0 M hexane solution), Me3Al 
(1.0 M hexane solution), Et3Al (1.0 M hexane solution), Et2Al(OEt) (1.0 M hexane solution) (Kanto 
Kagaku) were purchased and used without further purification.  2-Butyne, 3-hexyne, 4-octyne, 
diphenyl acetylene, dimethyl acetylenedicarboxylate, 1-trimethylsilyl-1-propyne, 
4-methyl-2-pentyne, 3,3-dimethyl-1-butyne, phenylacetylene,  and trimethylsilylacetylene (Tokyo 
Kasei Kogyo Co., Ltd) were purchased and distilled prior to use.  Diketene (Tokyo Kasei Kogyo 
Co., Ltd) was purchased and used without further purification.   
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Preparation of Me2Al(OMe) Reagent 
   A 25 mL two-necked round-bottomed flask equipped with a rubber septum was charged with 
Me3Al solution (2.0 mL of 1.0 M in hexane, 2 mmol, Kanto Kagaku) under argon atmosphere. 
Anhydrous MeOH (2.0 mmol, Wako) was added to the Me3Al solution via syringe at 0 ℃ for 30 
min. 
 
General Procedure A: Formation of Unsaturated Carboxylic Acids from Diketene Promoted 
by Ni-Catalyst (Entry 4, Table 1) 
   To a solution of Ni(cod)2 (27.5 mg, 0.1 mmol) in dry toluene (3.0 mL) were successively added 
diketene (252.2 mg, 3.0 mmol), 3-hexyne (82.1 mg, 1 mmol), and Me2Al(OMe) (1.2 mmol, 1.0 M 
hexane solution) via syringe under nitrogen atmosphere.  The mixture was stirred at room 
temperature for 72 h.  The mixture was diluted with 30 mL of EtOAc and washed with 2 N HCl, 
and then brine.  The extract was dried (MgSO4) and concentrated in vacuo and the residual oil was 
subjected to column chromatography over silica gel (hexane/EtOAc = 4/1 v/v) to give 4a along with 
3a as a minor product (180.3 mg, 77% and 22%, respectively, Rf = 0.33; hexane/EtOAc = 4/1 v/v).   
 
General Procedure B: Formation of Phenylacetic Acids from Diketene Promoted by 
Ni-Catalyst (Entry 6, Table 1) 
   To a solution of Ni(cod)2 (27.5 mg, 0.1 mmol) in dry toluene (3.0 mL) were successively 
added diketene (252.2 mg, 13.0 mmol), 3-hexyne (82.1 mg, 1 mmol), and Et2Al(OEt) (1.2 mmol, 
1 M hexane solution) via syringe under nitrogen atmosphere.  The mixture was stirred at room 
temperature for 72 h.  The mixture was diluted with 30 mL of EtOAc and washed with 2 N HCl, 
and then brine.  The extract was dried (MgSO4) and concentrated in vacuo and the residual oil 
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was subjected to column chromatography over silica gel (hexane/EtOAc = 2/1 v/v) to give 3a 
(100.7 mg, 81%, Rf = 0.67; hexane/EtOAc = 4/1 v/v). 
 
General Procedure C: C-C Bond Cleavage Reaction of Diketene Promoted by 
Stoichiometric Amount of Ni(0) Followed by Hydrolysis with Acid Aqueous Solution 
(Scheme 6, Eq.(b)) 
   To a solution of Ni(cod)2 (137.5 mg, 0.5 mmol), and PPh3 (262.3 mg, 1.0 mmol) in dry 
toluene (5 mL) were successively added diketene (42.0 mg, 0.5 mmol), 3-hexyne (82.1 mg, 1.0 
mmol) via syringe under nitrogen atmosphere.  The mixture was stirred at room temperature for 
1 h.  After the reaction, added 2 N HCl and stirred for overnight at room temperature.  The 
mixture was diluted with 30 mL of EtOAc and washed with brine.  The extract was dried 
(MgSO4) and concentrated in vacuo and the residual oil was subjected to column 
chromatography over silica gel (hexane/EtOAc = 4/1 v/v) to give 6a (67.3 mg, 80%, Rf = 0.33; 
hexane/EtOAc = 4/1 v/v). 
 
General Procedure D: C-C Bond Cleavage Reaction of Diketene Promoted by 
Stoichiometric Amount of Ni(0) Followed by Treatment with PhMgBr 
   To a solution of Ni(cod)2 (137.5 mg, 0.5 mmol), and PPh3 (262.3 mg, 1.0 mmol) in dry 
toluene (5 mL) were successively added diketene (42.0 mg, 0.5 mmol), 3-hexyne (41.1 mg, 0.5 
mmol) via syringes under nitrogen atmosphere.  The mixture was stirred at room temperature 
for 1 h.  PhMgBr solution (0.6 mmol of 1M THF solution) was introduced via a syringe and the 
reaction mixture was stirred at room temperature for 24 h.  After the reaction, added 2 N HCl 
and stirred for overnight at room temperature.  The mixture was diluted with 30 mL of EtOAc 
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and washed with 2 N HCl, and extraction with EtOAc.  Combined organic phase was washed 
with brine and the extracts were dried (MgSO4) and concentrated in vacuo, and the residual oil 
was subjected to column chromatography over silica gel (hexane/EtOAc = 4/1 v/v) to give a 
mixture of (3Z)-4-Ethyl-5-methylene-3-phenyl-3-heptenoic acid 7a (31.8 mg, 26%, Rf = 0.4; 
hexane/EtOAc = 4/1 v/v) and 
(3Z)-4-Ethyl-5-methylene-3-[(3Z)-4-phenyl-3-hexenyl]-3-heptenoic acid 8a (31.9 mg, 39%, Rf = 
0.43; hexane/EtOAc = 4/1 v/v) 
 
 
(E)-4-ethyl-3-methyl-5-methylenehept-3-enoic acid (4a).   
IR (neat) 3095 (s), 2965 (s), 2876 (s), 2563 (br), 1697 (s), 1633 (m), 1410 (m), 1377 (m), 1196 
(m), 899 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.93 (t, J = 7.3 Hz, 3 H), 0.99 (t, J = 7.3 Hz, 3 
H), 1.74 (s, 3 H), 2.09 (q, J = 7.3 Hz, 2 H), 2.11 (q, J = 7.3 Hz, 2 H), 3.13 (s, 2 H), 4.63 (d, J = 
1.9 Hz, 1 H), 4.96 (d, J = 1.9 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ12.0, 12.8, 20.4, 24.2, 
28.5, 38.7, 111.1, 121.2, 142.3, 150.4, 178.1; High-resolution MS, calcd for C11H18O2: 182.1307 
Found m/z (relative intensity): 183 (M++1, 12), 182.1300(M+, 100), 167(21), 153(91), 137(18). 
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IR (neat) 2964 (s), 2934 (s), 2874 (s), 2584 (brs), 1711 (s), 1630 (m), 1406 (m), 1375 (m), 907 (s) 
cm-1; 1H NMR (400 MHz, CDCl3) δ 0.92 (t, J = 7.6 Hz, 3 H), 0.98 (t, J = 7.6 Hz, 3 H), 1.67 (s, 3 H), 
2.06 (q, J = 7.6 Hz, 2 H), 2.10 (q, J = 7.6 Hz, 2 H), 3.10 (s, 2 H), 4.84 (d, J = 1.9 Hz, 1 H), 5.18 (d, 
J = 1.9 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 13.0, 13.4, 19.0, 23.1, 26.5, 41.4, 116.9, 133.0, 
135.6, 141.7, 175.7; High-resolution MS, calcd for C11H18O2: 182.1307. Found m/z (relative 
intensity): 183 (M++1, 14), 182.1312 (M+, 100), 137 (26). 
 
 
(3E)-3,4,5-Trimethylhexa-3,5-dienoic acid (4b). 
IR (neat) 3076 (s), 2916 (s), 2677 (br), 1715 (s), 1636 (m), 1437 (s), 1412 (s), 1375 (s), 1290 (s), 
897 (s), 741 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 1.77 (s, 6 H), 1.79 (dd, J = 1.5, 1.0 Hz, 3 H), 
3.11 (s, 2 H), 4.63 (dq, J = 2.4, 1.0 Hz, 1 H), 4.90 (dq, J = 2.4, 1.5 Hz, 1 H); 13C NMR (CDCl3, 
100MHz) δ 18.2, 20.1, 21.7, 39.0, 112.2, 121.0, 136.7, 147.2, 176.7; High-resolution MS, calcd for 
C9H14O2: 154.0994. Found m/z (relative intensity): 155 (M++1, 6), 154.0995 (M+, 57), 139 (100). 
 
 
4,5-Dimethyl-3-methylenehex-4-enoic acid (3b). 
IR (neat) 3085 (br), 2976 (s), 2920 (s), 2862 (s), 2679 (m), 2573 (m), 1713 (s), 1636 (m), 1412 (m), 
1294 (s), 907 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.68 (s, 3 H), 1.70 (s, 3 H), 1.73 (s, 3 H), 3.14 
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20.1, 21.7, 41.1, 115.8, 127.4, 129.0, 143.5, 176.9; High-resolution MS, calcd for C9H14O2: 
154.0994. Found m/z (relative intensity): 155 (M++1, 45), 154.0989 (M+, 100), 140 (68), 139 (100), 
137 (24), 125 (32). 
 
 
(E)-3-methyl-5-methylidene-4-propyloct-3-enoic acid (4c). 
IR (neat) cm-1; 3074 (s), 2961 (s), 2874 (s), 2654 (br), 1730 (s), 1632 (m), 1467 (m), 1379 (m), 
1173 (m), 901 (m) cm-1 ; 1H NMR (400 MHz, CDCl3) δ 0.87 (t, J = 7.3 Hz, 3 H), 0.92 (t, J = 7.6 
Hz, 3 H), 1.31-1.38 (m, 4 H), 1.76 (s, 3 H), 2.02-2.08 (m, 4 H), 3.13 (s, 2 H), 4.63 (d, J = 2.4 Hz, 
1 H), 4.95 (d, J = 2.4 Hz, 1 H) ; 13C NMR (100 MHz, CDCl3) δ13.9, 14.1, 20.5, 20.8, 21.4, 33.0, 
37.9, 38.9, 112.3, 122.1, 141.0, 149.3, 177.9 ; High-resolution MS, calcd for C13H22O2: 210.1620 
Found m/z (relative intensity): 211 (M++1, 10), 210.1615 (M+, 100), 195 (13), 181 (22), 167 (77). 
 
 
(E)-5-Methyl-3-methylene-4-propyloct-4-enoic acid (3c). 
IR (neat) 3074 (br), 2931 (s), 2872 (s), 2682 (br), 2598 (br), 1713 (s), 1632 (m), 1410 (m), 1302 (s), 
1223 (m), 905 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.87 (t, J = 7.6 Hz, 3 H), 0.89 (t, J = 7.6 Hz, 
3 H), 1.32 (sext, J = 7.6 Hz, 2 H), 1.40 (sext, J = 7.6 Hz, 2 H), 1.67 (s, 3 H), 2.03 (t, J = 7.6 Hz, 2 
H), 2.07 (t, J = 7.6 Hz, 2 H), 3.10 (s, 2 H), 4.83 (d, J = 2.0 Hz, 1 H), 5.17 (d, J = 2.0 Hz, 1 H); 13C 
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177.3; High-resolution MS, calcd for C13H22O2: 210.1620. Found m/z (relative intensity): 211 (M++1, 
2), 210.1612 (M+, 10), 167 (9), 135 (22), 121 (100). 
 
 
(3E)-4-Butyl-3-methyl-5-methylidenenon-3-enoic acid (4d). 
IR (neat) 3082 (s), 2961(s), 2926 (s), 2669 (br), 1712 (s), 1630 (m), 1460 (s), 1410 (s), 934 (m), 899 
(m), 735 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.90 (t, J = 7.1 Hz, 3 H), 0.91 (t, J = 6.8 Hz, 3 H), 
1.41-1.28 (m, 8 H), 1.75 (s, 3 H), 2.02-2.07 (m, 4 H), 3.21 (s, 2H), 4.62 (d, J = 2.3 Hz, 1 H), 4.95 
(dt, J = 2.3, 1.1 Hz, 1 H) ; 13C NMR (CDCl3, 100MHz) δ 14.0, 14.0, 20.5, 22.6, 22.7, 29.7, 30.5, 
30.7, 35.4, 38.9, 112.2, 121.8, 141.3, 149.5, 178.0; High-resolution MS, calcd for C15H26O2: 
238.1933. Found m/z (relative intensity): 239 (M++1, 11), 238.1933 (M+, 65), 223 (11), 209 (6), 195 
(24), 181 (100). 
 
 
(Z)-3-Methylene-4,5-diphenylhex-4-enoic acid (1e). 
IR (neat) 3020 (br), 2914 (m), 2856 (w), 1709 (s), 1599 (m), 1489 (m), 1443 (s), 1265 (m), 762 (s), 
698 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 2.28 (s, 3 H), 3.00 (s, 2H), 5,36 (d, J = 1.7 Hz, 1 H), 
5,44 (d, J = 1.7 Hz, 1 H), 6.94-7.19 (m, 10 H); 13C NMR (CDCl3, 100 MHz) δ 23.1, 40.9, 118.9, 
126.0, 126.2, 127.5, 127.5, 129.0, 130.2, 136.3, 138.7, 139.5, 141.8, 143.4, 176.8; High-resolution 
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33.7), 219 (100), 204 (26).  
 
 
(3E)-3,6,6-Trimethyl-5-methylidenehept-3-enoic acid (4f). 
IR (neat) 3090 (m), 2961 (s), 2872 (s), 2673 (br), 1715 (s), 1636 (m), 1412 (s), 1290 (s), 1221 (s), 
910 (s), 735 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 1.06 (s, 9 H), 1.78 (s, 3 H), 3.11 (s, 2 H), 4.97 
(s, 1 H), 5.18 (s, 1H), 5.69 (s, 1H); 13C NMR (CDCl3, 100MHz) δ 14.5, 29.0, 31.2, 43.2, 115.2, 
117.0, 121.0, 138.8, 177.4; High-resolution MS, calcd for C11H18O2: 182.1307. Found m/z (relative 
intensity): 183 (M++1, 10), 182.1288 (M+, 74), 181 (3), 167 (100), 152 (2). 
 
 
(3E)-3-Methyl-5-phenylhexa-3,5-dienoic acid (4g). 
IR (neat) 3032 (m), 2918 (m), 2675 (br), 1709 (s), 1443 (m), 1413 (m), 1292 (m), 1223 (m), 908 
(m), 760 (s), 735 (m), 698 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 2.16 (s, 3 H), 3.23 (s, 2 H), 5.18 
(s, 1 H), 5.31 (s, 1 H), 6.20 (s, 1H), 7.24-7.42 (m, 5H); 13C NMR (CDCl3, 100MHz) δ 17.6, 43.0, 
115.2, 118.3, 125.9, 127.1, 128.1, 137.7, 138.1, 143.4, 176.9 ; High-resolution MS, calcd for 
C13H14O2: 202.2491. Found m/z (relative intensity): 203 (M++1, 10), 202.0984 (M+, 67), 201 (1), 
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2-(2,3,5,6-Tetraethylphenyl)acetic acid (5a). 
IR (KBr) 3103 (br), 2968 (s), 2936 (s), 2876 (s), 2719 (br), 2363 (m), 1699 (s), 1483 (m), 1416 (s), 
1231 (s), 939 (m), 887 (s), 802 (m), 656 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.12 (t, J = 7.6 Hz, 
6 H), 1.23 (t, J = 7.6 Hz, 6 H), 2.63 (q, J = 7.6 Hz, 4 H), 2.64 (q, J = 7.6 Hz, 4 H), 3.79 (s, 2 H), 
6.98 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 14.8, 15.5, 22.3, 25.7, 34.4, 128.1, 129.4, 138.2, 139.3, 
177.8; High-resolution MS, calcd for C16H24O2: 248.1776. Found m/z (relative intensity): 249 (M++1, 
14), 248.1770 (M+, 77), 233 (16), 203 (17), 189 (100). 
 
 
2-(2,3,5,6-Tetramethylphenyl)acetic acid (5b). 
IR (KBr) 3086 (br), 3002 (s), 2924 (s), 2874 (s), 2732 (br), 2332 (m), 1695 (s), 1607 (m), 1408 (m), 
1381 (m), 1213 (s), 1010 (m), 935 (m), 868 (m), 681 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 2.20 
(s, 6 H), 2.23 (s, 3 H), 2.24 (s, 3 H), 3.79 (s, 2 H), 6.91 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 16.1, 
20.6, 35.5, 128.8, 129.4, 132.9, 133.7, 175.7; High-resolution MS, calcd for C12H16O2: 192.1150. 
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2-(2,3,5,6-Tetrapropylphenyl)acetic acid (5c). 
IR (KBr) 3103 (br), 2957 (s), 2932 (s), 2870 (s), 2711 (br), 2354 (m), 1703 (s), 1562 (m), 1454 (s), 
1414 (m), 1018 (m), 912 (m), 791 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.99 (t, J = 7.6 Hz, 6 H), 
1.01 (t, J = 7.6 Hz, 6 H), 1.45 (sext, J = 7.6 Hz, 4 H), 1.59 (sext, J = 7.6 Hz, 4 H), 2.50 (t, J = 7.6 
Hz, 4 H), 2.54 (t, J = 7.6 Hz, 4 H), 3.75 (s, 2H), 6.91 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 14.4, 
14.8, 24.0, 24.5, 31.9, 34.8, 35.2, 129.7, 130.0, 137.3, 138.0, 177.7; High-resolution MS, calcd for 
C20H32O2: 304.2402. Found m/z (relative intensity): 304.2392 (M+, 100), 275 (56), 245 (57). 
 
 
2-(2,3,5,6-Tetrabutylphenyl)acetic acid (5d). 
IR (neat) 3075 (br), 2957(s), 2930 (s), 2860 (s), 2669 (m), 2343 (m), 1709 (s), 1464 (m), 1410 (m), 
1379 (m), 1292 (m), 1227 (m), 930 (m), 899 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.95 (m, 12 
H), 1.38-1.46 (m, 16 H), 2.52-2.58 (m, 8 H), 3.75 (s, 1 H), 6.91. (s, 2 H) ; 13C NMR (CDCl3, 100 
MHz) δ 13.8, 13.9, 14.0, 23.0, 23.4, 29.4, 32.8, 32.9, 33.8, 34.9, 124.6, 129.7, 129.9, 137.3, 138.2, 
140.1, 178.6 ; High-resolution MS, calcd for C24H40O2: 360.3028. Found m/z (relative intensity): 
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2-{(2,3,5,6-Tetrahenyl)phenyl}acetic acid (5e). 
IR (neat) 3024 (br), 2866 (s), 2835 (s), 2500 (m), 1717 (s), 1653 (s), 1578 (m), 1420 (s), 1232 (s), 
918 (m), 692 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.66 (s, 2 H), 7.34-7.69 (m, 21 H); 13C NMR 
(CDCl3, 100 MHz) δ37.0, 127.4, 127.5, 128.3, 128.4, 128.5, 128.7, 131.9, 132.0, 171.1; 
High-resolution MS, calcd for C32H24O2: 440.1776. Found m/z (relative intensity): 441 (M++1, 29), 
440.1769 (M+, 43.8), 395 (100). 
 
 
2-(2,5-Dimethyl-3,6-bis(trimethylsilyl)phenyl)acetic acid (5f). 
IR(neat) 2959 (s), 2903 (s), 2667 (w), 1705 (s), 1636 (m), 1410 (m), 1252 (s), 1211 (m), 1150 (m), 
1032 (m), 837 (s), 760 (s), 691 (m), 635 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.31 (s, 9 H), 0.41 
(s, 9 H), 2.32 (s, 3 H), 2.45 (s, 3 H), 3.93 (s, 2 H), 7.19 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 0.0, 
0.8, 14.0, 20.1, 38.8, 136.2, 137.2, 139.3, 139.6, 140.0, 140.5, 176.4; High-resolution MS, calcd for 













	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  41 
 
2-(2,6-diisopropyl-3,5-dimethylphenyl)acetic acid (5g)：(a mixture of regioisomers in a 2 : 1 
ratio). 
IR(neat) 2874 (s), 2899 (s), 2548 (m), 2341 (m), 1713 (s), 1653 (m), 1418 (s), 1265 (s), 1209 (s), 
739 (s),704 (m) cm-1; 1H NMR (400 MHz, CDCl3, major isomer) δ 1.31 (d, J = 7.3 Hz, 12 H),  2.35 
(brs, 6 H), 3.38(br, 2 H), 3.88 (s, 2 H), 6.86 (s, 1 H) ; 13C NMR (100 MHz, CDCl3, major isomer) δ 
21.1, 23.3, 29.4, 36.0, 129.7, 130.2, 133.5, 143.6, 178.0 ; 1H NMR (400 MHz, CDCl3, minor isomer) 
δ 1.20(d, J = 6.8 Hz, 6 H), 1.31(d, J = 7.3 Hz, 6 H), 2.38(s, 6 H), 3.13(sept, J = 6.8 Hz, 2 H), 3.85(s, 
2 H), 6.96(s, 1 H) ; 13C NMR (100 MHz, CDCl3, minor isomer) δ 15.1, 21.7, 23.4, 27.6, 29.7, 30.0, 
36.1, 130.9, 131.4, 133.2, 134.8, 141.7, 143.8, 178.4 ; High-resolution MS, calcd for C16H24O2: 
248.1776 Found m/z (relative intensity): 249 (M++1, 6), 248.1771 (M+, 36.0), 233 (22), 206 (14). 
 
 
2-(2,5-Bis(trimethylsilyl)phenyl)acetic acid (5h). 
IR(neat) 2955 (s), 2899 (s), 2856 (m), 1713 (s), 1410 (m), 1373 (m), 1250 (s), 839 (s), 752 (s), 691 
(m),637 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.26 (s, 9 H), 0.33 (s, 9 H), 3.81 (s, 2 H), 7.40 (d, J 
= 1.0 Hz, 1 H), 7.42 (dd, J = 7.8, 1.0 Hz, 1 H), 7.51 (d, J = 7.3 Hz, 1 H); 13C NMR (CDCl3, 100 
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2-(2,5-Di-tert-butylphenyl)acetic acid (5i). 
IR(neat) 2868 (s), 2550 (s), 2341 (m), 1699 (s), 1464 (s), 1416 (s), 1362 (s), 1231 (s), 1204 (s), 910 
(s), 824 (s), 741 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.29 (s, 9 H), 1.39 (s, 9 H), 3.95 (s, 2 H), 
7.21 (s, 1 H), 7. 33 (d, J = 8.5 Hz, 1 H), 7.38 (d, J = 8.5 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) δ 
31.2, 31.6, 34.0, 36.5, 40.2, 124.0, 126.0, 130.0, 130.8, 148.4, 149.6, 177.8; High-resolution MS, 
calcd for C16H24O2: 248.1776. Found m/z (relative intensity): 248.1768 (M+, 49.5), 233 (100), 216 
(2.5), 203 (1.6). 
 
 
(3E)-4-Ethyl-5-methylene-3-heptenoic acid (6a). 
IR(neat) 2970 (s), 2936 (s), 2878 (s), 1713 (s), 1607 (m), 1413 (s), 1288 (s), 1219 (s), 893 (s) cm-1; 
1H NMR (CDCl3, 400 MHz) δ 0.98 (t, J = 7.5 Hz, 3 H), 1.05 (t, J = 7.5 Hz, 3 H), 2.25 (qd, J = 7.5, 
1.3 Hz, 2 H), 2.25 (q, J = 7.5 Hz, 2 H), 3.21 (d, J = 7.1 Hz, 2 H), 4.92 (d, J = 1.3 Hz, 1 H), 5.03 (s, 1 
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116.1, 144.5, 149.2, 177.7; High-resolution MS, calcd for C10H16O2: 168.1150. Found m/z (relative 
intensity): 169 (M++1, 83.7), 168.1143 (M+, 51.1), 153 (100).  
 
 
A mixture of (3Z)-4-ethyl-5-methylene-3-phenyl-3-heptenoic acid (7a) and 
(3Z)-4-ethyl-5-methylene-3-[(3Z)-4-phenyl-3-hexenyl]-3-heptenoic acid (8a) in a 1 : 2 ratio 
IR(neat) 3402 (br), 3084 (s), 3028 (s), 2966 (s), 2934 (s), 1705 (s), 1636 (s), 1441 (m), 1410 (m), 
1286 (m), 943 (s), 897 (s), 766 (s), 700 (s) cm-1; 1H NMR (CDCl3, 400 MHz, (3g)) δ 0.90 (t, J = 7.5 
Hz, 3 H), 1.05 (t, J = 7.5 Hz, 3 H), 2.31 (q, J = 7.5 Hz, 2 H), 2.33 (q, J = 7.5 Hz, 2 H), 2.78 (s, 2 H), 
4.89 (s, 1 H), 5.01 (s, 1 H), 7.08-7.32 (m, 5 H); 13C NMR (CDCl3, 100 MHz, (3g)) δ 11.9, 12.5, 
26.0, 28.5, 41.7, 118.4, 126.0, 127.6, 128.9, 139.1, 141.8, 143.0, 145.7, 176.2; High-resolution MS 
(3g), calcd for C16H20O2: 244.1463. Found m/z (relative intensity): 245 (M++1, 19.0), 244.1458 (M+, 
100), 242 (2.9). 
1H NMR (CDCl3, 400 MHz, (3h)) δ 0.86 (t, J = 7.5 Hz, 3 H), 0.87 (t, J = 7.5 Hz, 3 H), 1.02 (t, J = 
7.5 Hz, 3 H), 1.06 (t, J = 7.5 Hz, 3 H), 1.85 (q, J = 7.5 Hz, 2 H), 2.31 (q, J = 7.5 Hz, 2 H), 2.33 (q, J 
= 7.5 Hz, 2 H), 2.40 (q, J = 7.5 Hz, 2 H), 3.47 (s, 2 H), 4.65 (d, J = 1.5 Hz, 1 H), 4.80 (d, J = 1.5 Hz, 
1 H), 7.08-7.32 (m, 5 H); 13C NMR (CDCl3, 100 MHz, (3h)) δ 11.9, 12.5, 13.1, 13.2, 25.3, 25.9, 
27.4, 28.4, 39.5, 113.2, 126.1, 126.3, 127.0, 127.5, 127.9, 128.7, 138.4, 142.9, 150.2, 176.2; 
High-resolution MS (3h), calcd for C22H30O2: 326.2246. Found m/z (relative intensity): 327 (M++1, 
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X-ray Crystal Structure Determinations   
   X-ray quality single crystals were grown from solvent combinations of ethyl acetate/hexane for 
5a.  This measurement was made on a Rigaku Saturn724 diffractometer using multi-layer mirror 
monochromated Mo-Ka radiation.  Data was collected and processed using CrystalClear (Rigaku) 
at a temperature of -179+1 ˚C to a maximum 2q value of 55˚.  The structure was solved by direct 
method (SHELXL-97) and expanded using Fourier technique.  The non-hydrogen atoms were 
refined anisotropically and hydrogen atoms were refined using the riding model.  All calculations 
were performed using the CrystalStructure 4.0 (Crystal Structure Analysis Package, Rigaku 
Corporation) except for refinement, which was performed using SHELXL-97.  Crystal data and 
refinement parameter for the structurally characterized compound 5a is summarized in Table 5.  
An ORTEP drawing of 5a is shown in Figure 1.  CCDC 828924 contains the supplementary 
crystallographic data for 5a.  This data can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Table 5.  Crystal data and data refinement for 5a 
 







formula weight   248.36 
cryst system   triclinic 
space group   P-1 
cryst color   colorless, platelet 
cryst size (mm)  0.155 x 0.083 x 0.027 
a (Å)    4.876(3) 
b (Å)    9.006(6) 
c (Å)    16.659(10) 
a (deg)    97.07(2) 
b (deg)    94.054(8) 
g (deg)    94.82(2) 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  45 
V (Å3)    721.0(8) 
Z    2 
rcalc (gcm-3)   1.144 
μ (cm-1)   0.731 
2qmax (deg)  54.9 
no. of unique reflns  3284  
Rint   0.0407 
no. of parameters  171 
R1 a[I>2σ(I)]  0.0494 
R b(all data)  0.0816 
Rw c   0.1160 
GOF d   1.087 
 
a R1 = Σ ||Fo| − |Fc||/Σ |Fo|.  b R = Σ |Fo2 − Fc2|/Σ Fo2.  c Rw = {Σw(Fo2 − Fc2)2/Σw (Fo2)2}1/2. 
d GOF = [{Σw(Fo2 − Fc2)2}/(No − Np)]1/2, where No and Np denote the number of observations and 
parameters. 
 
Figure 1.  ORTEP drawing of 4a with 50% probability ellipsoids. 
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Chapter 2 
 
Nickel-Catalyzed CO2 Rearrangement of Enol Metal Carbonates 














Summary: 4-Methylene-1,3-dioxolan-2-one undergoes oxidative addition of Ni(0) catalyst in the 
presence of Me2Al(OMe) followed by a coupling reaction with alkynes to form δ,ε-unsaturated 
β-ketocarboxylic acids with high regio- and stereoselectivities.   The reaction proceeds via 
[1,3]-rearrangement of an enolative metal carbonate intermediate and the formal reinsertion of CO2 
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Introduction 
    
   β-Ketocarboxylic acids are useful and valuable key intermediates toward biologically active 
molecules.1   For example, crassulacean acid metabolism (CAM) is an important carbon resource 
utilization process in the photosynthesis of oxaloacetate from CO2 by pyruvate carboxylase of green 
plants.2   However, as b-ketocarboxylic acids are thermodynamically unstable, many problems, 
such as easy extrusion of CO2 via decarboxylation processes, often arise.3   Although metal 
enolates are highly reactive and convenient nucleophilic intermediates toward carbonyl compounds, 
little attention has been focused on the fixation of CO2 using metal enolates.4 
   1,3-Dioxolan-2-ones are also among the most important industrial materials, including 
electrolytes in lithium ion battery half-cells and as predominant monomers for polycarbonates.5  
Although cyclic carbonates are utilized in fine chemicals and as monomers for polymerization in 
modern industrial synthesis, most synthetic utilities of 1,3-dioxolan-2-ones face difficulties due to 
the decarboxylation reaction.6   
   Nickel catalyzed C-C bond transformations have been successfully developed and are powerful 
tools in modern organic synthesis.7   Insertion reactions of CO2,8 reductive coupling with alkynes 
and enones,9 and multicomponent coupling reactions with unsaturated hydrocarbons10 are extremely 
attractive and potent methods for efficient organic synthesis.   Recently we developed the first 
example of a Ni-catalyzed multicomponent coupling of diketene and alkynes with organometallic 
reagents, providing unsaturated carboxylic acids and phenylacetic acids (Scheme 1).11   In this 
case, the combination of Ni-catalyst and Et2Al(OEt) had a very important role in promoting C=C 
double bond cleavage reactions of diketene to undergo reconstruction of the molecular framework 
via cycloaddition and migratory processes. 
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Scheme 1. Nickel-Catalyzed Multicoupling Reaction of Diketene, Alkyne, and Organometallic 
Reagents via Cleavage of the C=C Bond 
 
   Herein, we disclose highly efficient and synthetic protocols for β-ketocarboxylic acids from 
4-methylene-1,3-dioxolan-2-one as CO2 and metal enolate equivalents, by treatment with alkynes 
and Me2Al(OMe) in the presence of Ni(0) catalyst (Scheme 2).   It is noteworthy that this reaction 




Scheme 2. Nickel-Catalyzed CO2 Rearrangement of Enol Metal Carbonates for the Efficient 
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Results and Discussion 
 
   The optimization of the reaction conditions are summarized in Table 1.   At first, the reaction 
was undertaken in the presence of Ni(cod)2 catalyst, 1,3-dioxolan-2-one 1a, and 4-octyne by 
treatment with Me2Al(OMe) at 60 ˚C under N2 atmosphere in a wide variety of solvents.   
Non-polar solvents, such as hexane and toluene, and cyclic ethers were insufficient, with the desired 
product 2a, obtained in low yields and most of substrate 1a remaining (Entries 1-2, Table 1).  
Ether solvent, such as 1,4-dioxane and THF were used, the desired reaction proceeds in low yields 
(Entries 3-4, Table 1).   In the case of DMF and DMA, the desired product 2a were obtained in 
27% and 34% yields, respectively (Entries 5-6, Table 1).   Further screening revealed that the 
DMSO was the most efficient solvent for this reaction  (Entry 7, Table 1).   Next, we examined 
a variety of organometallic reagents.   In the presence of 5 mol% of Ni(cod)2, the mixture of 
cyclic carbonate 1a, 4-octyne, and Me3Al underwent the coupling reaction at 60 ˚C in DMSO to 
give expected β-ketocarboxylic acid 2a in 73% yield, with decarboxylated product 3a in 21% yield 
(Entry 8, Table 1). Using Me2Zn instead of Me2Al(OMe), desired product 2a was obtained in 65% 
yield (Entry 9, Table 1).   In the case of Me3B, the desired transformation proceeded to give the 
corresponding product 2a in low yield along with decarboxylated ketone 3a as a major product  
(Entry 10, Table 1).   Et3Al, Et2Al(OEt), and Ph3Al were not effective at promoting the coupling 
reactions via ethyl and phenyl group insertion, resulting in complex mixture (Entries 11-13, Table 
1).   That is, Me2Al(OMe) was the most efficient organometallic reagent for the desired coupling 
reaction.   In the case of CO2 atmospheric pressure, total yields and the selectivities of formation 
of the desired product 2a and by-product 3a were almost same, irrespective of N2 and CO2 
atmosphere (Entries 7 vs 14, Table 1).  These results suggest that intramolecular rearrangement of 
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CO2 is probable rather than the decarboxylation-carboxylation sequence.   When Ni(acac)2 was 
used as a catalyst instead of Ni(cod)2, the product yield was lower (Entry 15, Table 1).   As 
expected, control experiments revealed no product formation when each parameter was omitted 
from the mixture (Entries 16-17, Table 1). 
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Table 1. Optimization of the Reaction Conditions for Nickel-Catalyzed CO2 Rearrangement of 
Enol Metal Carbonates for the Efficient Synthesis of δ,ε-Unsaturated β-Ketocarboxylic Acidsa 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (5.0 mol%), cyclic carbonate 1a (1.2 mmol), 
4-octyne (1.0 mmol), and organoaluminium reagent (1.2 mmol) in solvent (3.0 mL) at 60 ℃ under nitrogen 

























1 Hexana Me2Al(OMe) 9 trace
2 Toluene Me2Al(OMe) 26 15
3 1,4-Dioxane Me2Al(OMe) 24 13
4 THF Me2Al(OMe) 34 23
5 DMF Me2Al(OMe) 27 12
7 DMSO Me2Al(OMe) 82 14
6 DMA Me2Al(OMe) 34 10
8 DMSO Me3Al 73 21
9 DMSO Me2Zn 65 19
10 DMSO Me3B 18 70
11 DMSO Et3Al Complex Mixture
12 DMSO Et2Al(OEt) Complex Mixture
13 DMSO Ph3Al Complex Mixture
14b DMSO Me2Al(OMe) 84 12
15c DMSO Me2Al(OMe) 67 10
16d DMSO Me2Al(OMe) 0 0
17 DMSO None 0 0
1a 2a 3a
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   Next, we investigated the reaction of cyclic carbonate 1a with a various kinds of alkynes, and 
the results summarized in Table 2. Symmetrical alkynes, such as 2-butyne, 3-hexyne, 4-octyne, and 
5-decyne reacted smoothly with cyclic carbonate 1a in the presence of Me2Al(OMe) to provide 
corresponding β-ketocarboxylic acids 2a-2d in good yields (Entries 1-4, Table 2).   In the case of 
unsymmetrical alkynes, such as 4-methyl-2-pentyne, 1-trimethylsilyl-1-propyne, and 
1-phenyl-1-propyne, the corresponding β-ketocarboxylic acids 2e-2g were obtained in modest to 
good yields  (Entries 5-7, Table 2).   The less hindered substituted acetylenic carbon atoms 
tended to attack on the vinylogous carbon atoms of carbonate.   β-Keto acids 2e and 2f were 
obtained as a mixture of regioisomers, whereas 2g was obtained as a single isomer. 
 
Table 2. Ni-Catalyzed Coupling of Cyclic Carbonate 1a with Various Alkyne and Me2Al(OMe)a 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (5.0 mol%), cyclic carbonate 1a (1.2 mmol), 
alkyne (1.0 mmol), and Me2Al(OMe) (1.2 mmol) in DMSO (3.0 mL) at 60 ℃ under nitrogen atmosphere for 




1 Me Me 2b : 82 3b : 12
2 Et Et 2c : 79 3c : 13
3 nPr nPr 2a : 82 3a : 14
4 nBu nBu 2d : 76 3d : 14
5 iPr Me 2e : 77 [2.2:1]b 3e : 9
6 TMS Me 2f : 34 [5.5:1]b 3f : trace
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   The results of treating 4-substitited cyclic carbonates (1a, 1h-1l) with 3-hexyne are shown in 
Table 3.   Unsymmetrical 5-disubstituted carbonate 1h (R1=Et, R2=Me) gave unsymmetrical 
α-disubstituted β-keto acid 2h as the major product, as well as ketone 3h (Entry 2, Table 3).   
Phenyl and methyl substituted cyclic carbonate 1i was transformed into β-keto acid 2i in lower 
yield as a mixture with ketone 3i as a major product (Entry 3, Table 3).   Unsubstituted cyclic 
carbonate 1j (R1=H, R2=H) underwent a similar coupling reaction, giving rise to a mixture of β-keto 
acid 2j and ketone 3j as a minor product (Entry 4, Table 3).   In the case of mono-substituted 
carbonate 1k (R1=Me, R2=H), a mixture of regioisomers α-methyl-β-keto acid 2k 
and γ-methyl-β-keto acid 2’k were produced in 63% yield in a ca. 3:1 ratio, along with a small 
amount of ketone 3k and 3’k in 20% yield (Entry 5, Table 3).   Seemingly, 5-phenyl substituted 
carbonates undergo the decarboxylation as a side reaction (Entry 6, Table 3).   The ratios of 
β-keto acid 2 and ketone 3 might depend on the stability of the metal enolates as key intermediates, 
in addition to the steric bulk of the R1 and R2 groups. 
 
   The structures of the products 2f, 2g, 2k, and 2’k were determined based on coupling constants 
from 1H NMR, 13C NMR, HMBC, HMQC spectral data and NOE experiment.   The selected data 
for the NOE observed by the irradiation at the bold face protons are illustrated in Figure 1. 
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Table 3. Ni-Catalyzed Coupling of Various Cyclic Carbonate 1 with 3-hexyne and Me2Al(OMe)a 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (5.0 mol%), cyclic carbonate 1 (1.2 
mmol), 3-hexyne (1.0 mmol), and Me2Al(OMe) (1.2 mmol) in DMSO (3.0 mL) at 60 ℃ under 
nitrogen atmosphere for 24 h. bβ-Ketocarboxylic acids 2 and 2’ were isolated as methyl ester by 






1 Me Me 2c : 79 3c : 13
2 Et Me 2h : 52 3h : 35
3b Ph Me 2i : 15 3i : 72
4b H H 2j : 60 3j : 25
5b Me H 2k : 45, 2'k : 18 3k : 11, 3'k : 9
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Figure 1. Structure Determination for NOE Data of β-Ketocarboxylic Acids 2f, 2g, 2k, and 2’k 
 
   Next, the reaction of a stoichiometric amount of Ni(cod)2, alkyne, and cyclic carbonate without 
Me2Al(OMe) was conducted (Scheme 3).   In the absence of Me2Al(OMe), the mixture of 
Ni(cod)2 (0.5 mmol), 4-octyne (0.5 mmol), and cyclic carbonate (0.5 mmol) did not provide the 
expected β-keto acid 2m and the corresponding decarboxylated ketone 3m.   In this case, the 
reaction was not proceed at all and the almost carbonate was recovered.  This result shows 
Me2Al(OMe) is indispensable to carry out the reaction even in DMSO solvent.12   That is, we 
believe that Me2Al(OMe) acts as a Lewis acid and promotes the oxidative addition in the first step.  
 
 
































































2m : Not Observed 3m : Not Observed
H3O+
(0.5 mmol) (0.5 mmol)
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   Although it would be premature to provide a complete explanation of the reactivities and 
selectivities described herein, a plausible mechanism for the multicomponent coupling reaction of 
5-substituted 4-methylene-1,3-dioxolan- 2-ones with alkynes promoted by the Ni catalyst and 
Me2Al(OMe) is proposed in Scheme 4.   Thus, oxidative addition of the cyclic carbonate to the 
Ni(0) catalyst, promoted by Me2Al(OMe) as a Lewis acid, at the allylic moiety proceeds to form the 
oxanickelacycle intermediate I.   The stability of metallacycle I seems to depend on the type of 
5-substituents, and readily isomerizes to the more stabilized nickelacycle III via σ-π-σ allylnickel 
interconversions.13   The insertion of additional alkyne proceeds to form eight-membered 
oxanickelacycle intermediate V, which then undergoes transmetallation with Me2Al(OMe) to form 
enolative aluminum carbonate VII.14   This enol metal carbonate VII readily undergoes 
[1,3]-rearrangement to afford β-ketocarboxylic acid,15 followed by reductive elimination resulting 
in the generation of catalytically active Ni(0) species. 
 
 
Scheme 4. Plausible Reaction Mechanism for the Multicomponent Coupling Reaction of Cyclic 
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   In the case of mono-substituted cyclic carbonate, the coupling reaction proceeds to give 
γ-substituted β-keto acid 2’ as a by-product, and the plausible reaction mechanism shown in 
Scheme 5.   Oxidative addition of the cyclic carbonate to the Ni(0) catalyst, promoted by 
Me2Al(OMe) as a Lewis acid, at the allylic moiety proceeds to form the oxanickelacycle 
intermediate I.   The insertion of additional alkyne proceeds to form eight-membered 
oxanickelacycle intermediate V’, which then undergoes transmetallation with Me2Al(OMe) to form 
enolative aluminum carbonate VII’.   This enol metal carbonate VII’ readily undergoes 
[1,3]-rearrangement to afford γ-substituted β-ketocarboxylic acid 2’, followed by reductive 
elimination resulting in the generation of catalytically active Ni(0) species. 
 
 
Scheme 5. Plausible Reaction Mechanism for the Multicomponent Coupling Reaction of 
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Conclusion 
    
   In conclusion, we developed an efficient first synthesis of β-ketocarboxylic acids from 
4-methylene-1,3-dioxolan-2-one via oxidative addition of Ni(0) catalyst in the presence of 
Me2Al(OMe) and alkynes.   [1,3]-Rearrangement of enolative aluminum carbonate proceeds to 
form δ,ε-unsaturated β-ketocarboxylic acids with high regio- and stereoselectivities.   This 
protocol contributes to the efficient fixation of CO2 for the carbon resource utilization, as in the 
CAM process in biological photosynthesis. 
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Experimental Section 
 
   Reactions employed oven-dried glassware unless otherwise noted.  Thin layer chromatography 
(TLC) employed glass 0.25 mm silica gel plates with UV indicator (Merck, Silica gel 60F
254
).  
Flash chromatography columns were packed with 230-400 mesh silica gel as a slurry in hexane.  
Gradient flash chromatography was conducted eluting with a continuous gradient from hexane to 
the indicated solvent.  Proton and carbon NMR data were obtained with a JEOL-GX400 and 
Varian-500PS-SN with tetramethylsilane as an internal standard.  Chemical shift values were 
given in ppm downfield from the internal standard.  Infrared spectra were recorded with a JASCO 
A-100 FT-IR spectrophotometer.  High resolution mass spectra (HRMS) were measured with a 
JEOL JMS-700N.  
 
Solvents and Reagents 
   Anhydrous hexane, toluene, DME, dioxane, THF, DMA, DMF, DMSO were purchased (Wako) 
and used without further purification. Ni(cod)2, Me2Zn (1.0 M hexane solution), Me3Al (1.0 M 
hexane solution), Et3Al (1.0 M hexane solution), Et2Al(OEt) (1.0 M hexane solution) (Kanto 
Kagaku) were purchased and used without further purification. Me2Al(OMe) was prepared by 
adding an equimolar amount of MeOH to a hexane solution of Me3Al before used. Me3B was 
prepared from BCl3 (1.0 M heptane solution, Aldrich) and 3-equivalents of MeLi (1.17 M 
dietylether solution, Kanto Kagaku). 2-Butyne, 3-hexyne, 4-octyne, 5-decyne, 4-methyl-2-pentyne, 
1-trimethylsilyl-1-propyne, and 1-phenyl-1-propyne (Tokyo Kasei Kogyo Co., Ltd) were purchased 
and distilled prior to use. 
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Preparation of Me2Al(OMe) Reagent 
   A 25 mL two-necked round-bottomed flask equipped with a rubber septum was charged with 
Me3Al solution (2.0 mL of 1.0 M in hexane, 2 mmol, Kanto Kagaku) under argon atmosphere. 
Anhydrous MeOH (2.0 mmol, Wako) was added to the Me3Al solution via syringe at 0 ℃ for 30 
min.  
 
Preparation of Me3B Reagent 
   A 100 mL Schlenk tube equipped with a rubber septum was charged with BCl3 solution (2.0 mL 
of 1.0 M in heptane, 2.0 mmol, Aldrich) under argon atmosphere. A solution of MeLi (5.1 mL of 
1.17 M in diethylether, 6.0 mmol, Kanto Kagaku) was added to the BCl3 solution via syringe at 
0 ℃ to room temperature for 12 hours. 
 
Preparation of 1a 
   The reaction of 2-methyl-3-butyn-2-ol with CO2 was carried out in a 100 mL stainless steel 
autoclave equipped with a stirring bar in high pressure. The autoclave containing 
2-methyl-3-butyn-2-ol (1.95 mL, 20 mmol) was purged with argon gas to remove oxygen. nBu3P 
(0.25 mL, 1.0 mmol) was introduced into the autoclave with a syringe while the vessel was purged 
with argon. After the vessel was filled with carbon dioxide (5.0 MPa) and stirred for 16 hours at 
100 ℃. The crude product were purified by column chromatography on silica gel (hexane/ethyl 
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Preparation of 1k 
   To a solution of propargyl tert-butyl carbonate in dichloromethane (0.5 M) at room temperature 
was added the (PPh3)AuNTf2 catalyst (0.01 equiv). After the reaction, dichloromethane was 
evaporated in vacuo, and then the residue was purified by column chromatography over silica gel 
(hexane/ethyl acetate = 4/1 v/v) to yield 5-methyl-4-methylene-1,3-dioxolan-2-one 1k (85%). 
 
General Procedure: Formation of β-Ketocarboxylic Acid 2 from 
4-Methylene-1,3-dioxolan-2-one by Ni-catalyst (Entry 7, Table 1) 
   To a solution of Ni(cod)2 (13.8 mg, 0.05 mmol) in anhydrous DMSO (3.0 mL) were 
successively added 5,5-dimethyl-4-methylene-1,3-dioxolan-2-one 1a (153.8 mg, 1.2 mmol), 
4-octyne (110.2 mg, 1.0 mmol), and Me2Al(OMe) (1.2 mmol, 1.0 M hexane solution) via syringe 
under nitrogen atmosphere.  The mixture was stirred at 60 ℃ for 24 h.  The mixture was diluted 
with ethyl acetate (30 mL) and washed with 2 M HCl, and brine, and then dried (MgSO4) and 
concentrated in vacuo.  The residual oil was subjected to column chromatography over silica gel 
(hexane/EtOAc = 1/1 v/v) to give 2a (208.6 mg, 82%, Rf = 0.50; hexane/EtOAc = 1/1 v/v) along 
with 3a (29.4 mg, 14%, Rf = 0.73; hexane/EtOAc = 4/1 v/v). 
 
Typical Procedure for Isolation as Methyl Ester by Treatment of β-Ketocarboxylic Acid with 
Trimethylsilyldiazomethane (Entry 4, Table 3) 
   To a crude mixture of the products dissolved in Et2O (20.0 mL) and MeOH (5.0 mL), and was 
added TMSCHN2 (2.0 M in Et2O) at 0 ℃ and stirred for 1 hour.  AcOH (2.0 mL) was added at 
0 ℃ and stirred for 5 min, and sat. NaHCO3 was added.  The mixture was extracted with ethyl 
acetate (30 mL) and washed with brine, and then dried (MgSO4) and concentrated in vacuo.  The 
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residual oil was subjected to column chromatography over silica gel (hexane/EtOAc = 20/1 v/v) to 
give 2j (127.4 mg, 60%, Rf = 0.60; hexane/EtOAc = 4/1 v/v) along with 3j (38.3 mg, 25%, Rf = 




(E)-2,2,6-Trimethyl-3-oxo-5-propylnon-5-enoic acid (2a) 
IR (neat) 3153 (br), 2961 (s), 2934 (s), 2872 (s), 1717 (s), 1701 (s), 1466 (s) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.87 (t, J = 7.3 Hz, 3 H), 0.91 (t, J = 7.3 Hz, 3 H), 1.28 (sext, J = 7.3 Hz, 2 H), 1.42 
(sext, J = 7.3 Hz 2 H), 1.44 (s, 6 H), 1.53 (s, 3 H), 1.97 (t, J = 7.3 Hz, 2 H), 2.06 (t, J = 7.3 Hz, 2 H), 
3.33 (s, 2H) ; 13C NMR (100 MHz, CDCl3) δ 14.0, 14.2, 18.5, 21.6, 21.8, 22.4, 35.0, 36.2, 41.5, 
55.5, 125.4, 133.7, 179.5, 205.8 ; High-resolution MS, calcd for C15H26O3 : 254.1882. Found m/z 




IR (neat) 2961 (s), 2932 (s), 2872 (s), 1709 (s), 1466 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.88 (t, 
J = 7.3 Hz, 3 H), 0.91 (t, J = 7.3 Hz, 3 H), 1.08 (d, J = 6.8 Hz, 6 H), 1.32 (sext, J = 7.3 Hz, 2 H), 
1.42 (sext, J = 7.3 Hz, 2 H), 1.60 (s, 3 H), 1.99 (t, J = 7.3 Hz, 2 H), 2.06 (t, J = 7.3 Hz, 2 H), 2.69 
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21.8, 35.1, 36.3, 39.7, 44.9, 126.5, 133.1, 213.3 ; High-resolution MS, calcd for C14H26O: 210.1984. 
Found m/z (relative intensity): 210.1984 (M+, 100), 167 (65). 
 
 
2,2,5,6-Tetramethyl-3-oxohept-5-enoic acid (2b) 
IR (neat) 3167 (br), 2984 (s), 2918 (s), 2876 (m), 1713 (s), 1705 (s), 1470 (m) cm-1; 1H NMR (400 
MHz, CDCl3) δ 1.44 (s, 6 H), 1.60 (s, 3 H), 1.62 (s, 3 H), 1.71 (s, 3 H), 3.34 (s, 2 H); 13C NMR (100 
MHz, CDCl3) δ 19.1, 20.6, 20.6, 22.2, 43.7, 55.5, 120.5, 128.9, 179.5, 206.0; High-resolution MS, 




IR (neat) 2968 (s), 2926 (s), 2874 (s), 1711 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 1.09 (d, J = 6.8 
Hz, 6 H), 1.65 (s, 3 H), 1.66 (s, 3 H), 2.67 (sept, J = 6.8 Hz, 1H), 3.20 (s, 2H); 13C NMR (100 MHz, 
CDCl3) δ 18.4, 19.2, 20.6, 20.7, 39.8, 46.7, 121.3, 128.2, 213.3; High-resolution MS, calcd for 
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(E)-5-Ethyl-2,2,6-trimethyl-3-oxooct-5-enoic acid (2c) 
IR (neat)  2968 (s), 2936 (m), 2874 (m), 1717 (s), 1705 (s), 1456 (m) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.89 (t, J = 7.3 Hz, 3 H), 0.99 (t, J = 7.3 Hz, 3 H), 1.44 (s, 6 H), 1.55 (s, 3 H), 2.02 (q, J = 
7.3 Hz, 2 H), 2.09 (q, J = 7.3 Hz, 2 H), 3.33 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 13.2, 13.2, 18.1, 
22.4, 25.7, 27.1, 41.1, 55.5, 126.1, 134.8, 179.8, 205.8; High-resolution MS, calcd for C13H22O3: 




IR (neat) 2968 (s), 2934 (s), 2874 (s), 1713 (s), 1462 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.92 
(t, J = 7.3 Hz, 3 H), 0.99 (t, J = 7.3 Hz, 3 H), 1.08 (d, J = 6.8 Hz, 6 H), 1.61 (s, 3 H), 2.04 (q, J = 7.3 
Hz, 2 H), 2.09 (q, J = 7.3 Hz, 2 H), 2.69 (sept, J = 6.8 Hz, 1H), 3.18 (s, 2H); 13C NMR (100 MHz, 
CDCl3) δ 13.2, 13.3, 18.3, 18.6, 25.8, 27.1, 39.7, 44.5, 127.2, 134.2, 213.4; High-resolution MS, 
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(E)-5-Butyl-2,2,6-trimethyl-3-oxodec-5-enoic acid (2d) 
IR (neat) 2959 (s), 2930 (s), 2870 (m), 2860 (m), 1718 (s), 1703 (s), 1470 (m) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.88 (t, J = 7.3 Hz, 3 H), 0.91 (t, J = 7.3 Hz, 3 H), 1.19-1.39 (m, 8 H), 1.44 (s, 6 H), 
1.53 (s, 3 H), 1.97 (t, J = 7.3 Hz, 2 H), 2.07 (t, J = 7.3 Hz, 2 H), 3.33 (s, 2H); 13C NMR (100 MHz, 
CDCl3) δ 14.0, 14.1, 18.5, 22.3, 22.7, 22.8, 30.7, 30.8, 32.6, 33.9, 41.5, 55.5, 125.2, 133.7, 179.8, 
205.7; High-resolution MS, calcd for C17H30O3: 282.2195. Found m/z (relative intensity): 282.2199 




IR (neat) 2959 (s), 2930 (s), 2860 (s), 1709 (s), 1466 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.89 (t, 
J = 7.3 Hz, 3 H), 0.91 (t, J = 7.3 Hz, 3 H), 1.08 (d, J = 6.8 Hz, 6 H), 1.22-1.41 (m, 8 H), 1.60 (s, 3 
H), 2.00 (t, J = 7.3 Hz, 2 H), 2.06 (t, J = 7.3 Hz, 2 H), 2.68 (sept, J = 6.8 Hz, 1H), 3.18 (s, 2H); 13C 
NMR (100 MHz, CDCl3) δ 14.0, 14.1, 18.6, 18.7, 22.8, 22.8, 30.8, 30.9, 32.7, 34.0, 39.6, 44.9, 
126.3, 133.1, 213.3; High-resolution MS, calcd for C16H30O: 238.2297. Found m/z (relative 
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(E)-2,2,5,6,7-Pentamethyl-3-oxooct-5-enoic acid (2e, major isomer) and 
5-Isopropyl-2,2,6-trimethyl-3-oxohept-5-enoic acid (minor isomer): (a mixture of regioisomers 
in a 2.2 : 1 ratio) 
IR (neat) 3194 (br), 2964 (s), 2932 (s), 2870 (m), 1720 (s), 1709 (s), 1703 (s), 1691 (s), 1468 (s) 
cm-1; 1H NMR (400 MHz, CDCl3, major isomer) δ 0.95 (d, J = 6.8 Hz, 6 H), 1.44 (s, 6 H), 1.45 (s, 3 
H), 1.63 (s, 3 H), 2.90 (sept, J = 6.8 Hz, 1 H), 3.33 (s, 2 H); 1H NMR (400 MHz, CDCl3, minor 
isomer) δ 0.83 (d, J = 6.8 Hz, 6 H), 1.47 (s, 6 H), 1.48 (s, 3 H), 1.75 (s, 3 H), 2.90 (sept, J = 6.8 Hz, 
1 H), 3.30 (s, 2 H); 13C NMR (100 MHz, CDCl3, a mixture of regioisomers) δ 12.2, 18.4, 19.8, 20.5, 
20.6, 21.2, 22.3, 22.8, 29.8, 30.0, 36.4, 44.1, 55.4, 55.5, 119.3, 128.5, 129.1, 137.9, 179.8, 179.9, 
205.4, 205.9; High-resolution MS, calcd for C13H22O3 : 226.1569. Found m/z (relative intensity): 
226.1575 (M+, 64.8), 182 (100). 
 
 
(E)-2,5,6,7-Tetramethyloct-5-en-3-one (3e, major isomer) and 
5-Isopropyl-2,6,6,-trimethylhept-5-en-3-one (minor isomer): (a mixture of regioisomers in a 2.3 : 
1 ratio) 
IR (neat) 2964 (s), 2934 (s), 2872 (m), 1713 (s), 1466 (m) cm-1; 1H NMR (400 MHz, CDCl3, major 
isomer) δ 0.95 (d, J = 6.8 Hz, 6 H), 1.08 (d, J = 6.8 Hz, 6 H), 1.53 (s, 3 H), 1.63 (s, 3 H), 2.67 (sept, 
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isomer) δ 0.86 (d, J = 6.8 Hz, 6 H), 1.12 (d, J = 6.8 Hz, 6 H), 1.53 (s, 3 H), 1.75 (s, 3 H), 2.71 (sept, 
J = 6.8 Hz, 1 H), 2.90 (sept, J = 6.8 Hz, 1 H), 3.16 (s, 2 H); 13C NMR (100 MHz, CDCl3, a mixture 
of regioisomers) δ ; 12.4, 18.6, 18.6, 18.9, 19.9, 20.5, 20.8, 21.5, 29.9, 30.1, 39.4, 39.6, 40.3, 47.5, 
120.1, 127.6, 130.5, 137.5, 212.8, 213.4; High-resolution MS, calcd for C12H22O : 182.1671. Found 
m/z (relative intensity): 182.1660 (M+, 10.8), 163 (12), 139 (57), 121 (100). 
 
 
(E)-2,2,5-Trimethyl-6-(trimethylsilyl)-3-oxohept-5-enoic acid (2f, major isomer) and 
2,2,6-trimethyl-5-(trimethylsilyl)-3-oxohept-5-enoic acid (minor isomer): (a mixture of 
regioisomers in a 5.5 : 1 ratio) 
IR (neat) 3209 (br), 2976 (s), 2957 (s), 2912 (m), 1713 (s), 1703 (s), 1470 (s) cm-1; 1H NMR (400 
MHz, CDCl3, major isomer) δ 0.15 (s, 9H), 1.44 (s, 6 H), 1.59 (s, 3 H), 1.77 (s, 3 H), 3.42 (s, 2 H); 
1H NMR (400 MHz, CDCl3, minor isomer) δ 0.11 (s, 9H), 1.45 (s, 6 H), 1.60 (s, 3 H), 1.89 (s, 3 H), 
3.47 (s, 2 H); 13C NMR (100 MHz, CDCl3, major isomer) δ ; 0.3, 18.2, 22.2, 23.8, 44.0, 55.7, 132.5, 
137.6, 179.8, 205.2; 13C NMR (100 MHz, CDCl3, minor isomer) δ 0.1, 21.2, 22.6, 25.4, 41.3, 55.3, 
124.9, 146.7, 179.9, 207.0; High-resolution MS, calcd for C13H24O3Si : 256.1495. Found m/z 
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(E)-2,2,5-Trimethyl-3-oxo-6-phenylhept-5-enoic acid (2g) 
IR (neat) 3061 (br), 2984 (m), 2937 (m), 1703 (s), 1470 (m), 1443 (m), 1265 (s) cm-1; 1H NMR (400 
MHz, C5D5N) δ 1.68 (s, 6 H), 1.76 (s, 3 H), 2.01 (s, 3 H), 3.77 (s, 2 H), 7.24-7.38 (m, 5 H); 13C 
NMR (100 MHz, C5D5N) δ 21.2, 21.2, 22.8, 43.9, 56.3, 125.7, 126.6, 128.6, 128.8, 134.4, 145.1, 
176.5, 206.6; High-resolution MS, calcd for C16H20O3: E.M.:260.1412. Found m/z (relative 




IR(neat); 2970 (s), 2930 (s), 2872 (s), 1709 (s), 1437 (s) cm-1; 1H NMR (500 MHz, CDCl3) δ 1.15 
(d, J = 6.9 Hz, 6 H), 1.57 (q, J = 1.5 Hz, 3 H), 1.96 (q, J = 1.5 Hz, 3 H), 2.76 (sept, J = 6.9 Hz, 1H), 
3.36 (s, 2H), 7.14-7.33 (m, 5 H); 13C NMR (100 MHz, CDCl3) δ 18.5, 20.9, 21.1, 40.1, 46.7, 124.8, 
126.1, 128.0, 128.2, 134.3, 144.5, 212.5; High-resolution MS, calcd for C15H20O: 216.1514. Found 
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(E)-2,5-Diethyl-2,6-dimethyl-3-oxooct-5-enoic acid (2h) 
IR (neat) 3090 (br), 2968 (s), 2936 (s), 2874 (m), 1701 (s), 1695 (s), 1458 (m) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.89 (t, J = 7.3 Hz, 3 H), 0.90 (t, J = 7.3 Hz, 3 H), 0.99 (t, J = 7.3 Hz, 3 H), 1.40 (s, 
3 H), 1.54 (s, 3 H), 1.85-2.12 (m, 6 H), 3.32 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 8.8, 13.2, 13.2, 
18.1, 18.8, 25.7, 27.1, 28.4, 41.5, 59.8, 126.1, 134.8, 179.1, 206.1; High-resolution MS, calcd for 




IR (neat) 2964 (s), 2934 (s), 2874 (s), 1709 (s), 1456 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.86 
(t, J = 7.1 Hz, 3 H), 0.92 (t, J = 7.1 Hz, 3 H), 0.99 (t, J = 7.1 Hz, 3 H), 1.05 (d, J = 7.1 Hz, 3 H), 
1.35 (dquint, J = 14.2, 7.1 Hz, 1 H), 1.62 (s, 3 H), 1.68 (dquint, J = 14.2, 7.1 Hz, 1 H), 2.03 (q, J = 
7.1 Hz, 2 H), 2.09 (q, J = 7.1 Hz, 2 H), 2.53 (sext, J = 7.1 Hz, 1H), 3.17 (s, 2H); 13C NMR (100 
MHz, CDCl3) δ 11.8, 13.2, 13.3, 16.4, 18.3, 25.8, 26.2, 27.1, 45.4, 46.7, 127.0, 134.2, 213.1; 
High-resolution MS, calcd for C13H24O : 196.1827. Found m/z (relative intensity): 196.1925 (M+, 
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(E)-Methyl-5-ethyl-2,6-dimethyl-3-oxo-2-phenyloct-5-enoate (2i) 
IR (neat) 2964 (s), 2934 (m), 2872 (m), 1744 (s), 1720 (s), 1447 (m), 1252 (s) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.77 (t, J = 7.3 Hz, 3 H), 0.95 (t, J = 7.3 Hz, 3 H), 1.42 (s, 3 H), 1.83 (s, 3 H), 
1.87-1.99 (m, 2 H), 2.04 (q, J = 7.3 Hz, 2 H), 3.09 (d, J = 18.3 Hz, 1 H), 3.23 (d, J = 18.3 Hz, 1 H), 
3.80 (s, 3 H), 7.29-7.40 (m, 5 H); 13C NMR (100 MHz, CDCl3) δ 13.2, 13.2, 17.9, 21.5, 25.4, 27.0, 
42.0, 52.6, 64.5, 126.6, 127.5, 127.7, 128.6, 134.6, 138.5, 172.7, 205.0; High-resolution MS, calcd 




IR (neat) 2966 (s), 2932 (s), 2872 (s), 1709 (s), 1452 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.81 (t, 
J = 7.3 Hz, 3 H), 0.96 (t, J = 7.3 Hz, 3 H), 1.37 (d, J = 6.8 Hz, 3 H), 1.45 (s, 3 H), 1.85-2.00 (m, 2 
H), 2.05 (q, J = 7.3 Hz, 2 H), 3.06 (d, J = 16.1 Hz, 1 H), 3.13 (d, J = 16.1 Hz, 1 H), 3.83 (q, J = 6.8 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 13.1, 13.2, 18.0, 18.1, 25.5, 27.1, 45.0, 51.8, 127.0, 127.0, 
127.9, 128.8, 134.4, 140.9, 209.4; High-resolution MS, calcd for C17H24O: 244.1827. Found m/z 
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(E)-Methyl-5-ethyl-6-methyl-3-oxooct-5-enoate (2j) 
IR (neat) 2964 (s), 2936 (s), 2874 (s), 1751 (s), 1717 (s), 1437 (m), 1317 (s) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.93 (t, J = 7.3 Hz, 3 H), 1.00 (t, J = 7.3 Hz, 3 H), 1.65 (s, 3 H), 2.06 (q, J = 7.3 Hz, 
2 H), 2.10 (q, J = 7.3 Hz, 2 H), 3.24 (s, 2 H), 3.45 (s, 2H), 3.73 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 13.1, 13.2, 18.4, 25.7, 27.1, 47.0, 47.7, 52.3, 126.4, 135.6, 167.8, 201.7; High-resolution 
MS, calcd for C12H20O3: 212.1412. Found m/z (relative intensity): 212.1404 (M+, 96.0), 194 (100), 




IR (neat) 2964 (s), 2934 (s), 2874 (s), 17012 (s), 1456 (m), 1354 (s) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.94 (t, J = 7.3 Hz, 3 H), 0.99 (t, J = 7.3 Hz, 3 H), 1.66 (s, 3 H), 2.06 (q, J = 7.3 Hz, 2 H), 
2.11 (q, J = 7.3 Hz, 2 H), 2.11 (s, 3 H), 3.12 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 13.1, 13.2, 18.3, 
25.7, 27.1, 28.9, 47.7, 127.4, 134.5, 208.2; High-resolution MS, calcd for C10H18O: 154.1358 Found 
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(E)-Methyl-5-ethyl-2,6-dimethyl-3-oxooct-5-enoate (2k, major isomer) and (E)-Methyl 
5-ethyl-4,6-dimethyl-3-oxooct-5-enoate (2’k, minor isomer): (a mixture of regioisomers in a 2.5 : 
1 ratio) 
IR (neat) 2966 (s), 2936 (s), 2874 (m), 1755 (s), 1748 (s), 1718 (s), 1715 (s), 1456 (m) cm-1; 1H 
NMR (400 MHz, CDCl3, major isomer) δ 0.92 (t, J = 7.3 Hz, 3 H), 0.99 (t, J = 7.3 Hz, 3 H), 1.33 (d, 
J = 6.8 Hz, 3 H), 1.61 (s, 3 H), 1.99-2.12 (m, 4 H), 3.28 (d, J = 17.1 Hz, 1 H), 3.29 (d, J = 17.1 Hz, 
1 H), 3.63 (q, J = 6.8 Hz, 1 H), 3.72 (s, 3 H); 1H NMR (400 MHz, CDCl3, minor isomer) δ 0.96 (t, J 
= 7.3 Hz, 3 H), 1.01 (t, J = 7.3 Hz, 3 H), 1.16 (d, J = 6.8 Hz, 3 H), 1.71 (s, 3 H), 1.80-1.89 (m, 1 H), 
2.02-2.14 (m, 3H), 3.40 (d, J = 15.4 Hz, 1 H), 3.48 (d, J = 15.4 Hz, 1 H), 3.58 (q, J = 6.8 Hz, 1 H), 
3.72 (s, 3 H); 13C NMR (100 MHz, CDCl3, major isomer) δ ; 13.1, 13.1, 13.2, 18.3, 25.6, 27.1, 45.5, 
51.2, 52.4, 126.3, 135.3, 171.1, 204,5; 13C NMR (100 MHz, CDCl3, minor isomer) δ ; 12.8, 13.8, 
14.8, 17.9, 23.0, 27.6, 46.7, 51.0, 52.2, 132.1, 135.7, 168.0, 204.6; High-resolution MS, calcd for 
C13H22O3: 226.1569. Found m/z (relative intensity): 226.1570 (M+, 67.4), 197 (100). 
 
 
(E)-5-Ethyl-6-methyloct-5-en-3-one (3k, major isomer) and 
(E)-4-Ethyl-3,5-dimethylhept-4-en-2-one (3’k, minor isomer): (a mixture of regioisomers in a 
1.2 : 1 ratio) 
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CDCl3, major isomer) δ 0.93 (t, J = 7.6 Hz, 3 H), 0.99 (t, J = 7.6 Hz, 3 H), 1.03 (t, J = 7.3 Hz, 3 H), 
1.65 (s, 3 H), 2.05 (q, J = 7.6 Hz, 2 H), 2.09 (q, J = 7.6 Hz, 2 H), 2.43 (q, J = 7.3 Hz, 2 H), 3.12 (s, 
2 H); 1H NMR (500 MHz, CDCl3, minor isomer) δ 0.96 (t, J = 7.6 Hz, 3 H), 1.01 (t, J = 7.6 Hz, 3 
H), 1.12 (d, J = 6.9 Hz, 3 H), 1.71 (s, 3 H), 1.83-1.89 (m, 1 H), 2.03-2.13 (m, 3H), 2.07 (s, 3 H), 
3.43 (q, J = 6.9 Hz, 1 H); 13C NMR (100 MHz, CDCl3, major isomer) δ 7.9, 13.1, 13.3, 18.4, 25.8, 
27.1, 34.7, 46.5, 127.5, 134.2, 210.6; 13C NMR (100 MHz, CDCl3, minor isomer) δ 12.8, 13.9, 14.9, 
17.9, 23.0, 27.5, 28.1, 51.2, 133.0, 134.3, 210.9; High-resolution MS, calcd for C11H20O: 168.1514. 
Found m/z (relative intensity): 168.1514(M+, 40.0), 153 (55), 139 (100). 
 
 
(E)-Methyl 5-ethyl-6-methyl-3-oxo-2-phenyloct-5-enoate (2l) 
IR (neat) 2964 (s), 2934 (s), 2872 (m), 1755 (s), 1720 (s), 1641 (m), 1601 (m), 1456 (m), 1435 (m) 
cm-1; 1H NMR (400 MHz, CDCl3) δ 0.84 (t, J = 7.3 Hz, 3 H), 0.98 (t, J = 7.3 Hz, 3 H), 1.48 (s, 3 H), 
1.96 (q, J = 7.3 Hz, 2 H), 2.06 (q, J = 7.3 Hz, 2 H), 3.20 (s, 2 H), 3.73 (s, 2 H), 4.82 (s, 1 H), 
7.31-7.38 (m, 5 H); 13C NMR (100 MHz, CDCl3) δ 13.1, 13.1, 18.2, 25.5, 27.1, 45.6, 52.5, 63.3, 
126.3, 128.2, 128.8, 129.5, 132.6, 135.6, 169.1, 202.2; High-resolution MS, calcd for C18H24O3: 
288.1725. Found m/z (relative intensity): 288.1730 (M+, 100), 259 (6), 231 (28). 
 
(E)-Methyl 5-ethyl-6-methyl-3-oxo-4-phenyloct-5-enoate (2’l) 
1H NMR (400 MHz, CDCl3) δ 0.76 (t, J = 7.3 Hz, 3 H), 1.07 (t, J = 7.3 Hz, 3 H), 1.72 (s, 3 H), 
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H), 7.18-7.36 (m, 5 H); 13C NMR (100 MHz, CDCl3) δ 12.9, 14.2, 18.6, 24.4, 27.8, 48.0, 52.3, 61.5, 




IR (neat) 2964 (s), 2934 (s), 2872 (m), 1715 (s), 1497 (m), 1454 (m) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.89 (t, J = 7.3 Hz, 3 H), 0.99 (t, J = 7.3 Hz, 3 H), 1.58 (s, 3 H), 2.02 (q, J = 7.3 Hz, 2 H), 
2.09 (q, J = 7.3 Hz, 2 H), 3.17 (s, 2 H), 3.69 (s, 2 H), 7.18-7.34 (m, 5 H); 13C NMR (100 MHz, 
CDCl3) δ 13.1, 13.2, 18.3, 25.7,0 27.1, 46.0, 48.8, 126.8, 127.0, 128.6, 129.4, 134.4, 134.7, 207.0; 
High-resolution MS, calcd for C16H22O: 230.1671. Found m/z (relative intensity): 230.1671 (M+, 
100), 201 (65). 
 
(E)-4-Ethyl-5-methyl-3-phenylhept-4-en-2-one (3’l, minor isomer) 
1H NMR (400 MHz, CDCl3) δ 0.77 (t, J = 7.3 Hz, 3 H), 1.06 (t, J = 7.3 Hz, 3 H), 1.71 (s, 3 H), 
2.00-2.21 (m, 4 H), 2.23 (s, 3 H), 4.72 (s, 1 H), 7.17-7.33 (m, 5 H); 13C NMR (100 MHz, CDCl3) δ 
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13. In entries 5 and 6 of Table 3, a regioisomeric mixture of b-ketocarboxylic acids 2 and 2’ were 
produced. Both nickelacycles I and III through the s-p-s allylnickel interconversion would 
participate in the alkyne insertion to form a regioisomeric mixture of nickelacycle intermediates 
providing 2 along with 2’ (Scheme 4 and 5). However, the alternative reaction mechanism 
involving decarboxylation-carboxylation sequences can never be ruled out. 
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Chapter 3 
 
Nickel-Catalyzed Three-Component Coupling of 
















Summary: In the presence of Ni(0) catalyst, the regio- and stereoselective three-component 
coupling reaction of 4-methylene-2-oxazolidinone, alkynes, and Me3Al accompanied by extrusion 
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Introduction 
    
   Nickelacycles are one of the most attractive and efficient active species for C−C bond 
transformation in modern organic chmistry.1   In particularly, multi-component coupling reactions 
promoted by Ni-catalyst are extremely straightforward and convenient methods for construction of 
complicated molecules in material science and medicinal chemistry.2   The research of our group 
is mainly directed towards the development of novel transformation for the nickel-catalyzed 
multicomponent coupling reaction via nickelacycle as a key intermediate. 3    
   Recently, we have reported the Ni-catalyzed three-component coupling reactions of Me2Zn, 
alkynes with vinylepoxides and vinylcyclopropanes to afford dienyl alcohols and α-heptadienyl 
dimethyl malonates, respectively (Scheme 1).4   
 
 
Scheme 1. Ni-Catalyzed Three-Component Coupling Reaction of Me2Zn, alkynes with 
vinylepoxides and vinylcyclopropanes 
 
   More recently, we have developed the Ni-catalyzed three-component coupling reaction of 
4-methylene-1,3-dioxolan-2-one, alkyne, and Me2Al(OMe) proceeded to give δ,ε-unsaturated 
β-ketocarboxylic acids with high regio- and stereoselectivities  (Scheme 2).5   The reaction 
proceeds via [1,3]-rearrangement of an enolative metal carbonate intermediate and the formal 











X = O or 
C(CO2Me)2
Me2Zn
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Scheme 2. Ni-Catalyzed Three-Component Coupling Reaction of 4-Methylene-1,3-dioxolan-2-one, 
alkyne, and Me2Al(OMe) 
 
   In this research, we have focused on a 4-methylene-2-oxazolidinone as a starting material for 
the efficient formation of oxanickelacycle species.   Previously, we could succeed in the efficient 
formation of 4-methylene-2-oxazolidinones from propargyl alcohols with isocyanate followed by 
intramolecular addition of nitrogen atom to C-C triple bond promoted by Cu and Ag catalysts 
(Scheme 3).6   4-Methylene-2-oxazolidinones are densely functionalized useful and competent 
molecules possesing stereochemically defined enamine and protected allylic alcohols moieties.   
For examples, 4-methylene-2-oxazolidinones could serve as an aza-trimethylene methane 
intermediate to undergo the amphiphilic addition towards α,β-unsaturated enones and active 
alkenes.   The versatile heterocylic compounds have potential for the important synthon of 
physiologically active molecules and pharmaceutical products.   
 
 
Scheme 3. Synthesis of 4-methylene-2-oxazolidinone from propargyl alcohol and isocyanate 
 
   Herein, we would like to disclose that N-p-toluenesulfonyl-4-methylene-2-oxazolidinone can 
serve as an allylic aza-nickelacycle species to undergo the three-component coupling reactions with 
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protocol is an useful and efficient synthetic methodology of nitrogen containing compounds such as 
β-amino acids and unsaturated dienyl amines. 
 
 
Scheme 4. Ni-Catalyzed Three-Component Coupling Reaction of 4-Methylene-2-oxazolidinone, 
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Results and Discussion 
 
   The optimization of the reaction conditions are summarized in Table 1.   At first, we 
examined a variety of organometallic reagents.   In the presence of 5 mol% of Ni(cod), the 
reaction of 5,5-dimethyl-4-methylene-2-oxazolidinone 1a, 4-octyne, and Me3Al proceeded at 60 ℃ 
in toluene to give the corresponding 2-amino-1,4-hexadiene in 64% yield (Entry 1, Table 1).   
However, in the case of Me2Al(OMe), which was effective for the synthesis of β-ketocarboxylic 
acid (Chapter 2), did not work well in this case (Entry 2, Table 1).   Under similar conditions, 
complex mixtures were produced using Et3Al, and DIBAL-H (Entries 3 and 4, Table 1).  
Organozinc reagent, such as Me2Zn and Et2Zn, were not effective to promote the coupling reactions 
(Entries 5 and 6, Table 1).   Next, we investigated the solvent effects in the multi-component 
coupling reaction.  As the results of using non-polar and aprotic polar solvents, toluene is the best 
solvent for the expected reaction (Entries 1 and 7-14, Table 1).  Aprotic polar solvents such as 
DMA, DMF, and DMSO provided the isomerized dienyl enamine 3a as by-product.  Especially, 
NMP gave the conjugated diene 3a as major product (Entry 12, Table 1).  As the unconjugated 
diene 2a did not convert to conjugated diene 3a in the similar conditions, aprotic solvents might 
accelerate to isomerize from 2a to 3a in situ during the coupling reaction.   We have further 
examined ligands for the coupling reaction, and the results are shown in entries 15-19.  
Irrespective of the kinds of phosphine ligands, the yields of the products were diminished and, 
instead, no ligand resulted in the formation of the desired product in better yields. 
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Table 1. Optimization of the Reaction Conditions for Nickel-Catalyzed Three-Component 
Coupling of 4-Methylene-2-oxazolidinone, Alkyne, and Me3Ala 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (5.0 mol%), cyclic carbamate 1a (1.0 mmol), 
4-octyne (2.0 mmol), and organometallic reagent (1.2 mmol) in solvent (5.0 mL) at 60 ℃ under nitrogen 





1 TolueneMe3Al 64 0
2 TolueneMe2Al(OMe) 5 0
3 TolueneEt3Al Complex Mixture
4 TolueneDIBAL-H Complex Mixture
5 TolueneMe2Zn No Reaction
7 HexaneMe3Al 37 0
6 TolueneEt2Zn No Reaction
8 CPMEMe3Al 6 0
9 1,4-DioxaneMe3Al 8 0




14 DMSOMe3Al 22 23
15 TolueneMe3Al 23 0
16 TolueneMe3Al 33 0












































18 TolueneMe3Al 55 0
19 TolueneMe3Al 29 0
DPPE
Xantphos
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   Next, we investigated the reactions of 5,5-dimethyl-4-methylene-3-tosyloxazolidin-2-one 1a 
with a various kinds of alkynes and Me3Al, and the results summarized in Table 2.   Symmetrical 
alkynes, such as 2-butyne, 3-hexyne, 4-octyne, and diphenylacetylene reacted smoothly with cyclic 
carbamate 1a in the presence of Me3Al to provide corresponding 2-amino-1,4-hexadiene 2a-2d in 
moderate yields (Entries 1-4, Table 2).   In the case of unsymmetrical alkynes, such as 
4-methyl-2-pentyne and 1-trimethylsilyl-1-propyne, the corresponding 2-amino-1,4-hexadiene 
2e-2f were obtained in low to modest yields as a mixture of regioisomers in ratios of 1.8:1 to 4.0:1  
(Entries 5 and 6, Table 2).    
 
Table 2. Ni-Catalyzed Coupling of Cyclic Carbamate 1a with Various Alkyne and Me3Ala 
 
aThe reaction was undertaken in the presence of [Ni(cod)2] (5.0 mol%), cyclic carbamate 1a (1.0 mmol), 
alkyne (2.0 mmol), and Me3Al (1.2 mmol) in toluene (5.0 mL) at 60 ℃ under nitrogen atmosphere for 24 h. 
















Entry R1 Isolated Yield of 2 [%]
1 Me Me 2b : 64
2 Et Et 2c : 57
3 nPr nPr 2a : 64
4 Ph Ph 2d : 37
5 iPr Me 2e : 38 [1.8:1]b
6 TMS Me 2f : 25 [4.0:1]b
R2
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   The stereochemistry of the product 2a was unequivocally determined as E-isomer on the basis 
of NOE experiment.   The result of irradiation at the bold face protons are illustrated in Figure 1. 
 
 
Figure 1. NOE Data for Irradiation of Bold Face Protons in Dienylamine 2a 
 
   Next, the reaction of a stoichiometric amount of Ni(cod)2, alkyne, and cyclic carbonate without 
Me3Al was conducted (Scheme 5).   In the absence of Me3Al, the mixture of Ni(cod)2 (1.0 mmol), 
4-octyne (2.0 mmol), and 5,5-dimethyl-4-methylene-3-tosyloxazolidin-2-one 1a (1.0 mmol) did not 
provide the expected 2-amino-1,4-hexadiene 2g.   In this case, the reaction was not proceed at all 
and the almost cyclic carbamate was recovered.   This result shows Me3Al is indispensable to 
carry out the reaction, and we believe that Me3Al acts as a Lewis acid and promotes the oxidative 
addition in the first step.  
 
 

























(1.0 mmol) (2.0 mmol)
H3O+
Not Observed
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   In the absence of alkyne, the mixture of Ni(cod)2 catalyst, 
5,5-dimethyl-4-methylene-3-tosyloxazolidin-2-one 1a, and Me3Al proceeded to give the 
corresponding enylamine 4a in low yield (Scheme 6).   That is, oxidative addition of 
5,5-dimethyl-4-methylene-3-tosyloxazolidin-2-one 1a toward Ni(0) catalyst proceeds 
accompanying extrusion of carbon dioxide promoted by Me3Al as Lewis acid.  
Aza-trimethylenemethane nickel intermediate II can participate in the formation of azanickelcycle 















Under N2, 60 °C, 24 h 4a : 19%
1a
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A plausible reaction mechanism for three-component coupling reaction with 
4-methylene-2-oxazolidinone in the presence of Ni-catalyst, alkyne, and Me3Al is shown in Scheme 
6.   Oxidative addition of 4-methylene-2-oxazolidinone toward Ni(0) catalyst proceeds 
accompanying extrusion of carbon dioxide promoted by Me3Al as Lewis acid.  
Aza-trimethylenemethane nickel intermediate II can participate in the formation of azanickelcycle 
species III to undergo the insertion of alkyne in syn addition manner to form six-membered 
azanickelacycle V.   Transmetallation with Me3Al proceeds to afford methyl vinyl nickel 
intermediate VI following reductive elimination to afford dienylamine 2.   Ni(0) catalyst can be 
generated as an active species to promote the multi-component coupling reaction. 
 
 
Scheme 6. Plausible Reaction Mechanism for Ni-Catalyzed Three-Component Coupling of 











Ts N NiTs N NiTsAlMe3 AlMe3
-CO2






























	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  93 
Conclusion 
    
   In conclusion, we developed Ni-catalyzed three-component coupling reactions of 
4-methylene-2-oxazolidinone, alkyne, and Me3Al accompanied by extrusion of carbon dioxide to 
furnish 2-amino-1,4-hexadiene with high regio- and stereoselectivities.   The products are useful 
as the synthetic enamine key intermediates for the preparation of nitrogen containing compounds.  
The study is in progress to apply our protocol to the synthesis of physiologically active molecules, 
such as unsaturated amines and amino acids. 
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Experimental Section 
 
   Distillation were carried out in a Kugelrohr apparatus (SIBATA glass tube oven GTO-350RG).  
Boiling points are meant to refer to the oven temperature (± 1 °C).  Microanalyses were performed 
by the Instrumental Analysis Center of Nagasaki University.  Analysis agreed with the calculated 
values within ± 0.4%.  High resolution mass spectra (HRMS) were measured with JEOL 
JMSDX303.  Infrared spectra were recorded with a JASCO A-100 or SHIMAZU FTIR-8700 
infrared spectrophotometer.  1H and 13C magnetic resonance spectra were measured on 
JEOL-GX400 instrument with tetramethylsilane as an internal standard.  Chemical shift values 
were given in ppm downfield from the internal standard. 
 
Solvents and Reagents 
   Toluene was dried and distilled from sodium immediately prior to use under nitrogen 
atmosphere.  Tetrahydrofuran, 1,4-dioxane, DMSO, CPME, n-hexane, DMA, NMP, and DMF 
were purchased and used without further purification.  Me3Al, Me2Zn, Et3Al, Et2Zn, DIBAL-H 
were purchased and used without further purification.       Me2Al(OMe) was prepared by 
reacting Me3Al (1.0 M hexane solution) and methanol (Wako).  Ni(cod)2, PPh3, P(c-Hex)3, 
P(OPh)3, dppe, and Xantphos were purchased and used without further purification.  
5,5-Dimethyl-4-methylene-2-oxazolidinone was prepared from according to the literature.6 
 
Preparation of Me2Al(OMe) 
   A 25 mL of two-necked round-bottomed flask, equipped with a magnetic stir bar, a rubber 
septum and an air condenser at the top of which is attached a three-way stopcock fitted a nitrogen 
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balloon.  Me3Al (1.0 M hexane solution, 2.0 mL, 2.0 mmol) are placed in the flask under nitrogen 
atmosphere.  The stirring solution are cooled 0 °C and methanol (64.3 mg, 2.0 mmol) are 
dropwised over 5 min.  This reaction completes for 30 min. 
 
General procedure for multi-component coupling reaction (Entry 1, Table 1) 
   A 25 mL of two-necked round-bottomed flask, equipped with a rubber septum and an air 
condenser at the top of which is attached a three-way stopcock fitted a nitrogen balloon.  
N-p-Toluenesulfonyl-5,5-dimethyl-4-methylene-2-oxazolidinone (281.3 mg, 1 mmol) and Ni(cod)2 
(13.8 mg, 0.05 mmol) are placed in the flask and purged with nitrogen.  Freshly distilled toluene (5 
mL), 4-octyne (220.4 mg, 2.0 mmol), and Me3Al (1.2 mL of 1 M hexane solution; 1.2 mmol) are 
successively added while stirring the solution with a magnetic stirrer.  The stirring is continued for 
24 h at 60˚C.  After the reaction completes, the reaction mixture is diluted with ethyl acetate (20 
mL).  The organic phase is washed with sat. NaHCO3 (2 x 20 mL) and brine (2 x 20 mL), and then 
dried over magnesium sulfate, filtered, and concentrated.  The organic phase was dried (MgSO4) 
and concentrated in vacuo to give a pale yellow oil, which was subjected to column 
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16. (5E)-N-(2,6-Dimethyl-5-propyl-2,5-nonadienyl)-p-toluenesulfonamide (2a) 
17. IR (neat) 3277 (br), 2959 (s), 2930 (m), 2870 (m), 2343 (w), 1599 (w), 1456 (m), 1381 (m), 
1325 (m), 1165 (s), 1092 (m), 665 (m) cm-1; 1H NMR (C6D6, 400 MHz) δ 0.85 (t, J = 7.3 Hz, 3 
H), 0.87 (t, J = 7.3 Hz, 3 H), 1.26-1.41 (m, 4 H), 1.48 (s, 3 H), 1.54 (s, 3 H), 1.67 (s, 3 H), 1.87 
(s, 3 H), 1.88 (t, J = 7.3 Hz, 2 H), 1.98 (t, J = 7.3, 2 H), 3.03 (s, 2 H), 5.32 (s, 1 H), 6.75 (d, J = 
8.3 Hz, 2 H), 7.81 (d, J = 8.3 Hz, 2 H); 13C NMR (CDCl3, 100 MHz) δ 14.2, 14.4, 18.1, 20.3, 
21.0, 21.5, 21.7, 22.4, 32.9, 33.8, 36.6, 125.4, 127.4, 128.8, 129.4, 132.2, 133.4, 138.0, 143.3; 
High-resolution MS, calcd for C21H33NO2S: 363.2232. Found m/z (relative intensity): 363.2226 
(M+, 100), 361 (2), 348 (2). 
 
 
2,5,6-Trimethyl-N-p-toluenesulfonylhepta-2,5-dien-3-amine (2b): IR (neat) 3296 (w), 3055 (w), 
2920 (w), 2862 (w), 1599 (w), 1494 (w), 1373 (m), 1323 (m), 1265 (s), 1165 (s), 1092 (m), 739 (s), 
706 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.44 (s, 3 H), 1.46 (t, 3 H), 1.58 (s, 3 H), 1.62 (s, 3 H), 
1.74 (s, 3 H), 2.42 (s, 3 H), 2.77 (s, 2 H), 5.21 (s, 1 H), 7.28 (d, J = 8.3 Hz, 2 H), 7.72 (d, J = 8.3 Hz, 
2 H); 13C NMR (CDCl3, 100 MHz) δ 17.2, 20.3, 20.4, 20.84, 20.87, 21.5, 35.8, 123.6, 125.3, 127.3, 
128.2, 129.4, 132.2, 137.9, 143.3; High-resolution MS, calcd for C17H25NO2S: 307.1606. Found m/z 
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(E)-5-Ethyl-2,6-dimethyl-N-p-toluenesulfonylocta-2,5-dien-3-amine (2c) 
IR (neat) 3275 (s), 2964 (s), 2934 (s), 2874 (m), 1598 (w), 1454 (w), 1373 (m), 1325 (m), 1165 (s), 
1092 (m), 814 (m), 739 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.84 (t, J = 7.3 Hz, 3 H), 0.94 (t, J 
= 7.3 Hz, 3 H), 1.45 (s, 3 H), 1.58 (s, 3 H), 1.75 (s, 3 H), 1.82 (q, J =7.3 Hz, 2 H), 2.00 (q, J = 7.3 
Hz, 2 H), 2.42 (s, 3 H), 2.77 (s, 2 H), 5.19 (s, 1 H), 7.28 (d, J = 8.3 Hz, 2 H), 7.73 (d, J = 8.3 Hz, 2 
H); 13C NMR (CDCl3, 100 MHz) δ 13.3, 13.8, 17.7, 20.4, 21.0, 21.5, 23.5, 27.3, 33.4, 125.5, 127.4, 
129.5, 129.6, 132.3, 134.4, 137.9, 143.4; High-resolution MS, calcd for C19H29NO2S: 335.1919. 




IR (neat) 3277 (s), 3045 (m), 2918 (m), 2866 (m), 2363 (w), 1744 (w), 1599 (s), 1491 (s), 1445 (s), 
1367 (s), 920 (m), 812 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.29 (s, 3 H), 1.45 (s, 3 H), 2.09 (s, 3 
H), 2.44 (s, 3 H), 3.39 (s, 2 H), 5.09 (s, 1 H), 6.76-7.07 (m, 10 H), 7.27 (d, J = 8.3 Hz, 2 H), 7.68 (d, 
J = 8.3, 2 H); 13C NMR (CDCl3, 100 MHz) δ 20.1, 20.2, 21.2, 21.5, 36.4, 124.4, 125.7, 125.8, 126.5, 
127.2, 127.5, 128.8, 129.5, 131.4, 134.05, 134.12, 135.9, 137.9, 142.0, 143.2, 144.1; 
High-resolution MS, calcd for C27H29NO2S: 431.1919. Found m/z (relative intensity): 431.1934 
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(E)-2,5,6,7-Tetramethyl-N-p-toluenesulfonylocta-2,5-dien-3-amine (2e, major isomer) and 
5-isopropyl-2,6-dimethyl-N-p-toluenesulfonylhepta-2,5-dien-3-amine (2’e, minor isomer): (a 
mixture of regioisomers in a 1.8 : 1 ratio) 
IR (neat) 3275 (w), 2963 (m), 2932 (m), 2930 (m), 2870 (w), 1599 (w), 1323 (m), 1265 (m), 1165 
(s), 1092 (m), 814 (w), 739 (s) cm-1; 1H NMR (C6D6, 400 MHz, major isomer) δ 0.92 (d, J = 6.8 Hz, 
6 H), 1.47 (s, 3 H), 1.50 (s, 3 H), 1.50 (s, 3 H), 1.55 (s, 3 H), 1.89 (s, 3 H), 2.81 (sept, J = 6.8 Hz, 1 
H), 3.00 (s, 2 H), 5.48 (s, 1 H), 6.78 (d, J = 8.3 Hz, 2 H), 7.82 (d, J = 8.3 Hz, 2 H); 1H NMR (C6D6, 
400 MHz, minor isomer) δ 0.91 (d, J = 6.8 Hz, 6 H), 1.47 (s, 3 H), 1.58 (s, 3 H), 1.58 (s, 3 H), 1.74 
(s, 3 H), 1.87 (s, 3 H), 2.70 (sept, J = 6.8 Hz, 1 H), 3.05 (s, 2 H), 5.56 (s, 1 H), 6.75 (d, J = 8.3 Hz, 2 
H), 7.28 (d, J = 8.3 Hz, 2 H); 13C NMR (CDCl3, 100 MHz, major isomer) δ 11.9, 16.5, 20.4, 20.6, 
20.9, 21.5, 30.3, 36.2, 122.4, 125.3, 127.4, 129.5, 132.3, 137.7, 138.0, 143.3; 13C NMR (CDCl3, 100 
MHz, minor isomer) δ 20.6, 20.9, 21.2, 21.4, 21.5, 21.6, 30.5, 31.2, 126.1, 127.5, 129.4, 129.6, 
130.0, 132.7, 138.2, 143.3; High-resolution MS (major isomer), calcd for C19H29NO2S: 335.1919. 
Found m/z (relative intensity): 335.1922 (M+, 100), 333 (1), 320 (3); High-resolution MS (minor 
isomer), calcd for C19H29NO2S: 335.1919. Found m/z (relative intensity): 335.1930 (M+, 100), 333 
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(E)-Dimethyl-6-(trimethylsilyl)-N-p-toluenesulfonylhepta-2,5-dien-3-amine (2f, major isomer) 
and 2,6-dimethyl-5-(trimethylsilyl)- N-p-toluenesulfonylhepta-2,5-dien-3-amine (2’f, minor 
isomer): (a mixture of regioisomers in a 4.0 : 1 ratio) 
IR (KBr, major isomer) 3260 (s), 3252 (s), 2953 (s), 2862 (s), 2719 (m), 1904 (w), 1601 (s), 1402 
(s), 1157 (s), 953 (m), 754 (m) cm-1; 1H NMR (CDCl3, 400 MHz, major isomer) δ 0.10 (s, 9 H), 
1.49 (s, 3 H), 1.55 (s, 3 H), 1.62 (s, 3 H), 1.73 (s, 3 H), 2.42 (s, 3 H), 2.90 (s, 2 H), 5.20 (s, 1 H), 
7.28 (d, J = 8.3 Hz, 2 H), 7.72 (d, J = 8.3 Hz, 2 H); 1H NMR (CDCl3, 400 MHz, minor isomer) δ 
0.08 (s, 9 H), 1.43 (s, 3 H), 1.61 (s, 3 H), 1.71 (s, 3 H), 1.87 (s, 3 H), 2.42 (s, 3 H), 3.00 (s, 2 H), 
5.36 (s, 1 H), 7.27 (d, J = 8.3 Hz, 2 H), 7.72 (d, J = 8.3 Hz, 2 H); 13C NMR (CDCl3, 100 MHz, 
major isomer) δ 0.4, 17.9, 20.4, 20.7, 21.5, 22.0, 36.4, 125.1, 127.4, 129.5, 131.8, 132.4, 137.8, 
141.3, 143.4; 13C NMR (CDCl3, 100 MHz, minor isomer) δ 0.8, 20.7, 21.3, 21.5, 21.8, 26.1, 34.7, 
125.8, 127.5, 128.2, 129.4, 129.8, 138.4, 143.2, 149.2; High-resolution MS (major isomer), calcd 
for C19H31NO2SSi: 365.1845. Found m/z (relative intensity): 365.1856 (M+, 100), 363 (35), 350 
(47); High-resolution MS (minor isomer), calcd for C19H31NO2SSi: 365.1845. Found m/z (relative 
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Chapter 4 
 
Reconstruction of Carbon Bond Frameworks via Oxapalladacycle Promoted by 
















Summary: Pd-catalyzed β-carbon elimination of 3-hydroxy-4-pentenoic acid derivatives promoted 
by triethylborane proceeded to form conjugated dienes via a decarboxylation process. The formed 
conjugated dienes underwent the Prins reaction with aldehydes in situ to afford conjugated 
homoallylic alcohols. These sequential transformations enabled conversion of a diastereomeric 
mixture of 3-hydroxy-4-pentenoic acids, which were readily prepared from the simple crossed aldol 
reaction of esters and α,β-unsaturated aldehydes, to 3,5-hexadienyl alcohols with high regio- and 
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Introduction 
    
   C-C bond cleavage reactions are convenient and powerful tools for the transformations of 
functional groups and expansion of the carbon bond frameworks of cyclic compounds.1   
Although C-C bond cleavage reactions have received less attention than C-C bond formation, they 
still have considerable synthetic utility for efficient chemical transformations.2 
   We previously reported the transition metal-catalyzed Grob-type decarboxylative ring-opening 
reaction of vinyl cyclic carbonates into ω-dienyl aldehydes by β-carbon elimination via an 
oxapalladacyclopentane intermediate (Scheme 1).3   4-Pentene-1,3-diols also underwent the 
dehydrative β-carbon elimination of oxapalladacycles promoted by Pd(0) catalyst and organoboran 
reagent (Scheme 2).4   In this case, the combination of Pd(0) catalyst with B-Ph-9-BBN readily 
promoted the oxidative addition of an allylic alcohol moiety to form an oxapalladacyclopentane, 
followed by b-carbon elimination to efficiently provide a w-dienyl aldehyde.   Organoborane can 
serve as a Lewis acid to assist the oxidative addition of allylic alcohols to the Pd(0) catalyst to 
produce oxapalladacycle intermediates.5    
 
 
Scheme 1. Pd-Catalyzed C−C Bond Cleavage of Vinyl Cyclic Carbonates via Oxapalladacycle 
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   Furthermore, we have previously demonstrated that 3-hydroxy-4-pentenoic acids underwent 
C−C bond cleavage in the presence of Pd catalyst and Et3B via oxapalladacycle intermediates 
proceeds to provide conjugated dienes in good yields with excellent stereoselectivities (Scheme 3).6 
This methodology is useful for the stereodefined construction of conjugated dienes from readily 
available esters and α,β-unsaturated aldehydes.   
 
 
Scheme 3. Pd-Catalyzed C−C Bond Cleavage of 3-Hydroxy-4-pentenoic Acid via Oxapalladacycle 
 
   C−C bond formation using conjugated dienes and carbonyl compounds is also an attractive 
strategy in modern organic synthesis.7   Transition metal-catalyzed reductive couplings of 
conjugated dienes and carbonyls mediated by organometallic reagents such as hydrosilane, 
trialkylborane, and dialkylzinc can provide allyl alcohols, homoallyl alcohols, and bis-homoallyl 
alcohols with exceptionally high regio- and stereoselectivities.8   Most of these reactions proceed 
through the oxidative cyclization of low-valent transition metals across the conjugated dienes and 
carbonyls, followed by transmetallation with organometallic reagents via the oxametallacycles. 
Thus, the oxametallacycles formed in situ can serve as common important intermediates for C−C 
bond coupling as well as β-carbon elimination. 
Regarding C−C bond coupling, the ene-type coupling reaction (Prins reaction) can occur in the 
presence of a Pd catalyst and Xantphos ligand.9 Et3B promotes the allylation of aldehydes with 
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double bond of the conjugated diene bearing higher electron density through the oxapalladacycle 
intermediate (Scheme 4). 
 
 
Scheme 4. Pd-Catalyzed C−C Bond Formation of Conjugated Diene and Aldehyde via 
Oxapalladacycle 
 
   Based on these findings, 3-hydroxy-4-pentenoic acid was regarded as a conjugated diene 
equivalent and planned to be utilized as a synthetic intermediate.   Herein, we disclose the 
Pd-catalyzed β-carbon elimination of 3-hydroxy-4-pentenoic acids with accompanying 
decarboxylation promoted by Et3B to form 1,3-pentadiene derivatives, which is followed by Prins 
reactions with aldehydes in situ to afford the conjugated homoallylic alcohols (Scheme 5).   These 
sequential transformations enable conversion of a diastereomeric mixture of 3-hydroxy-4-pentenoic 
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Scheme 5. Pd-Catalyzed C−C Bond Formation Utilizing 3-Hydroxy-4-pentenoic Acids as an 
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Results and Discussion 
    
   The optimization of the reaction conditions are summarized in Table 1.  In the presence of 
Pd(OAc)2 (10 mol%), Xantphos (10 mol%), and Et3B (1.5 mmol, 1.0 M in THF), the coupling 
reaction of 3-hydroxy-4-pentenoic acid 1a (0.5 mmol) with benzaldehyde 2a (1.5 mmol) proceeded 
at 67 ℃ to give the corresponding (3E,5E)- and (3Z,5E)-3,5-hexadien-1-ol 3a in 91% yield in a 
10:1 ratio (Entry 1, Table 1).   When 1.0 mmol and 0.5 mmol of 2a were used, the desired 
product 3a was obtained in 85% and 72% yields, respectively (Entries 2 and 3, Table 1).  
Pd(acac)2 was also effective for this reaction (Entry 4, Table 1).   On the other hand, PdCl2 was 
not effective to promote the desired reaction (Entry 5, Table 1).   Using Pd(dba)2 significantly 
reduced the yield (Entry 6, Table 1).   Next, we investigated the ligand effects in this coupling 
reaction, and the results are summarized in entries 1, 7-16.   In the case of Cy-Xantphos as a 
ligand, the desired product obtained in low yield along with diene 4’a as major product (Entry 7, 
Table 1).   When N-Xantphos and DPEphos were used as ligand instead of Xantphos, the 
reactions proceeded to give 3a in 75% and 72% yields, respectively (Entries 8 and 9, Table 1).   
However, by use of DPPF and rac-BINAP, the yield decreased to 50% and 32%, respectively 
(Entries 10 and 11, Table 1).   In the case of DPPE and DPPP, the desired reaction did not 
proceed (Entries 12 and 13, Table 1).   Mono-dentate ligand, such as PPh3 and Xphos, the 
corresponding products were obtained in low to moderate yields (Entries 14 and 15, Table 1).   
Bathophenanthroline did not work well (Entry 16, Table 1).   We have further examined 
organometallic reagents for the coupling reaction, and the results are shown in entries 17-19.   
However, Et3Al, Et2Zn, and Ph3B were not effective to promote the coupling reactions.  As 
expected, control experiments revealed no product formation when Palladium catalyst or Xantphos 
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was omitted from the mixture (Entries 20-21, Table 1).   On the other hand, when Et3B was 
excluded from the mixture, desired product formation was not observed, but the diene 4’a was 
observed in moderate yield (Entry 22, Table 1).   That is, Et3B is indispensable for the C−C bond 
formation reaction, and accelerates the C−C bond cleavage reaction. 
 
Table 1. Optimization of the Reaction Conditions for Palladium-Catalyzed C−C Bond Formation 


















































10 50 [8:1]DPPF (10)
3 [1:2]
6 [2:1]
9 72 [10:1]DPEphosf (10)
11 32 [36:1]rac-BINAP (10)













16 0Bathophen (10) 0 19 [5:1]
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a3-Hydroxy-4-pentenoic acid 1a (0.5 mmol) and benzaldehyde 2a (1.5 mmol), in the presence of Pd catalyst 
(10 mol%), Ligand (10-20 mol%), and organometallic reagent (1.5 mmol, 1.0 M in THF) at 67 ℃ for 24 h 
under nitrogen atmosphere.   b1.0 mmol of 2a was used. c0.5 mmol of 2a was used.   dCy-Xantphos: 
4,5-Bis(dicyclohexylphosphino)-9,9-dimethylxanthene.   eN-Xantphos: 
4,6-Bis(diphenylphosphino)phenoxazine.   fDPEphos: Bis[2-(diphenylphosphino)phenyl] Ether.   gXphos: 
2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl.   hTHF (1.5 mL) and hexane (1.5 mL) were 




















21 0Pd(OAc)2 0 0None Et3B
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   With the optimal conditions in hand, we next explored the substrate scope of the coupling 
reactions of a variety of 3-hydroxy-4-pentenoic acids 1a with benzaldehyde 2a under the 
Pd(OAc)2/Xantphos/Et3B system, and the results are summarized in Table 2.   In the presence of 
Pd(OAc)2 (10 mol%), Xantphos (10 mol%), and Et3B (1.5 mmol, 1.0 M in THF), the coupling 
reaction of 3-hydroxy-4-pentenoic acid 1a with benzaldehyde 2a to provide (3E,5E)- and 
(3Z,5E)-3,5-hexadien-1-ol 3a in 91% yield in a 10:1 ratio (Entry 1, Table 2).   The 
3-hydroxy-4-pentenoic acids bearing a tolyl and p-methoxyphenyl group at R1 position provided the 
desired products in moderate to good yields (Entries 2 and 3, Table 2).   In the case of 
5-substituted 3-hydroxy-4-pentenoic acids 1d and 1e (R1=Ph, R2=Ph or Me), the desired reactions 
proceeded to give the corresponding 3E,5E-hexadien-1-ol in good yields with excellent 
stereoselectivities as a mixture of diastereomers (Entries 4 and 5, Table 2).   The 
3-hydroxy-4-pentenoic acid bearing a benzyl group at R1 position also provided the desired product 
in moderate yield (Entry 6, Table 2).   Cyclohexyl substituted 3-hydroxy-4-pentenoic acid 1g was 
transformed into 3,5-hexadien-1-ol 3g in moderate yield (Entry 7, Table 2).   Thus, aromatic 
substituents on R1 are not necessary to trigger a carbonyl–ene-type coupling reaction with an 
aldehyde to provide conjugated dienyl alcohols. 
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Table 2. Palladium-Catalyzed C−C Bond Formation Utilizing Various 3-Hydroxy-4-pentenoic 
Acids 1 as an Equivalent of Conjugated Diene with Benzaldehyde 2aa 
 
a3-Hydroxy-4-pentenoic acid 1 (0.5 mmol) and benzaldehyde 2a (1.5 mmol), in the presence of Pd(OAc)2 
(10 mol%), Xantphos (10 mol%), and Et3B (1.5 mmol, 1.0 M in THF) at 67 ℃ for 24 h under nitrogen 
atmosphere. 
 
   Next, we examined the reactions of a variety of aldehydes 2 with 3-hydroxy-4-pentenoic acid 1a, 
and the results are summarized in Table 3.  As expected, a host of aldehydes substituted with 
either aromatic (Entries 1-15, Table 3) or aliphatic backbones (Entries 16-19, Table 3) reacted 
equally well with the Pd(OAc)2/Xantphos/Et3B system.   Notably, the outcome of the latter was 
found to be insensitive to whether electron-rich or electron-poor arenes were employed, even in the 
presence of ortho-, meta-, or para-substituents (2b-2l).   In the case of 1-naphthaldehyde, the 
desired product was obtained in good yield (Entry 13, Table 3).  Likewise, the reaction could be 















Entry 1 [dr] Isolated Yield of 3 [(3E,5E) : (3Z,5E)] [%]
1 3a
2 3b: R1 = (p-Me)Ph, R2 = H [1.3:1]
3 3c: R1 = (p-OMe)Ph, R2 = H [1.8:1]
: R1 = Ph, R2 = H [1.4:1]
4 3d: R1 = Ph, R2 = Ph [2.0:1]
5 3e: R1 = Ph , R2 = Me [1.3:1]




: 79 [single, dr = 2.3:1]








7 3g: R1 = Cy , R2 = H [1.4:1] : 48 [7:1]1g
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Table 3. Palladium-Catalyzed C−C Bond Formation Utilizing 3-Hydroxy-4-pentenoic Acid 1a as 
an Equivalent of Conjugated Diene with Various Aldehyde 2a 
 
a3-Hydroxy-4-pentenoic acid 1a (0.5 mmol) and aldehyde 2 (1.5 mmol), in the presence of Pd(OAc)2 (10 
















1a (dr = 10:7) 3 [(3E,5E) : (3Z,5E)]2
Entry 2 Isolated Yield of 3 [(3E,5E) : (3Z,5E)] [%]
1 3a
9 3o: R = (p-Cl)Ph
7 3m: R = (p-OMe)Ph
2 3h: R = (o-Me)Ph
: R = Ph
13 3s
16 3v: R = -CH2CH2Ph
19 3y: R = Cy
14 3t: R = 2-furyl

















10 3p: R = (p-F)Ph : 71 [9:1]2j
4 3j: R = (m-OMe)Ph : 51 [9:1]2d
6 3l: R = (m-OPiv)Ph : 69 [16:1]2f
3 3i: R = (o-Cl)Ph : 73 [12:1]2c
17 3w: R = Et : 75 [>99:1]2q
12 3r: R = (p-NO2)Ph : 37 [9:1]2l
11 3q: R = (p-CN)Ph : 54 [10:1]2k
8 3n: R = (p-SMe)Ph : 86 [12:1]2h
15 3u: R = 3-benzothiophenyl : 79 [12:1]2o
18 3x: R = tert-Bu : 67 [>20:1]2r
5 3k: R = (m-Cl)Ph : 66 [13:1]2e
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   To shed light on the reaction mechanism, we studied the coupling reactions of conjugated 
dienes as the major intermediates with PhCHO in the formation of the coupling products (Scheme 
6).   Isolated conjugated dienes 4a and 4’a, which were independently prepared from 1a via 
decarboxylation, were treated with a mixture of Pd catalyst and Et3B in the presence of Xantphos. 
Diene 4a provided the desired homoallylic alcohol 3a with high 3E,5E selectivity (Eq. (a), Scheme 
6), whereas diene 4’a afforded the completely different allylic alcohol 5a as the sole product (Eq. 
(b), Scheme 6).   These results suggest that the sequential coupling of 1a with PhCHO proceeds in 
situ via 5-phenyl-1,3-pentadiene 4a as an important intermediate in the final step of the C−C bond 
coupling reaction and isomerization from 4a to 4'a is irreversible. 
 
 
Scheme 6. Pd-Catalyzed C−C Bond Formation Utilizing Conjugated Diene with Aldehyde 
 
   The structure of the product 5a was determined based on coupling constants from 1H NMR, 13C 
NMR, HMBC, HMQC spectral data and NOE experiment.   The selected data for the NOE 
observed by the irradiation at the bold face protons are illustrated in Figure 1. 
 
Ph
4'a [E:Z = 9:1]
Ph





























[(3E,5E) : (3Z,5E)] = [8:1]
Ph
5a : 35% [E only]
Ph
OH
(0.5 mmol) 3a : Not Observed
(a)
(b)
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Figure 1. Structure Determination for NOE Data of Dienyl Alcohol 5a 
 
   Next, a plausible reaction mechanism for the coupling reactions of 3-hydroxy-4-pentenoic acid 
and aldehyde promoted by a palladium catalyst, Xantphos, and Et3B are illustrated in Scheme 7.   
We propose that anti-oxapalladacycle-I is generated by oxidative addition of the Pd/Xantphos 
complex to the allylic position of syn-1 activated by Et3B with inversion of configuration.   
Similarly, syn-oxapalladacycle-I’ is generated from anti-1.   The intermediate 
syn-oxapalladacycle-I’ then isomerizes to the sterically more stable anti-oxapalladacycle-I from by 
σ-π-σ interconversion.10   Then, the anti-oxapalladacycle-I could undergo the C3-C4 bond fission 
with evolution of carbon dioxide to provide (E)-conjugated diene 4a.   Next, in the presence of Pd 
and Xantphos catalyst with Et3B, promotes conjugated diene 4a to undergo the oxidative cyclization 
with aldehyde to form the oxapalladacycle-II.   The intermediates II undergo transmetallation 
with Et3B to form allylpalladium species III.   This allylpalladium species III readily undergoes 
σ-π-σ interconversion to afford allylpalladium species V and V’, followed by β-hydride elimination 
resulting in the generation of (3E, 5E)- and (3Z, 5E)-dienyl alcohol 3 and is accompanied with the 
formation of the Pd/Xantphos complex as the key catalytic species.11 	  Despite use of a 
diastereomeric mixture of 1a as starting materials, stereocontrolled homoallylic alcohols were 
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Scheme 7. Plausible Reaction Mechanism for Palladium-Catalyzed C−C Bond Formation Utilizing 
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Conclusion 
    
   In conclusion, we developed the Pd-catalyzed β-carbon elimination of 3-hydroxy-4-pentenoic 
acid derivatives accompanied by a decarboxylation process promoted by Et3B to form pentadiene 
derivatives as E,E isomers.   The formed conjugated dienes can serve as major intermediates to 
undergo the Prins reaction with a wide variety of aldehydes in situ to afford conjugated homoallylic 
alcohols.   These sequential transformations enabled transformation of a diastereomeric mixture 
of 3-hydroxy-4-pentenoic acids, which was readily prepared by a crossed aldol reaction of esters 
and acrolein and their derivatives, to 3,5-hexadienyl alcohols in a single manipulation.   This 
consecutive cascade synthesis is a useful strategy for the stereodefined controlled reconstruction of 
carbon bond frameworks irrespective of the steric nature of the starting materials. 
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Experimental Section 
 
   Reactions employed oven-dried glassware unless otherwise noted.  Thin layer chromatography 
(TLC) employed glass 0.25 mm silica gel plates with UV indicator (Merck, Silica gel 60F254).  
Flash chromatography columns were packed with 230-400 mesh silica gel as a slurry in hexane.  
Gradient flash chromatography was conducted eluting with a continuous gradient from hexane to 
the indicated solvent.  1H, 13C, and 19F NMR spectra were recorded on a JEOL-GX400 and 
Varian-500PS-SN.  All 1H NMR spectra are reported in parts per million (ppm) downfield of TMS 
and were measured relative to the signals for CHCl3 (7.26 ppm) or acetone-d5 (2.05 ppm).  All 13C 
NMR spectra were reported in ppm relative to residual CHCl3 (77.16 ppm) or acetone-d5 (29.84 
ppm) and were obtained with 1H decoupling.  Chemical shift values were given in ppm downfield 
from the internal standard.  Infrared spectra were recorded with a JASCO A-100 FT-IR 
spectrophotometer.  High resolution mass spectra (HRMS) were measured with a JEOL 
JMS-700N.  Melting points were measured using open glass capillaries in a StuartTM melting point 
apparatus SMP3.   
 
Solvent and Reagents 
   Dehydrated THF, Pd(OAc)2, Pd(acac)2, PdCl2, Pd(dba)2, Xantphos, Cy-Xantphos, N-Xantphos, 
DPEphos, DPPF, rac-BINAP, DPPE, DPPP, PPh3, Xphos, Bathophenanthroline, Et3B (1.0 M in 
THF), Et2Zn (1.0 M in hexane), Et3Al (1.0 M in hexane), n-BuLi (1.6 M in hexane), 
diisopropylamine, 3-phenylpropionic acid, 3-(4-tolyl)propionic acid, 3-(4-methoxyphenyl)propionic 
acid, benzenebutanoic acid, 3-cyclohexylpropionic acid, aldehyde 2i, 2k, 2l, 2o and 
3-hydroxybenzaldehyde were purchased and used without further purification.  Aldehyde 2a-2e, 
2g-2h, 2j, 2m-2n, 2p-2s, acrolein, crotonaldehyde, and trans-cinnamaldehyde were purchased and 
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distilled prior to use by Kugelrohr apparatus.   Ph3B was prepared from BCl3 (1.0 M in heptane) 
and 3-equivalents of PhLi (1.6 M in butyl ether).  
 
Procedure for Preparing 3-Hydroxy-4-pentenoic Acids via Cross-Aldol Reaction:  
General Procedure A: A solution of lithium diisopropylamide (LDA) was prepared by the slow 
addition of n-BuLi (30 mL, 48 mmol, 1.6 M in hexane) to a solution of diisopropylamine (6.8 mL, 
48 mmol) in THF (30 mL) at -78 ℃ for 30 minutes.  Then, the corresponding carboxylic acid (20 
mmol dissolved in 30 mL of THF) was added dropwise at -78 ℃.  The reaction mixture was 
stirred for 30 minutes at room temperature and then the corresponding aldehyde (24 mmol) was 
added dropwise at -78 ℃.  The reaction mixture was stirred for 10 minutes at room temperature.  
After this time, it was quenched with a 2 M HCl and extracted 3 times with chloroform.  The 
combined organic phases were washed with brine, dried over MgSO4 and filtered.  The solvent 
was then removed under reduced pressure and it was purified by column chromatography 
(hexane/EtOAc = 4/1 to 1/1 v/v) to obtain the corresponding 3-hydroxy-4-pentenoic acid in good 
yield. 
 
General Procedure for the Pd-Catalyzed C−C Bond Formation Utilizing 
3-Hydroxy-4-pentenoic Acid 1a (Entry 3, Table 1): 
General Procedure B: An oven-dried reactor vessel containing Pd(OAc)2 (11.2 mg, 0.05 mmol), 
Xantphos (28.9 mg, 0.05mmol), and 2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.5 mg, 0.5 
mmol) were purged with nitrogen gas to remove oxygen.  Et3B (1.5 mmol, 1.0 M in THF) and 
benzaldehyde (2a, 155 µL, 1.5 mmol) were introduced into the reactor vessel with a syringe.  The 
mixture was stirred at 67 ℃ for 24 h.  After this time, it was quenched with a 2 M HCl and 
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extracted 3 times with Et2O.  The combined organic phases were washed with sat. NaHCO3 and 
brine, and then dried over MgSO4 and filtered.  Then, the solvent was then removed under reduced 
pressure, and the crude product was subjected to column chromatography over silica gel 
(hexane/EtOAc = 10/1 v/v) to give 3a (114.6 mg, 91% yield, Rf = 0.33; hexane/EtOAc = 4/1 v/v) as 
a mixture of stereoisomers (3E, 5E: 3Z, 5E = 10:1). White solid (m.p. 89.3-90.3 ℃).  
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Spectroscopic Data 
 
2-benzyl-3-hydroxypent-4-enoic acid (1a). Following the general procedure A using 
3-phenylpropionic acid (3.00 g, 20 mmol) and acrolein (1.6 mL, 24 mmol), afford 1a (3.78 g, 92% 
yield, Rf = 0.40; hexane/EtOAc = 1/1 v/v) as a mixture of diastereoisomers (1.4:1). White solid (m.p. 
77.7-78.5 ℃). 
 
1H NMR (500 MHz, Acetone-d6, major isomer) δ 7.27-7.15 (m, 5 H), 5.98 (ddd, J = 17.0, 10.5, 6.5 
Hz, 1 H), 5.32 (ddd, J = 17.0, 1.5, 1.5 Hz, 1 H), 5.17 (ddd, J = 10.5, 1.5, 1.5 Hz, 1 H), 4.30 (dddd, J 
= 6.5, 6.5, 1.5, 1.5 Hz, 1 H), 2.92-2.78 (m, 3 H) ppm. 
1H NMR (500 MHz, Acetone-d6, minor isomer) δ 7.27-7.14 (m, 5 H), 5.99 (ddd, J = 17.0, 10.5, 6.5 
Hz, 1 H), 5.31 (ddd, J = 17.0, 1.5, 1.5 Hz, 1 H), 5.14 (ddd, J = 10.5, 1.5, 1.5 Hz, 1 H), 4.33 (dddd, J 
= 6.5, 6.5, 1.5, 1.5 Hz, 1 H), 3.08-2.76 (m, 3 H) ppm. 
 
13C NMR (126 MHz, Acetone-d6, major isomer) δ 175.26, 140.51, 139.94, 129.63, 128.99, 126.85, 
116.25, 73.98, 54.53, 34.92 ppm.  
13C NMR (126 MHz, Acetone-d6, minor isomer) δ 174.88, 140.87, 139.87, 129.63, 128.96, 126.76, 
115.84, 73.86, 54.92, 34.65 ppm. 
 
IR (KBr, cm-1): 3265, 3067, 3055, 3028, 2953, 2939, 2677, 2646, 2320, 1705, 1456, 1393, 1265, 
1221, 1167, 1045, 1016, 961, 874, 826, 698, 648. 
 
High-resolution MS, (C12H14O3) calculated 206.0943, found 206.0943. 
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3-(4-tolyl)propionic acid (1.64 g, 10 mmol) and acrolein (1.0 mL, 15 mmol), afford 1b (1.98 g, 
90% yield, Rf = 0.33; hexane/EtOAc = 1/1 v/v) as a mixture of diastereoisomers (1.3:1). White solid 
(m.p. 94.9-95.6 ℃). 
 
1H NMR (500 MHz, Acetone-d6, major isomer) δ 7.11 (d, J = 8.0 Hz, 2 H), 7.05 (d, J = 8.0 Hz, 2 
H), 5.97 (ddd, J = 17.0, 10.5, 6.5 Hz, 1 H), 5.31 (ddd, J = 17.0, 1.5, 1.5 Hz, 1 H), 5.16 (ddd, J = 
10.5, 1.5, 1.5 Hz, 1 H), 4.28 (dddd, J = 6.5, 6.5, 1.5, 1.5 Hz, 1 H), 2.92-2.75 (m, 3 H), 2.25 (s, 3 H) 
ppm. 
1H NMR (500 MHz, Acetone-d6, minor isomer) δ 7.11 (d, J = 8.0 Hz, 2 H), 7.05 (d, J = 8.0 Hz, 2 
H), 5.98 (ddd, J = 17.0, 10.5, 6.5 Hz, 1 H), 5.31 (ddd, J = 17.0, 1.5, 1.5 Hz, 1 H), 5.13 (ddd, J = 
10.5, 1.5, 1.5 Hz, 1 H), 4.32 (dddd, J = 6.5, 6.5, 1.5, 1.5 Hz, 1 H), 3.03-2.74 (m, 3 H), 2.25 (s, 3 H) 
ppm. 
 
13C NMR (126 MHz, Acetone-d6, major isomer) δ 175.23, 140.12, 137.36, 136.14, 129.67, 129.58, 
116.21, 74.03, 54.62, 34.69, 20.99 ppm.  
13C NMR (126 MHz, Acetone-d6, minor isomer) δ 174.80, 139.95, 137.73, 136.03, 129.64, 129.58, 
115.84, 73.88, 54.98, 34.29, 20.99 ppm. 
 
IR (KBr, cm-1): 3252, 3047, 3022, 2997, 2953, 2939, 2878, 2652, 1908, 1707, 1516, 1447, 1396, 
1269, 1236, 1159, 1109, 1018, 949, 806, 694, 648. 
 
High-resolution MS, (C13H16O3) calculated 220.1099, found 220.1099. 
 
 
2-(4-methoxybenzyl)-3-hydroxypent-4-enoic acid (1c). Following the general procedure A using 
3-(4-methoxyphenyl)propionic acid (1.80 g, 10 mmol) and acrolein (1.0 mL, 15 mmol), afford 1c 
(1.96 g, 83% yield, Rf = 0.20; hexane/EtOAc = 1/1 v/v) as a mixture of diastereoisomers (1.8:1). 
White solid (m.p. 57.4-58.4 ℃). 
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5.87 (ddd, J = 17.0, 11.0, 6.0 Hz, 1 H), 5.30 (d, J = 17.0 Hz, 1 H), 5.21 (d, J = 11.0 Hz, 1 H), 4.20 
(dd, J = 6.0, 6.0 Hz, 1 H), 3.76 (s, 3 H), 2.98-2.73 (m, 3 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.09 (d, J = 8.5 Hz, 2 H), 6.80 (d, J = 8.5 Hz, 2 H), 
5.91 (ddd, J = 17.0, 10.5, 6.0 Hz, 1 H), 5.33 (d, J = 17.0 Hz, 1 H), 5.24 (d, J = 10.5 Hz, 1 H), 4.36 
(dd, J = 6.0, 6.0 Hz, 1 H), 3.76 (s, 3 H), 2.98-2.73 (m, 3 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 179.31, 158.38, 138.10, 130.05, 129.95, 117.08, 
114.08, 72.54, 55.30, 34.14, 32.30 ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 178.77, 158.26, 136.87, 130.86, 130.25, 117.60, 
114.04, 72.98, 53.10, 34.14, 31.68 ppm. 
 
IR (KBr, cm-1): 3395, 3082, 3013, 2953, 2935, 2835, 2365, 2341, 2247, 2058, 1713, 1612, 1582, 
1514, 1445, 1248, 1178, 1036, 910, 839, 756, 734. 
 
High-resolution MS, (C13H16O4) calculated 236.1049, found 236.1049. 
 
 
2-benzyl-3-hydroxy-5-phenylpent-4-enoic acid (1d). Following the general procedure A using 
3-phenylpropionic acid (2.25 g, 15 mmol) and trans-cinnamaldehyde (2.9 mL, 22.5 mmol), afford 
1d (3.26 g, 77% yield, Rf = 0.40; hexane/EtOAc = 1/1 v/v) as a mixture of diastereoisomers (2.0:1). 
White solid (m.p. 145.8-146.6 ℃). 
  
1H NMR (500 MHz, Acetone-d6, major isomer) δ 7.45 (d, J = 7.0 Hz, 2 H), 7.32 (t, J = 7.0 Hz, 2 
H), 7.26-7.22 (m, 5 H), 7.19-7.14 (m, 1 H), 6.70 (d, J = 15.5 Hz, 1 H), 6.41 (dd, J = 15.5, 6.5 Hz, 1 
H), 4.52-4.50 (m, 1 H), 3.03-2.91 (m, 3 H) ppm. 
1H NMR (500 MHz, Acetone-d6, minor isomer) δ 7.42 (d, J = 7.0 Hz, 2 H), 7.31 (t, J = 7.0 Hz, 2 
H), 7.26-7.21 (m, 5 H), 7.19-7.14 (m, 1 H), 6.68 (d, J = 15.5 Hz, 1 H), 6.42 (dd, J = 15.5, 6.5 Hz, 1 
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13C NMR (126 MHz, Acetone-d6, major isomer) δ 175.03, 140.60, 137.82, 131.99, 131.51, 129.74, 
129.38, 129.05, 128.37, 127.32, 126.91, 74.04, 54.98, 35.31 ppm.  
13C NMR (126 MHz, Acetone-d6, minor isomer) δ 174.61, 140.97, 137.86, 131.60, 131.36, 129.74, 
129.38, 129.05, 128.33, 127.28, 126.84, 73.82, 55.20, 34.88 ppm. 
 
IR (KBr, cm-1): 3240, 3086, 3061, 3028, 2953, 2934, 2881, 2652, 2359, 2340, 1707, 1495, 1456, 
1396, 1269, 1196, 993, 968, 824, 745, 692. 
 
High-resolution MS, (C18H18O3) calculated 282.1256, found 282.1256. 
 
 
2-benzyl-3-hydroxyhex-4-enoic acid (1e). Following the general procedure A using 
3-phenylpropionic acid (3.00 g, 20 mmol) and crotonaldehyde (2.0 mL, 24 mmol), afford 1e (1.75 g, 
40% yield, Rf = 0.33; hexane/EtOAc = 1/1 v/v) as a mixture of diastereoisomers (1.3:1). White solid 
(m.p. 138.1-139.0 ℃). 
  
1H NMR (500 MHz, Acetone-d6, major isomer) δ 10.59 (brs, 1 H), 7.24 (d, J = 7.0 Hz, 2 H), 7.22 
(d, J = 7.0 Hz, 2 H), 7.16 (t, J = 7.0 Hz, 1 H), 5.73 (dq, J = 15.5, 6.5 Hz, 1 H), 5.58 (dd, J = 15.5, 
7.5 Hz, 1 H), 4.23 (dd, J = 7.5, 7.5 Hz, 1 H), 4.10 (brs, 1 H), 2.89-2.73 (m, 3 H), 1.69 (d, J = 6.5 Hz, 
3 H) ppm. 
1H NMR (500 MHz, Acetone-d6, minor isomer) δ 10.59 (brs, 1 H), 7.26 (d, J = 7.0 Hz, 2 H), 7.22 
(d, J = 7.0 Hz, 2 H), 7.16 (t, J = 7.0 Hz, 1 H), 5.72 (dq, J = 15.5, 6.5 Hz, 1 H), 5.60 (dd, J = 15.5, 
7.5 Hz, 1 H), 4.23 (dd, J = 7.5, 7.5 Hz, 1 H), 4.10 (brs, 1 H), 3.07-2.73 (m, 3 H), 1.67 (d, J = 6.5 Hz, 
3 H) ppm. 
 
13C NMR (126 MHz, Acetone-d6, major isomer) δ 175.14, 140.73, 133.30, 129.71, 129.03, 128.18, 
126.87, 74.12, 54.95, 35.36, 17.84 ppm.  
13C NMR (126 MHz, Acetone-d6, minor isomer) δ 174.63, 141.10, 132.96, 129.71, 129.03, 127.68, 
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IR (KBr, cm-1): 3265, 3028, 2978, 2953, 2939, 2926, 2652, 2365, 1965, 1886, 1709, 1495, 1450, 
1433, 1393, 1269, 1204, 1042, 968, 880, 824, 746, 702, 654, 554. 
 
High-resolution MS, (C13H16O3) calculated 220.1099, found 220.1099. 
 
 
(1-Hydroxy-2-propen-1-yl)benzenebutanoic acid (1f). Following the general procedure A using 
benzenebutanoic acid (3.29 g, 20 mmol) and acrolein (1.6 mL, 24 mmol), afford 1f (4.26 g, 97% 
yield, Rf = 0.25; hexane/EtOAc = 1/1 v/v) as a mixture of diastereoisomers (1.4:1). Yellowish Oil. 
  
1H NMR (500 MHz, Acetone-d6, major isomer) δ 7.25 (d, J = 7.5 Hz, 2 H), 7.19 (d, J = 7.5 Hz, 2 
H), 7.15 (t, J = 7.5 Hz, 1 H), 5.87 (ddd, J = 17.0, 10.5, 6.5 Hz, 1 H), 5.27 (dd, J = 17.0, 1.5 Hz, 1 H), 
5.12 (dd, J = 10.5, 1.5 Hz, 1 H), 4.32 (dd, J = 6.5, 6.5 Hz, 1 H), 2.78-2.54 (m, 3 H), 2.05-1.81 (m, 2 
H) ppm. 
1H NMR (500 MHz, Acetone-d6, minor isomer) δ 7.26 (d, J = 7.5 Hz, 2 H), 7.20 (d, J = 7.5 Hz, 2 
H), 7.15 (t, J = 7.5 Hz, 1 H), 5.93 (ddd, J = 17.0, 10.5, 6.5 Hz, 1 H), 5.28 (dd, J = 17.0, 1.5 Hz, 1 H), 




13C NMR (126 MHz, Acetone-d6, major isomer) δ 176.14, 142.48, 139.82, 129.03, 129.00, 126.53, 
116.32, 74.33, 51.98, 34.11, 31.09 ppm.  
13C NMR (126 MHz, Acetone-d6, minor isomer) δ 175.73, 142.66, 139.84, 129.03, 128.99, 126.48, 
115.65, 73.79, 51.88, 34.26, 30.45 ppm. 
 
IR (neat, cm-1): 3354, 3086, 3067, 3022, 2989, 2953, 2939, 2862, 2646, 2359, 2332, 1707, 1603, 
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High-resolution MS, (C13H16O3) calculated 220.1099, found 220.1099. 
 
 
2-cyclohexyl-3-hydroxyhex-4-enoic acid (1g). Following the general procedure A using 
cyclohexanepropionic acid (2.4 mL, 15 mmol) and acrolein (1.5 mL, 22.5 mmol), afford 1g (3.00 g, 
92% yield, Rf = 0.40; hexane/EtOAc = 1/1 v/v) as a mixture of diastereoisomers (1.4:1). White solid 
(m.p. 51.2-52.0 ℃). 
  
1H NMR (500 MHz, CDCl3, major isomer) δ 6.64 (brs, 1 H), 5.85 (ddd, J = 17.0, 10.5, 6.5 Hz, 1 H), 
5.31 (d, J = 17.0 Hz, 1 H), 5.22 (d, J = 10.5 Hz, 1 H), 4.19 (dd, J = 6.5, 6.5 Hz, 1 H), 2.64-2.60 (m, 
1 H), 1.84-0.79 (m, 13 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 6.64 (brs, 1 H), 5.88 (ddd, J = 17.0, 10.5, 6.5 Hz, 1 
H), 5.32 (d, J = 17.0 Hz, 1 H), 5.22 (d, J = 10.5 Hz, 1 H), 4.37 (dd, J = 6.5, 6.5 Hz, 1 H), 2.72-2.68 
(m, 1 H), 1.84-0.79 (m, 13 H) ppm. 
 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 180.43, 138.28, 117.29, 74.29, 48.79, 36.73, 35.54, 
33.90, 32.64, 26.56, 26.26, 26.16 ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 180.06, 137.15, 117.07, 73.61, 48.21, 35.68, 34.40, 
33.93, 32.64, 26.59, 26.31, 26.20 ppm. 
 
IR (KBr, cm-1): 3207, 2926, 2853, 2671, 2365, 2332, 1705, 1450, 1288, 1252, 1196, 1123, 1045, 
1020, 926, 820, 696. 
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(3E, 5E)-1,6-diphenylhexa-3,5-dien-1-ol (3a, major isomer) and (3Z, 
5E)-1,6-diphenylhexa-3,5-dien-1-ol (3a, minor isomer). Following the general procedure B using 
2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.5 mg, 0.5 mmol) and benzaldehyde (2a, 155 µL, 1.5 
mmol), afford 3a (114.6 mg, 91% yield, Rf = 0.33; hexane/EtOAc = 4/1 v/v) as a mixture of 
stereoisomers (3E, 5E: 3Z, 5E = 10:1). White solid (m.p. 89.3-90.3 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.40-7.35 (m, 6 H), 7.32-7.28 (m, 3 H), 7.21 (tt, J = 
7.5, 1.5 Hz, 1 H), 6.75 (dd, J = 15.5, 10.5 Hz, 1 H), 6.48 (d, J = 15.5 Hz, 1 H), 6.32 (dd, J = 15.5, 
10.5 Hz, 1 H), 5.79 (dt, J = 15.5, 7.0 Hz, 1 H), 4.77 (t, J = 7.0 Hz, 1 H), 2.65-2.56 (m, 2 H), 2.03 
(brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.40-7.28 (m, 9 H), 7.22-7.19 (m, 1 H), 7.05 (dd, J = 
15.5, 10.5 Hz, 1 H), 6.55 (d, J = 15.5 Hz, 1 H), 6.35-6.30 (m, 1 H), 5.54 (dt, J = 10.5, 7.5 Hz, 1 H), 
4.79 (t, J = 7.5 Hz, 1 H), 2.85-2.77 (m, 1 H), 2.74-2.68 (m, 1 H), 2.03 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 143.98, 137.44, 134.11, 131.54, 130.34, 128.86, 
128.71, 128.59, 127.74, 127.52, 126.39, 125.93, 73.86, 43.01 ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 133.51, 131.89, 130.12, 129.03, 128.36, 127.82, 
127.56, 126.58, 125.97, 124.03, 74.04, 37.98 ppm. 
 
IR (KBr, cm-1): 3416, 3061, 3026, 2930, 2880, 1952, 1682, 1603, 1495, 1454, 1337, 1213, 989, 752, 
700. 
 
High-resolution MS, (C18H18O) calculated 250.1358, found 250.1356. 
 
 
(3E, 5E)-6-(4-methylphenyl)-1-phenylhexa-3,5-dien-1-ol (3b, major isomer) and (3Z, 
5E)-6-(4-methylphenyl)-1-phenylhexa-3,5-dien-1-ol (3b, minor isomer). Following the general 
3a OH
3b OHMe
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procedure B using 2-(4-methylbenzyl)-3-hydroxypent-4-enoic acid (1b, dr = 1.3:1, 110.3 mg, 0.5 
mmol) and benzaldehyde (2a, 155 µL, 1.5 mmol), afford 3b (110.8 mg, 84% yield, Rf = 0.33; 
hexane/EtOAc = 4/1 v/v m.p.) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 10:1). White solid 
(76.4-77.0 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.35-7.32 (m, 4 H), 7.28-7.24 (m, 3 H), 7.09 (d, J = 
8.0 Hz, 2 H), 6.68 (dd, J = 15.5, 10.5 Hz, 1 H), 6.43 (d, J = 15.5 Hz, 1 H), 6.27 (dd, J = 15.5, 10.5 
Hz, 1 H), 5.72 (dt, J = 15.5, 7.5 Hz, 1 H), 4.72-4.69 (m, 1 H), 2.60-2.51 (m, 2 H), 2.31 (s, 3 H), 2.23 
(brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.38-7.31 (m, 4 H), 7.29-7.24 (m, 3 H), 7.13 (d, J = 
8.0 Hz, 2 H), 6.94 (dd, J = 15.5, 10.5 Hz, 1 H), 6.50 (d, J = 15.5 Hz, 1 H), 6.29-6.24 (m, 1 H), 5.47 
(dt, J = 10.5, 7.5 Hz, 1 H), 4.74-4.72 (m, 1 H), 2.81-2.74 (m, 1 H), 2.70-2.64 (s, 1 H), 2.32 (s, 3 H), 
2.23 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 144.00, 137.32, 134.63, 134.16, 131.45, 129.70, 
129.40, 128.52, 127.90, 127.64, 126.27, 125.91, 73.81, 42.96, 21.31 ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 137.57, 133.42, 131.93, 129.03, 128.97, 128.93, 
127.71, 126.95, 126.48, 125.96, 123.09, 73.98, 37.90, 21.31 ppm. 
 
IR (KBr, cm-1): 3406, 3082, 3017, 2924, 2405, 2365, 1965, 1944, 1607, 1510, 1456, 1217, 1042, 
1028, 989, 812, 700, 667. 
 
High-resolution MS, (C19H20O) calculated 264.1514, found 264.1514. 
 
 
(3E, 5E)-6-(4-methoxyphenyl)-1-phenylhexa-3,5-dien-1-ol (3c, major isomer) and (3Z, 
5E)-6-(4-methoxyphenyl)-1-phenylhexa-3,5-dien-1-ol (3c, minor isomer). Following the general 
procedure B using 2-(4-methoxybenzyl)-3-hydroxypent-4-enoic acid (1c, dr = 1.8:1, 117.7 mg, 0.5 
mmol) and benzaldehyde (2a, 155 µL, 1.5 mmol), afford 3c (83.7 mg, 60% yield, Rf = 0.40; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 8:1). White solid (m.p. 
97.6-98.0 ℃). 
3c OHMeO
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1H NMR (500 MHz, CDCl3, major isomer) δ 7.39-7.25 (m, 7 H), 6.85-6.81 (m, 2 H), 6.60 (dd, J = 
15.5, 10.5 Hz, 1 H), 6.41 (d, J = 15.5 Hz, 1 H), 6.27 (dd, J = 15.5, 10.5 Hz, 1 H), 5.70 (dt, J = 15.5, 
7.5 Hz, 1 H), 4.73-4.71 (m, 1 H), 3.77 (s, 3 H), 2.61-2.52 (m, 2 H), 2.23 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.39-7.25 (m, 7 H), 6.87 (dd, J = 15.5, 10.5 Hz, 1 H), 
6.86-6.81 (m, 2 H), 6.48 (d, J = 15.5 Hz, 1 H), 6.29-6.24 (m, 1 H), 5.45 (dt, J = 10.5, 7.5 Hz, 1 H), 
4.76-4.73 (m, 1 H), 3.78 (s, 3 H), 2.81-2.75 (m, 1 H), 2.70-2.66 (s, 1 H), 2.23 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 159.18, 144.02, 134.25, 131.05, 130.24, 129.08, 
128.52, 127.63, 127.55, 126.87, 125.92, 114.15, 73.83, 55.36, 42.98 ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 159.35, 133.02, 132.03, 128.62, 127.78, 127.71, 
127.05, 126.35, 125.96, 122.08, 113.78, 74.00, 55.36, 37.93 ppm. 
 
IR (KBr, cm-1): 3404, 3017, 2959, 2930, 2895, 2835, 2399, 2359, 4950, 1879, 1605, 1574, 1510, 
1454, 1300, 1254, 1215, 1175, 1045, 1028, 984, 827, 700, 667. 
 
High-resolution MS, (C19H20O2) calculated 280.1463, found 280.1465. 
 
 
(3E, 5E)-1,2,6-triphenylhexa-3,5-dien-1-ol (3d, major isomer). Following the general procedure 
B using 2-benzyl-3-hydroxy-5-phenyl-4-pentenoic acid (1d, dr = 2.0:1, 141.2 mg, 0.5 mmol) and 
benzaldehyde (2a, 155 µL, 1.5 mmol), afford 3d (128.9 mg, 79% yield, Rf = 0.40; hexane/EtOAc = 
4/1 v/v) as a mixture of diastereoisomers (2.3:1). Colorless oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.36-7.23 (m, 14 H), 7.15 (t, J = 7.5 Hz, 1 H), 6.62 
(dd, J = 15.5, 10.5 Hz, 1 H), 6.31 (d, J = 15.5 Hz, 1 H), 5.97 (dd, J = 15.5, 10.5 Hz, 1 H), 5.85 (dd, 
J = 15.5, 8.0 Hz, 1 H), 4.91 (d, J = 8.0 Hz, 1 H), 3.71 (dd, J = 8.0, 8.0 Hz 1 H), 2.01 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.37-7.07 (m, 15 H), 6.80 (dd, J = 15.5, 10.5 Hz, 1 H), 
6.47 (d, J = 15.5 Hz, 1 H), 6.33 (dd, J = 15.5, 10.5 Hz, 1 H), 6.21 (dd, J = 15.5, 8.0 Hz, 1 H), 4.88 
(d, J = 8.0 Hz, 1 H), 3.64 (dd, J = 8.0, 8.0 Hz 1 H), 2.30 (brs, 1 H) ppm. 
3d OH
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13C NMR (126 MHz, CDCl3, major isomer) δ 141.95, 140.46, 137.34, 133.77, 132.89, 131.77, 
128.96, 128.87, 128.83, 128.63, 128.30, 127.93, 127.46, 127.22, 127.12, 126.30, 77.80, 57.62 ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 142.05, 140.96, 137.34, 134.01, 133.45, 132.25, 
128.71, 128.68, 128.53, 128.50, 128.09, 127.60, 126.76, 126.43, 77.81, 58.29 ppm. 
 
IR (neat, cm-1): 3445, 3086, 3061, 3026, 2964, 2905, 2403, 2313, 1946, 1869, 1595, 1495, 1454, 
1387, 1339, 1313, 1217, 1186, 1026, 989, 914, 756, 700, 584. 
 
High-resolution MS, (C24H22O) calculated 326.1671, found 326.1671. 
 
 
(3E, 5E)-2-methyl-1,6-diphenylhexa-3,5-dien-1-ol (3e). Following the general procedure B using 
2-benzyl-3-hydroxy-5-methyl-4-pentenoic acid (1e, dr = 1.3:1, 110.3 mg, 0.5 mmol) and 
benzaldehyde (2a, 155 µL, 1.5 mmol), afford 3e (108.3 mg, 82% yield, Rf = 0.40; hexane/EtOAc = 
4/1 v/v) as a mixture of diastereoisomers (1.5:1). Colorless oil. 
 
1H NMR (400 MHz, CDCl3, major isomer) δ 7.37-7.15 (m, 10 H), 6.76 (dd, J = 15.6, 10.4 Hz, 1 H), 
6.48 (d, J = 15.6 Hz, 1 H), 6.31 (dd, J = 15.6, 10.4 Hz, 1 H), 5.76 (dd, J = 15.6, 7.2 Hz, 1 H), 4.36 
(d, J = 7.6 Hz, 1 H), 2.55 (ddt, J = 7.6, 7.2, 6.8 Hz 1 H), 2.25 (brs, 1 H), 0.89 (d, J = 6.8 Hz, 3 H) 
ppm. 
1H NMR (400 MHz, CDCl3, minor isomer) δ 7.37-7.15 (m, 10 H), 6.69 (dd, J = 15.6, 10.4 Hz, 1 H), 
6.42 (d, J = 15.6 Hz, 1 H), 6.18 (dd, J = 15.6, 10.4 Hz, 1 H), 5.69 (dd, J = 15.6, 7.2 Hz, 1 H), 4.58 
(d, J = 5.6 Hz, 1 H), 2.64 (dtd, J = 7.2, 6.8, 5.6 Hz 1 H), 2.17 (brs, 1 H), 1.03 (d, J = 6.8 Hz, 3 H) 
ppm. 
 
13C NMR (101 MHz, CDCl3, mixture of diastereoisomers) δ 142.60, 137.48, 137.43, 136.63, 
136.57, 132.40, 131.59, 131.28, 131.19, 129.17, 128.90, 128.68, 128.63, 128.33, 128.16, 127.74, 
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IR (neat, cm-1): 3481, 3061, 3024, 2966, 2930, 2874, 2359, 2336, 1948, 1873, 1805, 1747, 1637, 
1595, 1495, 1454, 1373, 1304, 1217, 1192, 1070, 991, 941, 700, 667. 
 
High-resolution MS, (C19H20O) calculated 264.1514, found 264.1513. 
 
 
(3E, 5E)-1,7-diphenylhepta-3,5-dien-1-ol (3f, major isomer) and (3Z, 
5E)-1,7-diphenylhepta-3,5-dien-1-ol (3f, minor isomer). Following the general procedure B using 
(1-Hydroxy-2-propen-1-yl)benzenebutanoic acid (1f, dr = 1.4:1, 110.3 mg, 0.5 mmol) and 
benzaldehyde (2a, 155 µL, 1.5 mmol), afford 3f (68.8 mg, 52% yield, Rf = 0.33; hexane/EtOAc = 
4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 8:1). Yellow oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.37-7.17 (m, 10 H), 6.16 (dd, J = 15.0, 10.5 Hz, 1 H), 
6.07 (dd, J = 15.0, 10.5 Hz, 1 H), 5.78 (dt, J = 15.0, 7.0 Hz, 1 H), 5.58 (dt, J = 15.0, 7.0 Hz, 1 H), 
4.71 (ddd, J = 7.0, 5.0, 2.5 Hz, 1 H), 3.40 (d, J = 7.0 Hz 2 H), 2.60-2.38 (m, 2 H), 2.00 (d, J = 2.5 
Hz, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 144.05, 140.31, 133.82, 132.19, 131.18, 128.71, 
128.55, 128.09, 127.65, 126.22, 125.90, 73.76, 42.87, 39.06 ppm. 
 
IR (neat, cm-1): 3383, 3082, 3061, 3026, 2924, 2897, 2365, 2336, 2247, 1950, 1879, 1657, 1603, 
1495, 1454, 1429, 1290, 1200, 1047, 1028, 989, 910, 735, 698. 
 
High-resolution MS, (C19H20O) calculated 264.1514, found 264.1513. 
 
 
(3E, 5E)-6-cyclohexyl-1-phenylhexa-3,5-dien-1-ol (3g, major isomer) and (3Z, 
5E)-6-cyclohexyl-1-phenylhexa-3,5-dien-1-ol (3g, minor isomer). Following the general 
procedure B using 2-cyclohexyl-3-hydroxy-4-pentenoic acid (1g, dr = 1.4:1, 107.6 mg, 0.5 mmol) 
3f OH
3g OH
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and benzaldehyde (2a, 155 µL, 1.5 mmol), afford 3g (61.8 mg, 48% yield, Rf = 0.50; hexane/EtOAc 
= 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 7:1). Yellow oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.36-7.26 (m, 5 H), 6.13 (dd, J = 15.5, 10.5 Hz, 1 H), 
5.98 (dd, J = 15.5, 10.5 Hz, 1 H), 5.59 (dd, J = 15.5, 7.0 Hz, 1 H), 5.54 (dt, J = 15.5, 7.5 Hz, 1 H), 
4.71 (ddd, J = 7.5, 5.0, 3.0 Hz, 1 H), 2.56-2.44 (m, 2 H), 2.05-1.95 (m, 2 H), 1.74-1.62 (m, 5 H), 
1.31-1.03 (m, 5 H), ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 144.11, 140.08, 134.58, 128.50, 127.59, 127.36, 
126.99, 125.89, 73.74, 42.95, 40.77, 32.93, 26.26, 26.11 ppm. 
 
IR (neat, cm-1): 3360, 3088, 3065, 3024, 2924, 2851, 2665, 2359, 1948, 1877, 1805, 1657, 1603, 
1493, 1448, 1200, 1049, 1030, 988, 949, 758, 700. 
 
High-resolution MS, (C18H24O) calculated 256.1827, found 256.1827. 
 
 
(3E, 5E)-1-(2-methylphenyl)-6-phenylhexa-3,5-dien-1-ol (3h, major isomer) and (3Z, 
5E)-1-(2-methylphenyl)-6-phenylhexa-3,5-dien-1-ol (3h, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.2 mg, 0.5 mmol) and 
o-tolualdehyde (2b, 175 µL, 1.5 mmol), afford 3h (121.5 mg, 92% yield, Rf = 0.40; hexane/EtOAc 
= 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 11:1). Colorless oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.53 (d, J = 7.5 Hz, 1 H), 7.38 (d, J = 7.5 Hz, 2 H), 
7.30 (t, J = 7.5 Hz, 2 H), 7.26-7.14 (m, 4 H), 6.76 (dd, J = 15.5, 10.5 Hz, 1 H), 6.49 (d, J = 15.5 Hz, 
1 H), 6.34 (dd, J = 15.5, 10.5 Hz, 1 H), 5.84 (dt, J = 15.5, 7.5 Hz, 1 H), 5.01 (dd, J = 7.5, 5.0 Hz, 1 
H), 2.62-2.50 (m, 2 H), 2.35 (s, 3 H), 1.94 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.55 (d, J = 7.5 Hz, 1 H), 7.40-7.38 (m, 2 H), 7.31 (t, 
J = 7.5 Hz, 2 H), 7.26-7.14 (m, 4 H), 7.03 (dd, J = 15.5, 10.5 Hz, 1 H), 6.56 (d, J = 15.5 Hz, 1 H), 
6.35-6.30 (m, 1 H), 5.59 (dt, J = 10.5, 7.5 Hz, 1 H), 5.07-5.02 (m, 1 H), 2.81-2.66 (m, 2 H), 2.37 (s, 
3 H), 1.88 (brs, 1 H) ppm. 
OH Me3h
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13C NMR (126 MHz, CDCl3, major isomer) δ 142.07, 137.45, 134.46, 133.91, 131.50, 130.67, 
130.49, 128.86, 128.69, 127.49, 127.40, 126.41, 126.37, 125.27, 70.23, 41.78, 19.20 ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 134.52, 133.45, 131.78, 130.29, 129.02, 128.58, 
127.87, 127.71, 127.63, 126.55, 125.33, 124.01, 70.35, 36.82, 19.26 ppm. 
 
IR (neat, cm-1): 3341, 3076, 3059, 3022, 2930, 2365, 2336, 1668, 1595, 1489, 1462, 1447, 1217, 
1042, 988, 754, 691, 667. 
 
High-resolution MS, (C19H20O) calculated 264.1514, found 264.1512. 
 
 
(3E, 5E)-1-(2-chlorophenyl)-6-phenylhexa-3,5-dien-1-ol (3i, major isomer) and (3Z, 
5E)-1-(2-chlorophenyl)-6-phenylhexa-3,5-dien-1-ol (3i, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.1 mg, 0.5 mmol) and 
2-chlorobenzaldehyde (2c, 170 µL, 1.5 mmol), afford 3i (104.3 mg, 73% yield, Rf = 0.50; 
hexane/EtOAc = 4/1 v/v m.p.) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 12:1). White solid 
(87.1-87.7 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.58 (dd, J = 8.0, 1.5 Hz, 1 H), 7.38 (dd, J = 8.0, 1.5 
Hz, 2 H), 7.34-7.29 (m, 4 H), 7.21 (td, J = 8.0, 1.5 Hz, 2 H), 6.77 (dd, J = 15.5, 10.5 Hz, 1 H), 6.49 
(d, J = 15.5 Hz, 1 H), 6.33 (dd, J = 15.5, 10.5 Hz, 1 H), 5.85 (dt, J = 15.5, 7.5 Hz, 1 H), 5.20-5.18 
(m, 1 H), 2.73-2.68 (m, 1 H), 2.51-2.45 (m, 1 H), 2.16 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.62 (dd, J = 8.0, 1.5 Hz, 1 H), 7.39 (dd, J = 8.0, 1.5 
Hz, 2 H), 7.34-7.29 (m, 4 H), 7.21 (td, J = 8.0, 1.5 Hz, 2 H), 6.55 (d, J = 15.5 Hz, 1 H), 6.38-6.31 
(m, 1 H), 5.62 (dt, J = 10.5, 7.5 Hz, 1 H), 5.23-5.20 (m, 1 H), 2.85-2.80 (m, 1 H), 2.70-2.64 (m, 1 
H), 2.16 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 141.31, 137.45, 134.37, 131.82, 131.71, 130.09, 
129.55, 128.81, 128.74, 128.64, 127.56, 127.21, 127.18, 126.43, 70.23, 41.22ppm.  
13C NMR (126 MHz, CDCl3, minor isomer) δ 133.59, 132.31, 132.22, 130.37, 129.94, 129.21, 
OH Cl3i
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129.06, 128.38, 127.75, 127.29, 127.03, 126.61, 124.02, 70.64, 36.20 ppm. 
 
IR (KBr, cm-1): 3242, 3082, 3018, 2935, 2918, 2359, 2336, 1961, 1938, 1892, 1595, 1574, 1495, 
1472, 1447, 1410, 1348, 1123, 1032, 984, 885, 750.3, 691. 
 
High-resolution MS, (C18H17ClO) calculated 284.0968, found 284.0969. 
 
 
(3E, 5E)-1-(3-methoxyphenyl)-6-phenylhexa-3,5-dien-1-ol (3j, major isomer) and (3Z, 
5E)-1-(3-methoxyphenyl)-6-phenylhexa-3,5-dien-1-ol (3j, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 109.4 mg, 0.5 mmol) and 
3-anisaldehyde (2d, 185 µL, 1.5 mmol), afford 3j (76.0 mg, 51% yield, Rf = 0.23; hexane/EtOAc = 
4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 9:1). Yellowish oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.37-7.35 (m, 2 H), 7.30-7.24 (m, 3 H), 7.22-7.17 (m, 
1 H), 6.93-6.92 (m, 2 H), 6.81 (ddd, J = 7.5, 2.0, 0.5 Hz, 1 H), 6.73 (dd, J = 15.5, 10.5 Hz, 1 H), 
6.46 (d, J = 15.5 Hz, 1 H), 6.29 (dd, J = 15.5, 10.5 Hz, 1 H), 5.76 (dt, J = 15.5, 7.5 Hz, 1 H), 4.71 (t, 
J = 7.5 Hz, 1 H), 3.79 (s, 3 H), 2.60-2.53 (m, 2 H), 2.20 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.38-7.36 (m, 2 H), 7.31-7.24 (m, 3 H), 7.22-7.17 (m, 
1 H), 6.98 (dd, J = 15.5, 10.5 Hz, 1 H), 6.96-6.94 (m, 2 H), 6.83-6.79 (m, 1 H), 6.53 (d, J = 15.5 Hz, 
1 H), 6.36-6.30 (m, 1 H), 5.52 (dt, J = 10.5, 7.5 Hz, 1 H), 4.75-4.72 (m, 1 H), 3.79 (s, 3 H), 
2.80-2.75 (m, 1 H), 2.71-2.66 (m, 1 H), 2.20 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 159.83, 145.74, 137.43, 134.01, 131.48, 130.34, 
129.57, 128.85, 128.68, 127.47, 126.36, 118.23, 113.14, 111.41, 73.73, 55.32, 42.91 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 133.43, 131.79, 130.02, 129.00, 128.32, 127.69, 
127.55, 126.55, 124.04, 118.23, 113.14, 111.41, 73.90, 55.32, 37.87 ppm. 
 
IR (neat, cm-1): 3423, 3018, 2947, 2839, 2359, 2336, 1940, 1730, 1672, 1599, 1485, 1456, 1258, 
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High-resolution MS, (C19H20O2) calculated 280.1463, found 280.1463. 
 
 
(3E, 5E)-1-(3-chlorophenyl)-6-phenylhexa-3,5-dien-1-ol (3k, major isomer) and (3Z, 
5E)-1-(3-chlorophenyl)-6-phenylhexa-3,5-dien-1-ol (3k, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 108.2 mg, 0.5 mmol) and 
3-chlorobenzaldehyde (2e, 170 µL, 1.5 mmol), afford 3k (99.3 mg, 66% yield, Rf = 0.40; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 13:1). Yellowish oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.37-7.35 (m, 3 H), 7.29 (t, J = 7.5 Hz, 2 H), 
7.25-7.19 (m, 4 H), 6.73 (dd, J = 15.5, 10.5 Hz, 1 H), 6.47 (d, J = 15.5 Hz, 1 H), 6.29 (dd, J = 15.5, 
10.5 Hz, 1 H), 5.73 (dt, J = 15.5, 7.5 Hz, 1 H), 4.70 (dd, J = 7.5, 5.5 Hz, 1 H), 2.60-2.49 (m, 2 H), 
2.22 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.40-7.39 (m, 3 H), 7.30 (t, J = 7.5 Hz, 2 H), 
7.25-7.19 (m, 4 H), 6.95 (dd, J = 15.5, 10.5 Hz, 1 H), 6.54 (d, J = 15.5 Hz, 1 H), 6.32-6.26 (m, 1 H), 
5.48 (dt, J = 10.5, 7.5 Hz, 1 H), 4.73 (dd, J = 7.5, 5.5 Hz, 1 H), 2.78-2.72 (m, 1 H), 2.69-2.63 (m, 1 
H), 2.22 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 146.04, 137.32, 134.50, 134.47, 131.84, 129.83, 
129.58, 128.71, 128.64, 127.77, 127.59, 126.41, 126.10, 124.08, 73.11, 42.96 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 133.82, 132.32, 131.72, 129.38, 129.01, 128.37, 
127.84, 126.77, 126.61, 126.15, 124.13, 123.77, 73.30, 37.93 ppm. 
 
IR (neat, cm-1): 3366, 3065, 3022, 2924, 2901, 2853, 2365, 2336, 1944, 1873, 1798, 1641, 1597, 
1574, 1476, 1433, 1300, 1198, 1076, 1047, 989, 887, 785, 692. 
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(3E, 5E)-1-(3-pivaloyloxyphenyl)-6-phenylhexa-3,5-dien-1-ol (3l, major isomer) and (3Z, 
5E)-1-(3-pivaloyloxyphenyl)-6-phenylhexa-3,5-dien-1-ol (3l, minor isomer). Following the 
general procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.6 mg, 0.5 mmol) and 
3-(pivaloyloxy)aldehyde (2f, 309.4 mg, 1.5 mmol), afford 3l (121.5 mg, 69% yield, Rf = 0.30; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 16:1). Yellowish oil. 
 
1H NMR (400 MHz, CDCl3, major isomer) δ 7.36-7.26 (m, 5 H), 7.20-7.15 (m, 2 H), 7.07 (s, 1 H), 
6.96-6.94 (m, 1 H), 6.72 (dd, J = 15.6, 10.0 Hz, 1 H), 6.45 (d, J = 15.6 Hz, 1 H), 6.27 (dd, J = 15.6, 
10.0 Hz, 1 H), 5.74 (dt, J = 15.6, 7.2 Hz, 1 H), 4.70 (t, J = 7.2 Hz, 1 H), 2.60-2.30 (m, 3 H), 1.34 (s, 
9 H) ppm. 
1H NMR (400 MHz, CDCl3, minor isomer) δ 7.40-7.26 (m, 5 H), 7.20-7.15 (m, 2 H), 7.07 (s, 1 H), 
6.99-6.94 (m, 2 H), 6.52 (d, J = 15.6 Hz, 1 H), 6.30-6.24 (m, 1 H), 5.49 (dt, J = 10.8, 7.6 Hz, 1 H), 
4.72 (t, J = 7.6 Hz, 1 H), 2.80-2.63 (m, 2 H), 2.53 (brs, 1 H), 1.34 (s, 9 H) ppm. 
 
13C NMR (101 MHz, CDCl3, major isomer) δ 177.24, 151.28, 145.88, 137.42, 134.05, 131.48, 
130.16, 129.37, 128.84, 128.64, 127.43, 126.35, 123.15, 120.59, 119.01, 73.27, 42.81, 39.13, 27.20 
ppm. 
13C NMR (101 MHz, CDCl3, minor isomer) δ 177.24, 137.40, 133.47, 131.80, 128.99, 128.68, 
128.55, 128.31, 127.66, 127.38, 126.56, 124.00, 123.22, 120.66, 73.41, 42.81, 37.77, 27.20 ppm. 
 
IR (neat, cm-1): 3470, 3059, 3024, 2976, 2935, 2907, 2874, 2359, 2341, 1749, 1589, 1479, 1447, 
1396, 1366, 1279, 1234, 1148, 1115, 989, 746, 692. 
 
High-resolution MS, (C23H26O3) calculated 350.1882, found 350.1882. 
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5E)-1-(4-methoxyphenyl)-6-phenylhexa-3,5-dien-1-ol (3m, minor isomer). Following the 
general procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 102.3 mg, 0.5 mmol) and 
4-anisaldehyde (2g, 185 µL, 1.5 mmol), afford 3m (116.4 mg, 84% yield, Rf = 0.23; hexane/EtOAc 
= 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 11:1). White solid (m.p. 112.2-112.6 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.36 (d, J = 7.5 Hz, 2 H), 7.32-7.28 (m, 4 H), 7.20 (t, 
J = 7.5 Hz, 1 H), 6.90-6.87 (m, 2 H), 6.74 (dd, J = 15.5, 10.5 Hz, 1 H), 6.47 (d, J = 15.5 Hz, 1 H), 
6.30 (dd, J = 15.5, 10.5 Hz, 1 H), 5.76 (dt, J = 15.5, 7.5 Hz, 1 H), 4.70 (t, J = 7.5 Hz, 1 H), 3.80 (s, 
3 H), 2.62-2.54 (m, 2 H), 2.03 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.38 (d, J = 7.5 Hz, 2 H), 7.32-7.28 (m, 4 H), 7.20 (t, 
J = 7.5 Hz, 1 H), 7.00 (dd, J = 15.5, 10.5 Hz, 1 H), 6.90-6.87 (m, 2 H), 6.54 (d, J = 15.5 Hz, 1 H), 
6.30-6.26 (m, 1 H), 5.51 (dt, J = 10.5, 7.5 Hz, 1 H), 4.73 (t, J = 7.5 Hz, 1 H), 3.78 (s, 3 H), 
2.84-2.77 (m, 1 H), 2.70-2.64 (m, 1 H), 2.03 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 159.14, 137.44, 136.16, 133.86, 131.37, 130.59, 
128.92, 128.68, 127.46, 127.18, 126.35, 113.92, 73.49, 55.37, 42.88 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 159.20, 133.34, 131.62, 127.77, 127.68, 127.22, 
126.55, 124.08, 113.92, 73.64, 55.37, 37.86 ppm. 
 
IR (KBr, cm-1): 3389, 3024, 2924, 2991, 2835, 2359, 2330, 1888, 1612, 1510, 1447, 1246, 1177, 
1034, 984, 829, 741, 691. 
 
High-resolution MS, (C19H20O2) calculated 280.1463, found 280.1462. 
 
 
(3E, 5E)-1-(4-methylthiophenyl)-6-phenylhexa-3,5-dien-1-ol (3n, major isomer) and (3Z, 
5E)-1-(4-methylthiophenyl)-6-phenylhexa-3,5-dien-1-ol (3n, minor isomer). Following the 
general procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 107.3 mg, 0.5 mmol) and 
4-(methylthio)benzaldehyde (2h, 195 µL, 1.5 mmol), afford 3n (133.1 mg, 86% yield, Rf = 0.30; 
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1H NMR (500 MHz, CDCl3, major isomer) δ 7.37 (d, J = 7.5 Hz, 2 H), 7.33-7.19 (m, 7 H), 6.74 (dd, 
J = 15.5, 10.5 Hz, 1 H), 6.48 (d, J = 15.5 Hz, 1 H), 6.31 (dd, J = 15.5, 10.5 Hz, 1 H), 5.76 (dt, J = 
15.5, 7.5 Hz, 1 H), 4.73 (t, J = 7.5 Hz, 1 H), 2.61-2.53 (m, 2 H), 2.48 (s, 3 H), 2.04 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.39 (d, J = 7.5 Hz, 2 H), 7.33-7.19 (m, 7 H), 6.99 (dd, 
J = 15.5, 11.0 Hz, 1 H), 6.55 (d, J = 15.5 Hz, 1 H), 6.33-6.28 (m, 1 H), 5.51 (dt, J = 11.0, 7.5 Hz, 1 
H), 4.75 (t, J = 7.5 Hz, 1 H), 2.82-2.77 (m, 1 H), 2.71-2.65 (m, 1 H), 2.46 (s, 3 H), 2.04 (brs, 1 H) 
ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 140.92, 137.77, 137.42, 134.21, 131.63, 130.15, 
128.81, 128.72, 127.55, 126.84, 126.52, 126.40, 73.47, 42.93, 16.07 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 140.92, 133.60, 132.00, 128.65, 127.77, 127.35, 
126.90, 126.59, 126.55, 123.98, 73.64, 37.90, 16.07 ppm. 
 
IR (KBr, cm-1): 3377, 3018, 2924, 2918, 2907, 2895, 1900, 1661, 1491, 1447, 1435, 1402, 1329, 
1267, 1092, 1045, 982, 887, 812, 747, 692. 
 
High-resolution MS, (C19H20OS) calculated 296.1235, found 296.1235. 
 
 
(3E, 5E)-1-(4-chlorophenyl)-6-phenylhexa-3,5-dien-1-ol (3o, major isomer) and (3Z, 
5E)-1-(4-chlorophenyl)-6-phenylhexa-3,5-dien-1-ol (3o, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 104.2 mg, 0.5 mmol) and 
4-chlorobenzaldehyde (2i, 210.8 mg, 1.5 mmol), afford 3o (104.8 mg, 73% yield, Rf = 0.37; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 9:1). White solid (m.p. 
103.7-104.2 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.37 (d, J = 7.5 Hz, 2 H), 7.33-7.28 (m, 6 H), 
7.23-7.20 (m, 1 H), 6.74 (dd, J = 15.5, 10.5 Hz, 1 H), 6.48 (d, J = 15.5 Hz, 1 H), 6.30 (dd, J = 15.5, 
10.5 Hz, 1 H), 5.74 (dt, J = 15.5, 7.5 Hz, 1 H), 4.74 (t, J = 7.5 Hz, 1 H), 2.60-2.51 (m, 2 H), 2.14 
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1H NMR (500 MHz, CDCl3, minor isomer) δ 7.39 (d, J = 7.5 Hz, 2 H), 7.33-7.28 (m, 6 H), 
7.23-7.20 (m, 1 H), 6.97 (dd, J = 15.5, 10.5 Hz, 1 H), 6.56 (d, J = 15.5 Hz, 1 H), 6.33-6.27 (m, 1 H), 
5.48 (dt, J = 10.5, 7.5 Hz, 1 H), 4.76 (t, J = 7.5 Hz, 1 H), 2.80-2.74 (m, 1 H), 2.69-2.65 (m, 1 H), 
2.14 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 142.42, 137.34, 134.47, 133.34, 131.84, 129.68, 
128.73, 128.71, 128.65, 127.61, 127.33, 126.41, 73.12, 43.04 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 135.45, 133.84, 133.42, 132.26, 127.84, 127.37, 
126.92, 126.60, 123.80, 73.30, 38.00 ppm. 
 
IR (KBr, cm-1): 3373, 3024, 2926, 2905, 2365, 1908, 1591, 1489, 1406, 1323, 1092, 1047, 1013, 
982, 887, 818, 745, 691. 
 
High-resolution MS, (C18H17ClO) calculated 284.0968, found 284.0969. 
 
 
(3E, 5E)-1-(4-fluorophenyl)-6-phenylhexa-3,5-dien-1-ol (3p, major isomer) and (3Z, 
5E)-1-(4-fluorophenyl)-6-phenylhexa-3,5-dien-1-ol (3p, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.7 mg, 0.5 mmol) and 
4-chlorobenzaldehyde (2j, 160 µL, 1.5 mmol), afford 3p (95.9 mg, 71% yield, Rf = 0.33; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 9:1). White solid (m.p. 
99.8-100.5 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.40-7.29 (m, 6 H), 7.21 (t, J = 7.5 Hz, 1 H), 
7.06-7.02 (m, 2 H), 6.74 (dd, J = 15.5, 10.5 Hz, 1 H), 6.49 (d, J = 15.5 Hz, 1 H), 6.30 (dd, J = 15.5, 
10.5 Hz, 1 H), 5.75 (dt, J = 15.5, 7.5 Hz, 1 H), 4.75 (t, J = 7.5 Hz, 1 H), 2.62-2.52 (m, 2 H), 2.06 
(brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.40-7.29 (m, 6 H), 7.23-7.20 (m, 1 H), 7.06-7.02 (m, 
2 H), 6.99 (dd, J = 15.5, 11.0 Hz, 1 H), 6.56 (d, J = 15.5 Hz, 1 H), 6.33-6.28 (m, 1 H), 5.50 (dt, J = 
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13C NMR (126 MHz, CDCl3, major isomer) δ 162.34 (d, J = 246.5 Hz), 139.70 (d, J = 2.8 Hz), 
137.38, 134.38, 131.78, 129.90, 128.74, 127.60, 127.59 (d, J = 7.6 Hz), 126.42, 115.41 (d, J = 21.9 
Hz), 73.21, 43.13 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 162.37 (d, J = 246.5 Hz), 140.09 (d, J = 2.7 Hz), 
133.77, 132.15, 127.84, 127.67, 127.14, 126.61, 123.87, 115.41 (d, J = 21.9 Hz), 73.39, 38.09 ppm. 
 
19F NMR (471 MHz, CDCl3, major isomer) δ -115.04 ppm. 
19F NMR (471 MHz, CDCl3, minor isomer) δ -114.94 ppm. 
 
IR (KBr, cm-1): 3389, 3069, 3018, 2932, 2918, 2901, 2897, 1954, 1894, 1607, 1508, 1447, 1414, 
1225, 1157, 1047, 982, 887, 831, 743, 691. 
 
High-resolution MS, (C18H17FO) calculated 268.1263, found 268.1262. 
 
 
(3E, 5E)-1-(4-cyanophenyl)-6-phenylhexa-3,5-dien-1-ol (3q, major isomer) and (3Z, 
5E)-1-(4-cyanophenyl)-6-phenylhexa-3,5-dien-1-ol (3q, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 106.1 mg, 0.5 mmol) and 
4-formylbenzonitrile (2k, 196.7 mg, 1.5 mmol), afford 3q (75.9 mg, 54% yield, Rf = 0.15; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 10:1). White solid (m.p. 
117.2-118.0 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.63 (d, J = 7.5 Hz, 2 H), 7.47 (d, J = 7.5 Hz, 2 H), 
7.37 (d, J = 7.5 Hz, 2 H), 7.30 (t, J = 7.5 Hz, 2 H), 7.22 (t, J = 7.5 Hz, 1 H), 6.73 (dd, J = 15.5, 10.5 
Hz, 1 H), 6.49 (d, J = 15.5 Hz, 1 H), 6.30 (dd, J = 15.5, 10.5 Hz, 1 H), 5.73 (dt, J = 15.5, 7.5 Hz, 1 
H), 4.83-4.81 (m, 1 H), 2.63-2.49 (m, 2 H), 2.33 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.63 (d, J = 7.5 Hz, 2 H), 7.50 (d, J = 7.5 Hz, 2 H), 
7.38 (d, J = 7.5 Hz, 2 H), 7.32 (t, J = 7.5 Hz, 2 H), 7.22 (t, J = 7.5 Hz, 1 H), 6.94 (dd, J = 15.5, 10.5 
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(m, 1 H), 2.79-2.66 (m, 2 H), 2.33 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 149.27, 137.18, 134.95, 132.36, 132.19, 128.81, 
128.73, 128.37, 127.71, 126.59, 126.42, 118.95, 111.28, 72.92, 43.01 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 149.27, 137.40, 134.18, 132.77, 128.97, 127.95, 
126.71, 126.64, 126.08, 123.48, 111.34, 73.11, 37.96 ppm. 
 
IR (KBr, cm-1): 3474, 3088, 3065, 3024, 2953, 2918, 2895, 2876, 2230, 1607, 1595, 1491, 1310, 
1285, 1080, 1059, 995, 901, 853, 845, 693. 
 
High-resolution MS, (C19H17NO) calculated 275.1310, found 275.1310. 
 
 
(3E, 5E)-1-(4-nitrophenyl)-6-phenylhexa-3,5-dien-1-ol (3r, major isomer) and (3Z, 
5E)-1-(4-nitrophenyl)-6-phenylhexa-3,5-dien-1-ol (3r, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 104.5 mg, 0.5 mmol) and 
4-nitrobenzaldehyde (2l, 226.6 mg, 1.5 mmol), afford 3r (55.9 mg, 37% yield, Rf = 0.20; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 9:1). Yellowish solid 
(m.p. 113.6-114.5 ℃). 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 8.21 (d, J = 7.5 Hz, 2 H), 7.54 (d, J = 7.5 Hz, 2 H), 
7.37 (d, J = 7.5 Hz, 2 H), 7.31 (t, J = 7.5 Hz, 2 H), 7.22 (t, J = 7.5 Hz, 1 H), 6.74 (dd, J = 15.5, 10.5 
Hz, 1 H), 6.50 (d, J = 15.5 Hz, 1 H), 6.31 (dd, J = 15.5, 10.5 Hz, 1 H), 5.74 (dt, J = 15.5, 7.5 Hz, 1 
H), 4.90-4.87 (m, 1 H), 2.66-2.52 (m, 2 H), 2.28 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 8.21 (d, J = 7.5 Hz, 2 H), 7.57 (d, J = 7.5 Hz, 2 H), 
7.37 (d, J = 7.5 Hz, 2 H), 7.31 (t, J = 7.5 Hz, 2 H), 7.22 (t, J = 7.5 Hz, 1 H), 6.93 (dd, J = 15.5, 10.5 
Hz, 1 H), 6.57 (d, J = 15.5 Hz, 1 H), 6.38-6.32 (m, 1 H), 5.49 (dt, J = 10.5, 7.5 Hz, 1 H), 4.93-4.89 
(m, 1 H), 2.81-2.69 (m, 2 H), 2.29 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 151.22, 147.43, 137.17, 135.17, 132.35, 128.76, 
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13C NMR (126 MHz, CDCl3, minor isomer) δ 151.22, 147.43, 134.35, 133.01, 128.99, 128.40, 
128.00, 126.73, 126.61, 125.83, 123.40, 72.97, 38.08 ppm. 
 
IR (KBr, cm-1): 3352, 3076, 3030, 2953, 2935, 2907, 2881, 2876, 2359, 1609, 1597, 1524, 1489, 
1447, 1344, 1312, 1107, 1107, 1051, 986, 854, 750, 694. 
 
High-resolution MS, (C18H17NO3) calculated 295.1208, found 295.1206. 
 
 
(3E, 5E)-1-(1-naphthyl)-6-phenylhexa-3,5-dien-1-ol (3s, major isomer) and (3Z, 
5E)-1-(1-naphthyl)-6-phenylhexa-3,5-dien-1-ol (3s, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.9 mg, 0.5 mmol) and 
1-naphthaldehyde (2m, 205 µL, 1.5 mmol), afford 3s (131.9 mg, 87% yield, Rf = 0.37; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 7:1). Colorless oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 8.10 (d, J = 8.0 Hz, 1 H), 7.89 (d, J = 8.0 Hz, 1 H), 
7.80 (d, J = 8.0 Hz, 1 H), 7.69 (d, J = 8.0 Hz, 1 H), 7.55-7.48 (m, 3 H), 7.38 (d, J = 8.0 Hz, 2 H), 
7.31 (t, J = 8.0 Hz, 2 H), 7.21 (t, J = 8.0 Hz, 1 H), 6.78 (dd, J = 15.5, 10.5 Hz, 1 H), 6.51 (d, J = 
15.5 Hz, 1 H), 6.38 (dd, J = 15.5, 10.5 Hz, 1 H), 5.91 (dt, J = 15.5, 7.5 Hz, 1 H), 5.58-5.56 (m, 1 H), 
2.88-2.83 (m, 1 H), 2.74-2.68 (m, 1 H), 2.16 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 8.15 (d, J = 8.0 Hz, 1 H), 7.89 (d, J = 8.0 Hz, 1 H), 
7.79 (d, J = 8.0 Hz, 1 H), 7.70 (d, J = 8.0 Hz, 1 H), 7.56-7.48 (m, 3 H), 7.38 (d, J = 8.0 Hz, 2 H), 
7.31 (t, J = 8.0 Hz, 2 H), 7.21 (t, J = 8.0 Hz, 1 H), 6.95 (dd, J = 15.5, 10.5 Hz, 1 H), 6.54 (d, J = 
15.5 Hz, 1 H), 6.38-6.31 (m, 1 H), 5.67 (dt, J = 10.5, 8.0 Hz, 1 H), 5.60-5.56 (m, 1 H), 3.01-2.89 (m, 
2 H), 2.18 (brs, 1 H) ppm. 
 
13C NMR (126 MHz, CDCl3, major isomer) δ 139.55, 137.47, 134.07, 133.96, 131.64, 130.71, 
130.39, 129.13, 128.88, 128.73, 128.19, 127.55, 126.42, 126.24, 125.70, 125.61, 123.11, 122.99, 
70.63, 42.10 ppm. 
13C NMR (126 MHz, CDCl3, minor isomer) δ 139.49, 137.42, 133.48, 131.99, 129.20, 129.05, 
128.37, 128.27, 127.87, 127.71, 126.57, 126.28, 124.05, 123.17, 71.04, 37.06 ppm. 
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IR (neat, cm-1): 3408, 3059, 3017, 2930, 2399, 2341, 1597, 1510, 1495, 1448, 1215, 1053, 991, 800, 
756, 692, 667. 
 
High-resolution MS, (C22H20O) calculated 300.1514, found 300.1512. 
 
 
(3E, 5E)-1-(2-furyl)-6-phenylhexa-3,5-dien-1-ol (3t, major isomer) and (3Z, 
5E)-1-(2-furyl)-6-phenylhexa-3,5-dien-1-ol (3t, minor isomer). Following the general procedure 
B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 107.6 mg, 0.5 mmol) and furfural (2n, 125 µL, 
1.5 mmol), afford 3t (41.4 mg, 33% yield, Rf = 0.50; hexane/EtOAc = 4/1 v/v) as a mixture of 
stereoisomers (3E, 5E: 3Z, 5E = >20:1). Yellow oil. 
 
1H NMR (400 MHz, CDCl3, major isomer) δ 7.39-7.36 (m, 3 H), 7.29 (t, J = 7.6 Hz, 2 H), 
7.22-7.18 (m, 1 H), 6.74 (dd, J = 15.6, 10.8 Hz, 1 H), 6.48 (d, J = 15.6 Hz, 1 H), 6.36-6.26 (m, 3 H), 
5.78 (dt, J = 15.6, 7.6 Hz, 1 H), 4.77 (t, J = 7.6 Hz, 1 H), 2.77-2.66 (m, 2 H), 2.15 (brs, 1 H) ppm. 
1H NMR (400 MHz, CDCl3, minor isomer) δ 7.43-7.36 (m, 3 H), 7.29 (t, J = 7.6 Hz, 2 H), 
7.22-7.18 (m, 1 H), 7.06 (dd, J = 15.6, 10.8 Hz, 1 H), 6.56 (d, J = 15.6 Hz, 1 H), 6.36-6.26 (m, 3 H), 
5.51 (dt, J = 10.8, 7.6 Hz, 1 H), 4.81-4.77 (m, 1 H), 2.89-2.85 (m, 2 H), 2.15 (brs, 1 H) ppm. 
 
13C NMR (101 MHz, CDCl3, major isomer) δ 156.15, 142.16, 137.43, 134.23, 131.64, 129.52, 
128.83, 128.71, 127.53, 126.40, 110.32, 106.32, 67.41, 39.30 ppm. 
13C NMR (101 MHz, CDCl3, minor isomer) δ 156.06, 142.21, 133.65, 131.99, 128.36, 127.77, 
126.74, 126.61, 123.95, 110.32, 106.44, 67.55, 34.42 ppm. 
 
IR (neat, cm-1): 3369, 3024, 2953, 2926, 2876, 2855, 2365, 2336, 1948, 1871, 1595, 1495, 1447, 
1294, 1265, 1223, 1148, 1013, 989, 743, 692. 
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(3E, 5E)-1-(benzo[b]thiophen-3-yl)-6-phenylhexa-3,5-dien-1-ol (3u, major isomer) and (3Z, 
5E)-1-(benzo[b]thiophen-3-yl)-6-phenylhexa-3,5-dien-1-ol (3u, minor isomer). Following the 
general procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 104.8 mg, 0.5 mmol) and 
benzo[b]thiophene-3-carboxaldehyde (2o, 243.3 mg, 1.5 mmol), afford 3u (122.9 mg, 79% yield, Rf 
= 0.40; hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (3E, 5E: 3Z, 5E = 12:1). Yellow oil. 
 
1H NMR (500 MHz, CDCl3, major isomer) δ 7.86-7.83 (m, 2 H), 7.39-7.17 (m, 8 H), 6.73 (dd, J = 
15.6, 10.4 Hz, 1 H), 6.46 (d, J = 15.6 Hz, 1 H), 6.32 (dd, J = 15.6, 10.4 Hz, 1 H), 5.82 (dt, J = 15.6, 
7.2 Hz, 1 H), 5.12-5.09 (m, 1 H), 2.82-2.66 (m, 2 H), 2.31 (brs, 1 H) ppm. 
1H NMR (500 MHz, CDCl3, minor isomer) δ 7.91-7.83 (m, 2 H), 7.39-7.17 (m, 8 H), 6.90 (dd, J = 
15.6, 10.8 Hz, 1 H), 6.51 (d, J = 15.6 Hz, 1 H), 6.35-6.29 (m, 1 H), 5.57 (dt, J = 10.8, 7.6 Hz, 1 H), 
5.15-5.09 (m, 1 H), 2.97-2.85 (m, 2 H), 2.31 (brs, 1 H) ppm. 
 
13C NMR (101 MHz, CDCl3, major isomer) δ 141.08, 138.94, 137.39, 137.28, 134.18, 131.66, 
130.12, 128.78, 128.71, 127.54, 126.39, 124.56, 124.19, 123.09, 122.43, 122.32, 69.40, 40.99 ppm. 
13C NMR (101 MHz, CDCl3, minor isomer) δ 141.10, 138.79, 137.34, 137.31, 133.56, 132.09, 
127.71, 126.55, 124.23, 123.90, 123.17, 122.67, 69.69, 35.93 ppm. 
 
IR (neat, cm-1): 3383, 3059, 3022, 2959, 2924, 2876, 2856, 2399, 2365, 1944, 1871, 1595, 1524, 
1495, 1427, 1256, 1217, 1059, 1026, 989, 735, 692, 667. 
 
High-resolution MS, (C20H18OS) calculated 306.1078, found 306.1077. 
 
 
(5E, 7E)-1,8-diphenylocta-5,7-dien-3-ol (3v). Following the general procedure B using 
2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.1 mg, 0.5 mmol) and benzenepropanal (2p, 200 µL, 
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1H NMR (500 MHz, CDCl3) δ 7.39-7.37 (m, 2 H), 7.32-7.27 (m, 4 H), 7.23-7.17 (m, 4 H), 6.76 (dd, 
J = 15.5, 10.5 Hz, 1 H), 6.49 (d, J = 15.5 Hz, 1 H), 6.30 (dd, J = 15.5, 10.5 Hz, 1 H), 5.81 (dt, J = 
15.5, 7.5 Hz, 1 H), 3.74-3.69 (m, 1 H), 2.85-2.80 (m, 1 H), 2.73-2.67 (m, 1 H), 2.43-2.38 (m, 1 H), 
2.32-2.26 (m, 1 H), 1.87-1.76 (m, 2 H), 1.60 (brs, 1 H) ppm. 
 
13C NMR (101 MHz, CDCl3) δ 142.14, 137.46, 134.10, 131.48, 130.56, 128.86, 128.74, 128.60, 
128.57, 127.55, 126.40, 126.01, 77.16, 70.60, 41.28, 38.69, 32.22 ppm. 
 
IR (neat, cm-1): 3423, 3088, 3065, 3024, 2930, 2858, 2359, 2341, 1944, 1867, 1603, 1495, 1452, 
1333, 1261, 1217, 1136, 1047, 1030, 989, 700, 667. 
 
High-resolution MS, (C20H22O) calculated 278.1671, found 278.1671. 
 
 
(5E, 7E)-8-phenylocta-5,7-dien-3-ol (3w). Following the general procedure B using 
2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.1 mg, 0.5 mmol) and propanal (2q, 110 µL, 1.5 
mmol), afford 3w (75.7 mg, 75% yield, Rf = 0.33; hexane/EtOAc = 4/1 v/v). Colorless oil. 
 
1H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 7.5 Hz, 2 H), 7.30 (t, J = 7.5 Hz, 2 H), 7.21 (t, J = 7.5 
Hz, 1 H), 6.77 (dd, J = 15.5, 10.5 Hz, 1 H), 6.48 (d, J = 15.5 Hz, 1 H), 6.30 (dd, J = 15.5, 10.5 Hz, 1 
H), 5.83 (dt, J = 15.5, 7.5 Hz, 1 H), 3.64-3.59 (m, 1 H), 2.41-2.36 (m, 1 H), 2.28-2.21 (m, 1 H), 
1.65 (brs, 1 H), 1.58-1.46 (m, 2 H), 0.97 (t, J = 7.5 Hz, 3 H) ppm. 
 
13C NMR (126 MHz, CDCl3) δ 137.51, 133.82, 131.27, 130.98, 128.96, 128.72, 127.48, 126.37, 
72.70, 40.60, 29.80, 10.09 ppm. 
 
IR (neat, cm-1): 3435, 3059, 3018, 2966, 2934, 2878, 2399, 1950, 1595, 1495, 1462, 1217, 1113, 
1072, 989, 758, 692, 667. 
 
High-resolution MS, (C14H18O) calculated 202.1358, found 202.1358. 
OH3w
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(5E, 7E)-2,2-dimethyl-8-phenylocta-5,7-dien-3-ol (3x, major isomer) and (5Z, 
7E)-2,2-dimethyl-8-phenylocta-5,7-dien-3-ol (3x, minor isomer). Following the general 
procedure B using 2-benzyl-3-hydroxypent-4-enoic acid (1a, 103.7 mg, 0.5 mmol) and 
2,2-dimethyl-propanal (2r, 170 µL, 1.5 mmol), afford 3x (78.1 mg, 67% yield, Rf = 0.60; 
hexane/EtOAc = 4/1 v/v) as a mixture of stereoisomers (5E, 7E: 5Z, 7E = >20:1). Colorless oil. 
 
1H NMR (400 MHz, CDCl3, major isomer) δ 7.38 (d, J = 7.2 Hz, 2 H), 7.30 (t, J = 7.2 Hz, 2 H), 
7.19 (t, J = 7.2 Hz, 1 H), 6.77 (dd, J = 15.6, 10.8 Hz, 1 H), 6.48 (d, J = 15.6 Hz, 1 H), 6.31 (dd, J = 
15.6, 10.8 Hz, 1 H), 5.86 (dt, J = 15.6, 7.2 Hz, 1 H), 3.31-3.29 (m, 1 H), 2.44-2.41 (m, 1 H), 
2.13-2.05 (m, 1 H), 1.61 (brs, 1 H), 0.94 (s, 9 H) ppm. 
1H NMR (400 MHz, CDCl3, minor isomer) δ 7.41 (d, J = 7.2 Hz, 2 H), 7.30 (t, J = 7.2 Hz, 2 H), 
7.19 (t, J = 7.2 Hz, 1 H), 7.04 (dd, J = 15.6, 10.8 Hz, 1 H), 6.57 (d, J = 15.6 Hz, 1 H), 6.36-6.31 (m, 
1 H), 5.62 (dt, J = 10.8, 8.0 Hz, 1 H), 3.33-3.29 (m, 1 H), 2.50-2.32 (m, 2 H), 1.61 (brs, 1 H), 0.98 
(s, 9 H) ppm. 
 
13C NMR (101 MHz, CDCl3, major isomer) δ 137.56, 133.54, 132.73, 131.13, 129.00, 128.72, 
127.46, 126.38, 78.93, 35.71, 34.92, 25.89 ppm. 
13C NMR (101 MHz, CDCl3, minor isomer) δ 133.28, 129.05, 128.74, 128.40, 127.70, 126.57, 
124.11, 79.44, 35.71, 30.71, 25.93 ppm. 
 
IR (neat, cm-1): 3429, 3024, 2955, 2907, 2868, 2365, 2336, 1944, 1641, 1597, 1495, 1479, 1448, 
1364, 1290, 1238, 1177, 1070, 988, 743, 691. 
 
High-resolution MS, (C16H22O) calculated 230.1671, found 230.1671. 
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1H NMR (500 MHz, CDCl3) δ 7.40-7.17 (m, 10 H), 6.99 (dd, J = 15.5, 11.0 Hz, 1 H), 6.58 (d, J = 
15.5 Hz, 1 H), 6.44 (d, J = 11.0 Hz, 1 H), 5.14 (s, 1 H), 2.38 (brs, 1 H), 1.69 (s, 3 H) ppm. 
 
13C NMR (126 MHz, CDCl3) δ 142.09, 140.06, 137.66, 132.87, 128.68, 128.44, 127.62, 127.50, 
126.52, 126.40, 125.78, 124.79, 78.98, 13.20 ppm.  
 
IR (neat, cm-1): 3441, 3065, 3018, 2982, 2959, 2930, 2858, 2359, 2336, 1597, 1491, 1447, 1373, 
1250, 1217, 1105, 1074, 1045, 964, 908, 700, 667. 
 
High-resolution MS, (C18H18O) calculated 250.1358, found 250.1358. 
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